sP (EO-stat-PO) - glycosaminoglycans (GAGs) hybrid-hydrogels for medical applications by Dhanasingh, Anandhan
  
 
 
 
 
 
 
 
 
 
sP (EO-stat-PO) - Glycosaminoglycans 
(GAGs) Hybrid-Hydrogels for Medical 
Applications 
 
 
 
 
 
Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der 
RWTH Aachen University zur Erlangung des akademischen Grades eines 
Doktors der Naturwissenschaften genehmigte Dissertation 
 
 
vorgelegt von 
 
 
  Anandhan Dhanasingh, B.E., M.Sc., 
 
aus Chennai, Indien 
 
 
 
 
Berichter: Univ.Prof. Dr. Martin Möller 
 Prof. Dr. Jürgen Groll 
 
 
Tag der mündlichen Prüfung: 01.12.2011 
 
 
 
 
 
 
 
Diese Dissertation ist auf den Internetseiten der Hochschulbibliothek online verfügbar. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
-ஔவையார் 
 
What has learnt is a handful, and what has still to acquire is wide as the world                                                                                                                                 
 
- Auvaiyar  
                                                                                                          (Before 9
th
 century, India) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table of Contents 
 
 
Table of Contents 
Acknowledgement...................................................................................................... ii 
Summary..................................................................................................................... iv 
List of abbreviations................................................................................................... vii 
 
1.   Introduction 
  1.1   Hydrogels as DDS and TE Scaffolds................................................................. 
  1.2   Description of this thesis.................................................................................... 
  1.3   References.......................................................................................................... 
 
2.   Literature Overview 
   2.1    Hydrogel........................................................................................................... 
     2.1.1   Introduction.................................................................................................. 
     2.1.2   Classification of hydrogels........................................................................... 
     2.1.3   Properties of hydrogels................................................................................. 
     2.1.4   Classification of water in hydrogels............................................................. 
     2.1.5   Common applications of hydrogels.............................................................. 
     2.1.6   Summary of the important physico-chemical parameters and properties                      
                of hydrogels in general................................................................................. 
 
2.2  Hydrogels as biomedical materials 
2.2.1 Introduction................................................................................................ 
2.2.2 Hydrogels in drug delivery system............................................................. 
2.2.3 Hydrogels as tissue engineering scaffolds.................................................. 
 
2.3  Extra-cellular matrix (ECM) 
2.3.1 Introduction................................................................................................ 
2.3.2 Classes of ECM.......................................................................................... 
2.3.3 Component of CM...................................................................................... 
 
2.4  GAGs and their importance in connective tissue/ECM 
2.4.1 Introduction................................................................................................ 
2.4.2 Classification of GAGs............................................................................... 
2.4.3 Properties of GAGs.................................................................................... 
2.4.4 Proteoglycans.............................................................................................. 
2.4.5 Hyaluronan................................................................................................. 
 
2.5 References......................................................................................................... 
 
3 NCO-sP(EO-stat-PO) as cross-linker to HA 
3.1  Introduction......................................................................................................           
3.2  Materials........................................................................................................... 
3.3  Hydrogels preparation...................................................................................... 
3.4  Contact angle measurements............................................................................ 
3.5  Equilibrium water content measurements........................................................ 
3.6  Differential scanning calorimetry..................................................................... 
3.7  FT-IR spectroscopy.......................................................................................... 
3.8  Cryo-FESEM.................................................................................................... 
3.9  Rheological analysis......................................................................................... 
3.10  In-vitro stability test in PBS............................................................................. 
 
 
1 
3 
4 
 
 
5 
5 
5 
8 
11 
12 
 
13 
 
 
14 
15 
19 
 
 
22 
23 
23 
 
 
24 
24 
25 
26 
27 
 
38 
 
 
43
44 
44 
45 
45 
46 
46 
46 
46 
47 
Table of Contents 
 
 
3.11  Enzymatic degradation.................................................................................... 
3.12  Statistical nalysis.............................................................................................. 
3.13  Results and discussions.................................................................................... 
3.14  Conclusion........................................................................................................ 
3.15  References........................................................................................................ 
 
4 Comparison of sP(EO-stat-PO) with isocyanate and acrylate end groups 
as respective cross-linker for unmodified and thiol modified  
Hyaluronic acid 
4.1  Introduction...................................................................................................... 
4.2  Materials........................................................................................................... 
4.3  Hydrogel preparation........................................................................................ 
4.4  Contact angle measurements............................................................................ 
4.5  Equilibrium water content measurements........................................................ 
4.6  Differential scanning calorimetry..................................................................... 
4.7  FT-IR spectroscopy.......................................................................................... 
4.8  RAMAN spectroscopy..................................................................................... 
4.9  Cryo-FESEM.................................................................................................... 
4.10  Rheological analysis......................................................................................... 
4.11  In-vitro stability in PBS.................................................................................... 
4.12  Enzymatic degradation..................................................................................... 
4.13  Statistical nalysis.............................................................................................. 
4.14  Results and discussion...................................................................................... 
4.15  Conclusion........................................................................................................ 
4.16  References........................................................................................................ 
 
5 NCO-sP(EO-stat-PO) as universal cross-linker to GAGs 
5.1    Introduction...................................................................................................... 
5.2    Materials........................................................................................................... 
5.3    Hydrogel preparation........................................................................................ 
5.4    Contact angle measurements............................................................................ 
5.5    Equilibrium water content measurements......................................................... 
5.6    FT-IR spectroscopy........................................................................................... 
5.7    Cryo-FESEM.................................................................................................... 
5.8    Rheological analysis......................................................................................... 
5.9    In-vitro stability test in PBS............................................................................. 
5.10  Results and discussions.................................................................................... 
5.11  Conclusion........................................................................................................ 
5.12  References........................................................................................................ 
 
6 PEG based hydrogels in drug delivery system 
6.1    Introduction...................................................................................................... 
6.2    Materials........................................................................................................... 
6.3    Hydrogel preparation together with drug encapsulation.................................. 
6.4    Drug release by diffusion controlled mechanism............................................. 
6.5    Equilibrium water content measurement of hydrogels without the model 
drug................................................................................................................... 
6.6    In-vitro drug release system............................................................................. 
6.7    Results and discussions..................................................................................... 
6.8    Conclusion........................................................................................................ 
6.9    References......................................................................................................... 
47 
47 
48 
58 
60 
 
 
 
 
62 
63 
63 
64 
64 
65 
65 
65 
65 
65 
66 
66 
66 
67 
77 
78 
 
 
81 
82 
82 
83 
83 
83 
83 
84 
84 
84 
90 
91 
 
 
92 
93 
93 
95 
 
95 
95 
96 
101 
102 
Table of Contents 
 
 
7 Poly-saccharide based covalently linked multi-membrane hydrogels 
7.1     Introduction..................................................................................................... 
7.2     Materials.......................................................................................................... 
7.3     Single layered bulk hydrogel preparation........................................................ 
7.4     Preparation of multi-membrane hydrogels….................................................. 
7.5     Drug loading procedure……………............................................................... 
7.6     Rheological analysis of the hydrogels...…...................................................... 
7.7     Drug release study………………………………………............................... 
7.8     Results and discussions……………………………....................................... 
7.9     Conclusion and outlook…............................................................................... 
7.10   References....................................................................................................... 
 
8 Hydrogels as Cell-Scaffold 
8.1     Introduction..................................................................................................... 
8.2     Materials.......................................................................................................... 
8.3     Cell culture....................................................................................................... 
8.4     Hydrogel preparation-Cell encapsulation........................................................ 
8.5     Cell culture on PEG electrospun fibres-encapsulated in hydrogel.................. 
8.6     Viability staining.............................................................................................. 
8.7     Immunological staining................................................................................... 
8.8     Optical and fluorescence microscopy.............................................................. 
8.9     Results and discussions.................................................................................... 
8.10   Conclusion....................................................................................................... 
8.11   References....................................................................................................... 
 
Appendix 
   A1     Preparation of hydrogels (free form hydrogels).............................................. 
   A1a   Hydrogels in constricted environment............................................................. 
   A2     Swelling experiments of hydrogels................................................................. 
   A3     Sample preparation for FT-IR and RAMAN spectroscopy............................. 
   A4     Contact angle measurement by goniometer..................................................... 
   A5     Differential scanning calorimetry.................................................................... 
   A6     Cryo-FESEM................................................................................................... 
   A7     Rheological analysis........................................................................................ 
   A8     Stability test in PBS......................................................................................... 
   A9     Enzymatic degradation study........................................................................... 
   A10   Quantification of drug deliverd by UV-spectrophotometer............................. 
   A11   Flory-Rehner calculation................................................................................. 
   A12   Diffusion co-efficient calculation.................................................................... 
 
Curriculum Vitae 
 
103 
104 
104 
105 
105 
106 
106 
106 
113 
114 
 
 
115 
116 
117 
117 
117 
118 
118 
118 
118 
120 
122 
 
 
x 
xi 
xi 
xii 
xii 
xii 
xiii 
xiii 
xiv 
xiv 
xiv 
xv 
xvii 
 
xix 
 
 
 
 
 
 
 
Acknowledgement 
i 
 
 
Acknowledgement 
    
  The success of a Ph.D thesis depends not only on the performance of the student but 
also on the relationship between the student and his supervisor. In the worst case it is a 
nightmare that both the student and the supervisor want to get over with. In my case, I was 
very fortunate to have Prof. Dr. Jürgen Groll as my supervisor who became my friend and 
moral advisor in the last three years. With my knowledge in the field of mechanical and 
biomedical engineering, it was really difficult for me to get the chemistry behind my Ph.D 
thesis and it was Prof. Dr. Jürgen Groll who took much pain and never fed up in teaching me 
the basics of chemistry. It is indeed not enough to simply thank him for giving me such an 
interesting topic, for all of his help and financial support.  
 
   I thank Prof. Dr. Martin Möller for giving me the permission to use all the facilities 
of DWI e.V and Institute of technical and macromolecular chemistry of Aachen University of 
Technology (RWTH) in performing all the practical part of my thesis work from May 2006 to 
August 2009 and for extending the financial support in the form of stipend that helped me to 
do part-time job at the weekends. 
 
  My special thanks to Prof. Dr.Doris Klee who welcomed me in her research group to 
make my master thesis that ultimately showed me the way to my PhD. Thanks to Dr. Jochen 
Salber, project leader in Prof. Dr. Doris Klee’s group, for their supervision in a project that 
was done in co-operation with Uni-klinik Aachen and for their worthy ideas and timely 
encouragement. 
 
  I am grateful to Dipl. Chem. Haika Hildebrandt and Mrs. Michaela Meuthrath for the 
synthesis of Isocyanate starPEG. FTIR and RAMAN spectroscopy would not have been 
possible without the help of Dr. Walter Tillmann and I thank him. My thanks further goes to 
Mr. Stefan Rütten and Mrs. Claudia Formen for their assistance in FESEM and UV-
spectrophotometry respectively. 
 
  My sincere gratitude to Dipl.Biotech. Vera Schulte for the cell experiments on my 
hydrogels. I would like to thank Dr. Arthur Henke for performing some of the dynamic light 
Acknowledgement 
ii 
 
scattering experiments, although those results were not included in this thesis and also for his 
discussions in the statistical analysis of my results. 
 
  I thank Prof. Dr. Crisan Popescu and Dipl. Ing. Daniel Istrate for their support in 
performing the thermal analysis of my hydrogels. I further thank Dipl. Ing. Dora Alves for her 
introduction to rheometer. 
  I would like to extend my thanks to all the members of Prof. Dr .Juergen Groll’s group 
especially to Mrs. Konstantina Dyankova and Mrs. Smriti Singh for their moral support. 
 
  Finally I would like to thank my parents for initiating me to do Ph.D and my wife for 
her deep cooperation when I had to spend long hours in the lab and during the weekends of 
my part-time job and I dedicate this work to them. 
 
 
 
 
 
 
 
 
A timely benefit, -though thing of little worth,  
the gift itself, -in excellence transcends the earth. 
 
                                                                -- Thiruvalluvar 
                                                                                                          (Before 9
th
 century, India) 
 
 
 
 
 
 
 
 
Summary 
iii 
 
Summary 
 
The primary focus of this work is to develop a highly stable hydrogel system as a 
depot for drug delivery and as material for tissue engineering scaffolds. Two separate cross-
linkers namely six arm star shaped (EO-stat-PO) prepolymers with isocyanate endgroups 
[NCO-sP(EO-stat-PO)] and six arm star shaped (EO-stat-PO) prepolymers with acrylate 
endgroups [Acr-sP(EO-stat-PO)] were prepared to gel unmodified and thiol-modified bio-
polysaccharides respectively. In particular we discuss three types of hydrogel systems for the 
above mentioned bio-applications namely, hydrogels formed by gelation of NCO-sP(EO-stat-
PO) only, i.e., the hydrogel system-1, hydrogel formed by addition of hyaluronic acid to 
NCO-sP(EO-stat-PO), i.e. the hydrogel system-2 and hydrogel formed by addition of thiol-
modified hyaluronic acid to Acr-sP(EO-stat-PO), i.e. the hydrogel system-3. 
 
 Different than hydrophobic particles or layers, hydrogels are open to water. Water 
molecules can diffuse in and out and thus extract a drug, that has been loaded to the hydrogel 
rather unrestricted. In systemic application, the organism does not easily recognize hydrogel 
particles as foreign and circulation times are rather long. Thus hydrogel particles can 
overcome delivery barriers such as early uptake in the liver. Hydrophobic drugs can be loaded 
to hydrogels within hydrophobic pockets, while hydrophilic drugs usually have to be bound 
covalently and released by bond splitting to prevent premature drug release. In order to ensure 
that the hydrogels cannot be harmful, degradability is essential. In the systems observed here, 
degradation will yield fragments not larger than the prepolymers, whose molecular weight 
was chosen to allow excretion via the renal system. For the application as scaffold for cell 
culture and tissue engineering, the hydrogels have the advantage that they interact little with 
the cells but can be equipped with biological components such as peptides to mimic the 
natural extracellular matrix (ECM). Biocompatibility, drug-release, but also mechanical 
strength of hydrogels are controlled by their degree of swelling, that depends on the chemical 
nature and the degree of cross-linking. 
 
 Water content and the size of the pores increases with a decrease in cross-linking 
density and it is the other way around with the increase in the cross-linking density. As the 
network is formed from the hexafunctional sP(EO-stat-PO) as a cross-linker and hyaluronic 
acid as a linear polysaccharide, the degree of cross-linking depends on the relative 
concentration of the two components. We also studied the effect of different molecular weight 
Summary 
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of the unmodified hyaluronic acid. Higher molecular weight (longer chains) HA yielded gels 
with a higher water content, bigger pore size and lower mechanical strength than the lower 
molecular weight (shorter chains). Within the time of the experiment, i.e. up to several weeks, 
the hydrogel system-1 showed no degradation. The equilibrium degree of swelling and 
internal micro-porous structures are inversely proportional to the concentration of NCO-
sP(EO-stat-PO) of the gelling solution. The hydrogel system-2 showed slow degradation and 
the equilibrium degree of swelling and internal micro-porous structures could be varied by the 
relative concentrations of the two components. The hydrogel system-3, which is also semi-
synthetic, showed complete degradation. Here cross-links are formed by Michael-type 
addition of thiols to acrylates, but degradation occurs via hydrolysis of the acrylate ester 
groups. 
 
 Testing these hydrogels as drug carrying and delivering vehicles showed for a 
hydrophilic drug, i.e. Dexamethasone 21 phosphate disodium salt, a quick and complete 
release by a diffusion controlled mechanism. Actually 90% of the drug is released within 8 
hours (swelling controlled burst release) followed by a slow release of the rest of the drug by 
a diffusion controlled mechanism. It was shown that the release can be retarded by 
encapsulating the hydrogel by a silicone tube with one end closed and the other end open for 
the controlled release of the drug. 
 
 In order to use these hydrogels as cell scaffolds, the primary requirement apart from 
high water content and high porous structures is the incorporation of cell attachment sites. 
This can be achieved by linking RGD peptides to our hydrogel system. It is a particular 
advantage of using NCO-sP(EO-stat-PO) as cross-linker system that the isocyanates can react 
not only with the hydroxyl groups of the polysaccharides but also with the amine functional 
groups of the peptide sequence. Thus co-addition of the peptides enables biofunctionalisation 
in the cross-linking step. Cyto-compatibility tests showed that the bio-functionalised and non-
bio-functionalised cross-linked hydrogels were non-toxic provided complete conversion of the 
NCO-groups. The cell experiments using mouse fibroblast L929 showed clearly the cells 
adhering on to the RGD decorated sites of the hydrogel coated surfaces. When we added the 
cells to the hydrogel precursor prior to complete conversion the NCO-sP(EO-stat-PO) based 
hydrogel systems were toxic to cells. In contrast, the Acrylate sP(EO-stat-PO) based hydrogel 
system were non-toxic to cells irrespective of the full conversion of the acrylate groups. 
Hence, the hydrogel system-1 and 2 cannot be used as cell encapsulation matrix but the cross-
Summary 
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linked material can be employed, for example as a plaster to open wounds. Such a wound 
dressing has the advantage to promote healing by keeping the wound wet while it does not 
stick to the wound and can be removed without the risk of a new trauma. The hydrogel 
system-3 can be used as both cell scaffolds and as wound heal dressing. 
 
 Core shell hydrogel particles and multi-layer hydrogel coatings have been prepared in 
an attempt to enable sequential drug release. It has been possible to combine hydrogels of 
different composition, cross-linking and with different drug loadings. In the case of acrylate-
thiol gels, different drugs can be incorporated in order to prepare scaffolds with multiple types 
of seed cells even in a locally controlled manner. In tissue engineering, this is particular 
important for the structuring of the regenerated tissue. 
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1. Introduction 
 
1.1 Hydrogels as Drug Delivery System and as Tissue Engineering 
Scaffolds 
The success in the field of tissue engineering and drug delivery system relies on the 
advancement made in the fabrication of scaffold, an artificial 3D environment for the cells to 
feel like home and as drug carrier and releasing system. Apart from providing space for the 
cells, an ideal scaffold for tissue engineering should have exact mechanical properties and 
macro-molecular composition as that of the cells native environment (ECM) [1]. ECM is a 
mixture of GAGs and fibrous proteins [2]. One of the important properties of GAGs in ECM 
is to maintain the water content while the fibrous proteins maintain the tensile strength of the 
ECM matrices [3]. As scaffold for drug delivery system made of GAGs would be nice as most 
of the parts of human body contain GAGs and it would not end up with any unwanted 
biological reactions. 
 
α-hydroxy esters such as poly (glycolic acids) (PGA), poly (lactic acid) (PLA) and 
their copolymers are widely used in the biomedical applications because of their biological 
friendly and biodegradable properties [4]. Scaffolds made from these materials offers high 
compressive strength which can be applied for making hard tissue formation for instance, 
bone. Several fabrication techniques for the fabrication of scaffolds from these polymers, 
includes salt leaching method [5], gas foaming method [6], electro-spinning [7] and so on. 
However these scaffolds cannot provide highly moisturous environment, which is the pre-
requisite property of a native ECM and does not swell for the release of drugs. 
 
Hydrogels, a class of biomedical materials, has its applications in a wide variety of 
fields starting from food additives, to pharmaceuticals, to biomedical implants, to tissue 
engineering scaffolds as a result of several scientific innovations by researchers for years 
since the break through in 1954 by Wichterle and Lim on cross-linked HEMA hydrogels [8]. 
Hydrogels has several nice physical properties like maintaining high water content, pores or 
space in which cells and drugs can house itself and mild mechanical properties like that of the 
native ECM. In-order to make these hydrogels to function biologically similar to native ECM, 
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hydrogels itself can be prepared from the GAGs decorated with peptide containing RGD 
sequence, that mimics the natural environment of the cells [9]. 
Hyaluronic acid (HA) is the most abundant form of GAGs and it is present in almost 
all the tissues [10]. HA is highly hygroscopic molecule that absorbs almost thousand times its 
own dry weight [11]. Since it is highly soluble in water, there are several modification 
methods available that uses different cross-linkers by which it is possible to increase the 
stability of this macromolecule. Some of the methods are too time consuming while most of 
the methods were done in non-physiological conditions [12]. In-order to make an easy and 
straight forward method of modifying HA to prepare hydrogels out of it, we employ a special 
cross-linker, Isocyanate terminated six arm star shaped poly ethylene glycol [NCO-sP(EO-
stat-PO)] which reacts with the hydroxyl group of HA forming stable urethane bonds. Also 
we studied the possibilities of Acrylate terminated six arm star shaped poly ethylene glycol 
[ACR-sP(EO-stat-PO)] as cross-linker to thiol-modified polysaccharides, in which acrylates 
adds to thiols by Michael-Addition reaction type. The speciality of our new cross-linkers is 
that they are highly soluble in water even at higher concentrations and at physiological 
conditions. Since Isocyanates can react with hydroxyl and primary amines, our cross-linker 
can be used to prepare hydrogel from all the GAGs and also attach the peptide sequences 
(biofunctionalisation) to the matrices in a single step.  
 
The hydrogels prepared using this new cross-linker can be employed as tissue 
engineering scaffolds, drug delivery system, surface coatings to avoid bacterial adhesion and 
unspecific protein adsorption. 
 
This thesis work focuses mainly on the preparation of hydrogels from all the 
unmodified GAGs using NCO-sP(EO-stat-PO) as the universal cross-linker, and ACR-
sP(EO-stat-PO) as specific cross-linker to thiol-modified polysaccharides, followed by its 
application as drug carrying-delivery vehicle and as tissue engineering scaffolds. A special 
form of hydrogel called multi-membrane hydrogel is also focussed in this thesis, which is 
meant to create tissues with different cell types that can be arranged in any sequence as per 
our wish. Also this multi-membrane hydrogels can be utilised in drug delivering system with 
a sequential release of different drugs that are loaded in the different layers of the multi-
membrane system. 
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 1.2 Description of this thesis 
 
Chapter-2 covers the literature overview of hydrogels, its application as biomedical materials 
in the field of tissue engineering scaffolds and drug delivering system followed by extra-
cellular matrix and its components. 
 
Chapter-3 introduces NCO-sP(EO-stat-PO) as a new cross-linker to HA in the formation of 
hydrogels. Here, the effect of molecular weight of HA on the hydrogel properties were 
studied. 
 
Chapter-4 describes the hydrogel formation from thiol-modified HA using acrylate 
terminated six armed star shaped PEG (ACR-sP(EO-stat-PO)) as cross-linker. 
 
Chapter-5 shows the ability of NCO-sP(EO-stat-PO) as an universal cross-liker in forming 
hydrogels from several other polysaccharides from GAGs in addition to HA having hydroxyl 
groups. 
 
Chapter-6 deals with the drug delivery system using hydrogels from the chapter 3 and 4 as 
the drug carrying vehicle. 
 
Chapter-7 exhibits a new form of multi-membrane hydrogels describing its fabrication 
techniques and its future applications as sequential tissue forming scaffolds and sequential 
drug delivering vehicle. 
 
Chapter-8 is all about the biofunctionalisation, followed by the introduction of cells in the 
hydrogel matrices as tissue engineering scaffolds. 
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2. Literature Overview 
 
2.1 Hydrogel 
 
2.1.1 Introduction 
Certain materials, when placed in excess water, are able to swell rapidly and retain 
large volumes of water in their swollen structures. These materials do not dissolve in water 
and maintain three-dimensional networks. Such aqueous gel networks are called hydrogel 
(also called aquagels). In the word Hydrogel, GEL is (derived from a Latin word Gelatus, 
meaning frozen, immobile) is a colloidal system in which a porous network of interconnected 
polymer chains covers the volume of the liquid medium [1]. In simple terms, a gel is a liquid 
system that acts like a solid. Hydrogel is a network of hydrophilic polymer chains that are 
water-insoluble, which may absorb up to thousands of times their dry weight in water. 
Hydrogels has its applications in a wide variety of fields starting from food additives, to 
pharmaceuticals to biomedical implants to tissue engineering scaffolds as a result of research 
done by scientists for years since the break through in 1954 in Wichterle’s and Lim’s work on 
cross-linked HEMA hydrogels [2]. 
 
2.1.2 Classification of Hydrogels 
Gel formation through physical, molecular, or chemical association results in an 
infinite molecular weight for the system. The stability of hydrogel in water is determined by 
the nature of the links that hold the hydrophilic polymer chains together [3]. When the 
networks of polymer chains are held by chain entanglements (highly concentrated polymer 
solution) or by secondary forces including ionic, H-bonding or hydrophobic forces, self 
assembly systems then it is called physical or reversible hydrogels [4]. Physical gels are 
considered to be in-homogeneous as a result of molecular entanglements, or hydrophobically 
or ionically-associated domains. Free dangling chain ends or chain loops also represents one 
of the defects in physical hydrogels.  
 
A class of hydrogel called permanent or chemical gel or irreversible gels, when the 
polymer chains in the networks are connected by means of chemical covalent bonds. This 
type of hydrogel is highly stable in water and the stability depends on the type of polymers 
used. Synthetic polymers linked by covalent bonds are theoretically non-degradable (Fig. 1). 
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A combination of synthetic and natural polymers may results in semi-degradable form, where 
in the synthetic part and the part of natural polymers that in direct connection with the 
synthetic polymers will not degrade leaving the natural polymer part to hydrolyse in water [5]. 
 
 
 
Fig.1 Schematic representation of the formation of physical and chemical hydrogel. (Scheme 
redrawn from Ref: 3) 
 
The macromolecular structures of the physical and chemical hydrogels vary depending 
on the type of polymers used. When the hydrogel networks contain only one type of 
hydrophilic polymers then it is called homo-polymer hydrogel.  
 
 
Fig. 2 Schematic representation of the composition and alignment of hydrogel components. 
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When it contains two types of polymers, with at least one hydrophilic polymer then it 
is called copolymer hydrogel. Multi-polymer hydrogel is the result of networks containing 
more than three types of polymers (Fig. 2). Interpenetrating polymer hydrogel is a class of 
hydrogels prepared by swelling a network of polymer-A in polymer-B solution making an 
inter-penetrating network (IPN) of polymer A and B [3]. 
 
 
 
Fig. 3 Schematic representation of the formation of ionic hydrogels.  
(Scheme taken from Ref: 3) 
 
Based on the charges of the polymers in the hydrogel networks, hydrogels are 
classified as anionic hydrogel when the polymers are negatively charged, cationic hydrogel 
when the polymers are positively charged and neutral hydrogel when the network contains 
both types of charged polymers (Fig. 3). 
 
The term hydrogel indicates that the material is already swollen in water. The dried 
hydrogel is called a xerogel or dry gel [6]. When the hydrogel is being dried, water evaporates 
from the gel and the surface tension causes the collapse of the gel body and the gel shrinks to 
only a small fraction of its swollen size. If the water is removed without disturbing the 
polymer network, either by lyophilization (freeze drying) or by extraction with organic 
solvents, then the remaining material is extremely light with a porosity as high as 98 percent 
and such a dehydrated hydrogel is called aerogel [7]. 
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2.1.3 Properties of Hydrogels 
As hydrogel having so many classification based on the cross-linking methods, 
polymer selection and ionic charges, it has a wide spectrum of properties. All those properties 
are dependent on each other. Though water content is one of the most important properties of 
hydrogel, it mainly depends on the cross-linking density. Hydrogels are considered to be 
highly porous and the pore size depends again on the cross-linking density. The mechanical 
properties or the strength of hydrogel again depends on cross-linking density. So to 
summarise, higher the cross-linking density, higher the strength of the hydrogel, smaller the 
pore size (smaller the molecular weight between the cross-links) as a result, lower will be the 
water content and vice-versa. Out of all these properties, water content is the one, that can be 
studied easily and with that, the other properties like the pore size, strength and the molecular 
weight between the cross-links can be judged approximately when a series of hydrogel are 
kept under comparison study.  
 
Equilibrium water content (EWC) of a hydrogel can be measured by a simple swelling 
experiment in water or other solvents using the equation 
 
100




 

s
ds
W
WW
EWC                                                    (1) 
Ws = Weight of the swollen hydrogel at equilibrium 
Wd = Weight of the dry gels 
 
Water enters the polymer network promoted by osmotic force and the hydrophilic 
polymer chains are stretched between the cross-links. As the gel swells and grows in size, the 
retractive forces from the cross-linking points and from the polymer itself opposes and a point 
is reached when the osmotic and the retractive forces are equal and there the swelling stops 
and it is said to be in the equilibrium state [3]. 
 
Volumetric swelling ratio ( vQ ) is a measure of the volume increase of a hydrogel from 
its initial dry state to its equilibrium swelling state and it can be calculated by the equation 
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ρp: density of the polymer network (1.229 g/cm
3
 for HA) 
ρs: density of the swelling agent (1 g/cm
3 
for water) 
ms: mass of the swollen network 
md: mass of the dry network 
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L
L
L
L
o
o
o
Unconstrained Gel
 
 
The parameters that control the swelling behaviour of hydrogels are 
 Cross-linking density (υe) 
 Polymer solvent interaction (χ) 
Cross-linking density (υe) can be influenced by the ratio of cross-linker to the hydrophilic 
polymer, functionality of the cross-linker, reaction time or radiation time for the cross-linking 
and finally the molecular weight of the polymer chain segments and as a result, a higher 
cross-linking density leads to smaller mesh size or pore size or molecular weight between 
cross-links that enhances a higher retractive or opposing force of the swollen network and 
thus a smaller degree of swelling or lower water content. 
 
Flory-Rehner equation [8] makes it possible to describe quantitatively the swelling 
process. 






 
2
1
1
3
5
V
Mv
Q cv                                                     (3) 
 
Here, vQ  [9] is the volumetric swelling ratio, v  is the specific volume of the dry 
polymer, 
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cM  is the average molecular weight between cross-links, V1 is the molar volume of the 
solvent (18 M/cm
3
 for water) and χ is the Huggins polymer-solvent interaction parameter. 
 Huggins polymer-solvent interaction parameter can be calculated using the equation 
 2134.0 ps
RT
V
                                                      (4) 
s , p = solubility parameters of solvent and polymer 
The effective cross-linking density, (υe) can be calculated using the relation 
c
p
e
M

                                                                   (5) 
The swollen hydrogel mesh size, ξ, can be determined with the following equation 
 
23/1
ov rQ                                                               (6) 
where 2
or  is the root mean square distance between the cross-links and depends on the 
molecular weight between cross-links. For HA, the following root-mean-square end-to-end 
distance value was previously reported [10] 
 
nm
n
ro 4.2
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2/1
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


                                                  (7) 
 
where n is the number of disaccharide repeat units for HA with a given molecular weight (Mn) 
 
 nmMr no 1748.0
2                                                    (8) 
 
A combination of Equations (6) and (8) and a substitution of cM  for Mn give 
 
 nmQM vc
3/1
1748.0  
 
As approximations were made in the Flory-Rehner calculations, the values determined 
(e.g., cM , υe, ξ) were considered approximations. 
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2.1.4 Classification of water in hydrogels 
Water content in the context of hydrogel as such can be classified in to two main 
types, namely bound water and the free water [Ref-3 for detailed report on water 
classification in a hydrogel]. These two types of water play a vital role in the permeation of 
nutrients into and cellular products out of the gels when it is used as scaffolds for tissue 
engineering purposes. When a dry gel is placed in an abundant of water, the water that enters 
the network initially will first hydrate the hydrophilic, polar groups of the polymers forming 
the primary bound water. Once the hydrophilic groups of the polymers are hydrated, the 
network swell and makes the hydrophobic part of the polymers exposed to water leading to 
hydrophobic bound water or secondary bound water. Simply these two types of bound water 
are collectively called as total bound water. Usually this bound water is very hard to remove 
from the hydrogels. As the hydrogel is saturated with the bound water content, the network 
observes additional water due to the osmotic driving force of the network towards infinite 
dilution which will be opposed by the physical or chemical cross-links, leading to an elastic 
opposing force. This force stops the water entering in to the network and the system is said to 
be in an equilibrium state. The water observed by the osmotic driving force is called free 
water or bulk water and is estimated to fill the space between the network chains and the 
pores or voids. The fate of the hydrogel in terms of its stability depends on the type of 
polymer chain or the cross-links. 
 
There are two easy methods of measuring the relative amount of free water and bound 
water as fractions of total water content. They are DSC and Small molecular probes. 
 
 DSC is based on the assumption that only free water may be frozen and melted again. 
It is assumed here that the endotherm measured during the melting of the frozen water 
corresponds to free water and the bound water is determined as the difference of the 
free water measured by DSC from the total water content measured by the swelling 
experiments.  
 Small molecular probes method uses the labelled probe solution to equilibrate the 
hydrogel and the concentration of the probe molecule is the gel at equilibrium is 
measured, assuming only the free water can in the gel can dissolve the probe solute, 
one can calculate the free water content from the amount of probe that is in the 
hydrogel and the known probe molecule concentration in the external solution.. Then 
the bound water is obtained by the difference of the measured total water content of 
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the hydrogel and the calculated free water content. Additional assumptions in this 
method are, all the free water is accessible to the molecular probes and the 
concentration of the molecular probes inside the hydrogel is same as that of the 
external solution [11]. 
 Hydrogels are highly porous materials that stores water in these pores which are 
formed as a result of the cross-linking of hydrophilic polymers either by physical or by 
chemical means. The pore size depends and is inversely proportional to the cross-linking 
density. The average pore size, the pore size distribution and the inter-connectivity of the 
pores are often difficult to measure and are included together in the parameter called 
‘Tortuosity’. Because of its porous nature, hydrogel is an attractive material in the medical 
field for drug delivery system, as tissue engineering scaffolds and in the commercial field for 
sanitary napkins, as source to transport dangerous chemicals and etc. 
 
2.1.5 Common applications of hydrogels: [Ref: 73] 
 Environmentally sensitive hydrogels. These hydrogels have the ability to sense 
changes of pH, temperature, or the concentration of metabolite and release their 
load as result of such a change. 
 As sustained-release delivery systems 
 Provide absorption, desloughing and debriding capacities of necrotic and fibrotic 
tissue. 
 Hydrogels that are responsive to specific molecules, such as glucose or antigens 
can be used as biosensors as well as in drug delivery system. 
 Used in disposable diapers where they "capture" urine, or in sanitary napkins 
 Contact lenses (silicone hydrogels, polyacrylamides) 
 Medical electrodes using hydrogels composed of cross linked polymers 
(polyethylene oxide, polyAMPS and polyvinylpyrrolidone) 
 Water gel explosives 
Other, less common uses include 
 Breast implants 
 Dressings for healing of burn or other hard-to-heal wounds. Wound gels are 
excellent for helping to create or maintain a moist environment. 
 Reservoirs in topical drug delivery; particularly ionic drugs, delivered by 
iontophoresis.  
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2.1.6 Summary of the important physico-chemical parameters and properties of 
hydrogels in general (taken from Ref: 3) 
 
Type of hydrogels 
Physical gel 
Chemical gel 
 
Molecular structures 
Linear polymers 
Block copolymers 
Graft copolymers 
Interpenetrating networks (IPNs) 
Polyblends 
 
Composition of hydrogels 
Natural polymers and their derivatives 
Synthetic polymers 
Combinations of natural and synthetic polymers 
 
Important properties 
Degradable or non-degradable 
Injectable or pre-fabricated 
Mechanical strength 
Ease of handling 
Shape and surface/volume ratio 
Closed vs. open pores 
Water content and character 
Chemical modifications 
Added bioactive components 
Sterilizability 
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2.2 Hydrogels as Biomedical material 
 
2.2.1 Introduction 
 Materials with specific and tunable properties for a wide variety of applications are 
required in the fast developing field of biomedical engineering [12].  It is hard to find 
materials with all the features that are perfectly suitable for any biomedical applications. As 
biomedical material, in most cases works together with the living cells or with physiological 
fluids inside the body and therefore, it should be non-toxic, it should not induce unspecific 
protein adsorption, it should attract cells to adhere on it, in-order to become a part of a tissue 
and if any biomedical material finds all these properties in it, it is said to be biocompatible 
materials. Bio-inert materials are materials which does not involve in any kind of biological 
activities but they remain non-toxic and does neither unspecific protein adsorption nor cell 
adhesion. In-order to make these bio-inert materials to be a biocompatible one, it requires 
some modifications, like decorating its surfaces with amino acid sequences (RGD) to which 
specific receptors on cell membranes can attach [13]. In addition, bioactive molecules such as 
growth factors can be incorporated and released from the material [14].  
 
Hydrogel finds its place in the biomedical materials group as highly biocompatible and 
bio-inert with few unique properties. First it has low interfacial tension with surrounding 
biological fluids and tissues and that minimizes the driving force for protein adsorption and 
cell adhesion [15]. Since hydrogels have high water content, its surface is said to be super-
hydrophilic diffusible surface and such surface is known to be highly biocompatible. Second, 
hydrogels simulate some hydrodynamic properties of natural biological gels, cells and tissues 
in many ways [16]. The high mobility of polymer chains at the hydrogel surface contributes to 
the prevention of protein adsorption and cell adhesion. This is mainly due to the steric 
repulsion exerted by the polymer chains. The protein adsorption and cell adhesion is 
prevented by the non-specific repulsion resulting from “entropic” and “mixing” interactions 
between the polymer chains and proteins or cell membranes. Third, the soft and rubbery 
nature of hydrogels minimizes mechanical and frictional irritation to the surrounding tissues 
[17]. With all these properties hydrogel mimic the natural ECM to house cells, bioactive 
molecules and other biological fluids makes a perfect candidate as a biomedical material. The 
two major areas where hydrogels are applicable are (i) Drug Delivery System (DDS) and (ii) 
Tissue Engineering Scaffolds (TES). 
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2.2.2 Hydrogels in Drug Delivery System 
 Drug delivery occurs when a polymer, whether natural or synthetic, is judiciously 
combined with a drug or other active agent in such a way that the active agent is released 
from the material in a pre-designed manner [18]. Today we are in a point where we are able to 
achieve drug release even for years at a relatively constant rate. The major advantages of such 
a system are (1) effective treatment with low side effects, (2) the maintenance of effective 
drug concentration levels in the blood, (3) helps patients to take medicines less frequently. All 
these advantages were made possible with the advancement in polymers and hydrogels. The 
goal of many of the controlled release system was to achieve a delivery profile that would 
yield a high blood level of the drug over a long period of time. With traditional tablets or 
injections, the drug level in the blood follows the profile as shown in fig. 4a, in which the 
level rises after each time of administration of the drug and then decreases until the next 
administration. The key point to the traditional drug administration method is that the blood 
level of the drug should remain between a maximum value or toxic level and minimum value 
or non-effective level. In controlled drug delivery system designed for long-term 
administration, the drug level in the blood follows the profile as shown in fig. 4b, remaining 
constant between the maximum and minimum level for a period of time. 
 
 
Fig. 4 Drug levels in the blood with a) traditional drug administration and b) controlled drug 
delivery. 
 
 There are three primary mechanisms by which active agents can be released from a 
delivery system: (i) diffusion, (ii) swelling followed by diffusion and (iii) dissolution or 
degradation. Any or all of these mechanisms may occur in a given release system. 
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Diffusion controlled release 
Diffusion is defined as the process by which solute (drug) moves from a region of 
higher concentration to a region of lower concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Drug delivery from a) matrix system and b) reservoir system.  
(Scheme taken from Ref: 18) 
 
In fig 5(a), a polymer and solute (drug) have been mixed to form a homogenous matrix 
system. Diffusion occurs when the drug moves from the matrix system (higher concentration) 
to the external environment (lower concentration). As the release continues, its rate normally 
decreases with this type of system, since the drug has a longer distance to travel and therefore 
requires a longer diffusion time to release [19]. For the reservoir system fig. 5(b), the drug 
delivery rate can remain fairly constant. In this design, a reservoir of polymer matrix 
containing drug in any form is surrounded by a film or membrane of rate controlling material. 
The only structure effectively limiting the release of the drug is the membrane surrounding 
the reservoir. Since this membrane is essentially uniform and non-changing thickness, the 
diffusion rate of the drug can be kept fairly stable throughout the lifetime of the delivery 
system. The diffusion controlled system described so far, the drug delivery device is 
fundamentally stable in the biological environment and does not change its size either through 
swelling or degradation. In this system, the combinations of polymer matrix and the drug 
chosen must allow for the drug to diffuse through the pores or macromolecular structure of 
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the polymer upon introduction of the delivery system into the biological environment without 
inducing any change in the polymer itself. 
 
Swelling followed by diffusion 
 There is another possibility for a drug delivery system to be designed so that it is 
incapable of releasing its active agent or drug, until it is placed in an appropriate biological 
environment. For instance, the release system is initially dry and when placed in the body, this 
dry system will absorb water or any other body fluid and swells. Swelling increases the 
solvent content inside the matrix along with the increase in the size of the mesh size, enabling 
the drug to diffuse out of the matrix (fig. 6). 
 
 
 
 
 
 
Fig. 6 Drug delivery from swellable matrix. (Scheme taken from Ref: 18) 
 
Table1 Environmentally sensitive polymers for drug delivery [20] 
Stimulus Hydrogel Mechanism 
pH Acidic or basic hydrogel Change in pH-Swelling-release of drug 
Ionic strength Ionic hydrogel Change in ionic strength-change in 
concentration of ions inside the gel-change in 
swelling-release of drug 
Chemical 
species 
Hydrogel containing electron- 
accepting groups 
Electron-donating compounds-formation of 
charge/transfer complex-change in swelling-
release of drug 
Enzyme-
substrate 
Hydrogel containing immobilized 
enzymes 
Substrate present-enzymatic conversion-
product changes swelling of gel-release of drug 
Magnetic Magnetic particles dispersed in 
alginate micro-spheres 
Applied magnetic field-change in pores in gel-
change in swelling-release of drug 
Thermal Thermo-responsive hydrogel 
poly(N-isopropylacrylamide) 
Change in temperature-change in polymer-
polymer and polymer-water interactions-change 
in swelling-release of drug 
 
Swelling can be triggered by a change in the environment surrounding the delivery 
system. Depending upon the polymer, the environment change can involve pH, temperature, 
or ionic strength, and the system can either shrink or swell upon a change in any of these 
environmental factors. A number of these environmentally sensitive hydrogel materials are 
2. Literature Overview 
18 
 
listed in table 1. For most of these polymers, the structural changes are reversible and 
repeatable upon additional changes in the external environment. 
 
Dissolution or degradation controlled release 
The above two described systems are based on polymers that do not change their 
chemical structure beyond what occurs during swelling. There is another possibility for the 
drug to release from the matrix. Here the polymer matrix undergoes either bulk or surface 
degradation by which the drug molecules are exposed to the external environment [21]. Most 
of the biodegradable polymers are designed to degrade as a result of hydrolysis of the polymer 
chains into biologically acceptable and progressively smaller compounds (fig. 7). 
 
 
 
Fig. 7 Drug delivery from bulk eroding and surface eroding. (Scheme taken from Ref: 18) 
 
Drug delivery and the treatment of diabetes 
 Diabetes is a disease that has received a great deal of attention because of the potential 
for therapies using controlled drug delivery system. For this disease, an optimal delivery 
system would be one that could deliver insulin upon detection of glucose in the bloodstream. 
Most of the system under study for the release of insulin is based on the reaction of glucose in 
the blood with glucose oxidase that can be immobilised on polymers within the drug delivery 
system [22]. This reaction causes a lowering of the pH in the microenvironment of the 
delivery system. This causes an increase in the swelling of the polymer system, leading to an 
increased release of insulin, for delivery systems that are based on copolymers containing N, 
N-dimethylaminoethyl methacrylate or polyacrylamide [23] (fig. 8). 
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Fig. 8 Delivery of insulin through molecular gates initiated by the presence of glucose in the 
blood stream. 
 
 
2.2.3 Hydrogels as Tissue Engineering Scaffolds 
 
Introduction 
Tissue Engineering in general is to fabricate a living replacement parts for the body. 
The necessity of tissue engineering is expanding as the other sources like organ and tissue 
donor’s and conventional treatment methods are not enough meeting the demands. The 
advancements in the field of tissue engineering have developed to meet the tremendous need 
for organs and tissues [24].  
 
Scaffold is the base for tissue engineering. These scaffolds serve as an artificial extra-
cellular matrix for the cells to feel like its natural environment, which directs the growth and 
formation of a desired tissue [25]. The scaffold material and its properties are selected based 
on the tissue of interest following its applications. PLA and PGA are approved by FDA as 
scaffold materials that are mechanically strong and non-toxic [26]. Since they are 
hydrophobic in nature along with the severe conditions that involves during the fabrication of 
scaffold it is hard to entrap cells in it.  
 
As an alternative, a class of biomedical materials called hydrogels which contains high 
water content that resembles the natural extra-cellular matrix. It is composed of hydrophilic 
polymer chains that are connected either by chemical or physical means that determines the 
stability of the scaffolds in the physiological environment. Hydrogels used in these 
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applications are processed under relatively mild conditions, its mechanical and structural 
properties resembles that of the natural ECM and can be delivered in a minimally invasive 
manner [27]. 
 
Material choices for Hydrogels 
A group of hydrophilic synthetic and natural polymers are being employed for the 
preparation of hydrogels. Synthetic materials include poly (ethylene oxide) (PEO), poly (vinyl 
alcohol) (PVA), poly (acrylic acid) (PAA) and poly-peptides. Synthetic hydrogels are 
prominent for tissue engineering because their properties and chemistries are controllable and 
reproducible as synthetic polymers can be produced with required molecular weight, block 
structures, degradable linkages and the cross-linking modes [24]. These properties in-turn 
dictates the properties of the formed hydrogel in terms of its gel forming dynamics, cross-
linking density, its degradation kinetics, its mechanical strength and its ability to bind other 
bio-active molecules. Natural polymers are more frequently used in the formation of tissue 
engineering scaffolds at they forms a part of the natural ECM or have macromolecular 
properties similar to natural ECM. Some of the natural polymers employed as the tissue 
engineering scaffold materials include agarose, alginate, chitosan, collagen, fibrin, gelatine, 
and hyaluronic acid (HA). 
  
Properties of tissue engineering scaffolds 
 Physical properties, mass transport properties and the biological interaction 
requirements of each specific application govern the selection of appropriate scaffold 
materials. These properties are specified by the environment into which the scaffold will be 
placed based on what application it is designed for. The physical properties of a scaffold 
include its mechanical strength to withstand the forces created by the cells, its gelling 
dynamics-how fast it gelates without damaging the cells [28]. Mass transport property specify 
the diffusion requirements in-terms of the possibilities of cell nutrients to go inside the 
scaffold and the metabolic products to come out of the scaffold and this property depends on 
how porous the scaffold is and the porosity depends on the cross-linking density, polymer size 
and the concentration [29]. The biological properties specifies the non-toxicity behaviour of 
the scaffold materials and how far it is friendly in attracting cells to adhere on it and how far it 
repels the unspecific protein adsorption on it [28]. 
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Successful application of hydrogels as scaffold in tissue engineering 
As hydrogels are having many properties that are closely relating to the natural ECM, 
researchers are always busy in finding different material combinations in obtaining required 
scaffold properties for the specific applications. Here are some of the combinations of 
materials and cell types that were successful in fabricating tissues out of a certain cell types 
using certain materials as scaffolds.  
 
Table 2 A good combinations of biopolymers and cell types 
Material Cell type References 
Collagen Skeletal muscle, Blood 
vessels 
30,31 
Peptide modified 
alginate 
Skeletal muscle 32 
Freeze-dried 
collagen sponges 
Pre-adiposites 33 
Alginate Schwann cells 34 
Hyaluronic acid Bone marrow stromal 
cells, human aortic 
endothelial cells 
35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Literature Overview 
22 
 
2.3 Extra-cellular matrix (ECM) 
  
2.3.1 Introduction 
Cells need a substrate to adhere, proliferate and to divide. In-vitro cell culture utilizes 
tissue culture poly-styrene (TCPS) plates as the substrates for the cells, in which cell divide in 
2-D direction. In order to get a tissue, cells need to grow in 3-D directions, for which it need a 
3-D substrate called scaffold [36]. In-vivo, cells are surrounded by a gel matrix called the 
extra-cellular matrix (ECM), secreted by the cells and it functions as a scaffold for the cells. 
In addition to structural support to cells [37], ECM is composed of many different 
biologically active molecules or matrix macromolecules that are arranged in a highly 
regulated manner and its composition determines the action and fate of cells that it surrounds 
[38]. ECM contains more than 90% of water that keeps the cells from drying out. Cells 
communicate with each other by sending signals in the form of bio-molecules that are 
transferred by the ECM. A schematic representation of the ECM is given in fig. 9. 
 
 
 
Fig. 9 Cell in the extra-cellular matrix. (Scheme taken from Ref: 36) 
 
Variations in the relative amounts of the different types of matrix macromolecules and 
its organisation in the extra-cellular matrix give rise to an amazing diversity of forms, each 
adapted to the functional requirements of the particular tissue. The matrix takes different 
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forms like rock-hard to form bone or teeth by calcification or it can form the transparent 
matrix of the cornea or it can form the rope-like structure to have enormous tensile strength to 
form tendons [38]. Connective tissues form the framework of all the vertebrates and ECM is 
the major content of the connective tissues. Its amount determines the physical properties of 
the tissues and it is high in content in tissues like bone and cartilage and is low in tissues like 
brain and spinal cord [38]. 
 
2.3.2 Classes of ECM 
There are two basic forms of ECM available. 
1. Basal membrane 
2. Interstitial matrix 
Basal membrane (BM) is a thin layer of ECM that forms between the epithelium and 
endothelium. It surrounds muscle, fat and nerve cells and it serves as a boundary to these 
tissue types. 
 
Interstitial matrix is the gel like structure that holds the cells in any tissues to give its 
mechanical properties along with other biological properties as mentioned already.  
 
2.3.3 Components of ECM 
Two main classes of extra-cellular macromolecules that make up the matrix are 
1. Polysaccharide chains of the class called glycosaminoglycans (GAGs), which are 
usually found covalently linked to protein in the form of proteoglycans 
2. Fibrous proteins, including collagen, elastin, fibronectin and laminin having both 
structural and adhesive functions. 
 
The proteoglycans forms a highly hydrated gel-like matrix substance in which fibrous 
proteins are distributed [39]. The GAG gel resists compressive forces on the matrix but 
allowing diffusion of nutrients, metabolic products, and hormones between the blood and the 
cells. Collagen of the fibrous protein family helps in the organisation and providing tensile 
strength to the matrix and elastin gives the matrix its resilience. Also these fibrous proteins 
help cells to attach to the appropriate locations. 
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2.4 GAGs and their importance in connective tissue/ECM 
 
2.4.1 Introduction 
GAGs are unbranched polysaccharide chains of repeating disaccharide units. One of 
the two sugars in the repeating disaccharide units is always an amino sugar (N-
acetylglucosamine or N-acetylgalactosamine) and because of this reason they are called as 
Glycosaminoglycans. In most cases GAGs are sulphated. The other sugar of the repeating 
disaccharide unit is an uronic acid (glucuronic or iduronic). GAGs are considered to be the 
most anionic molecules synthesised by animal cells as they are highly negatively charged 
because of the presence of sulphate and carboxylic groups in the repeating disaccharide units.  
 
2.4.2 Classification of GAGs 
Based on the type of sugar molecules, type of cross-linkages by which these sugar 
molecules are attached, the number and the position of the sulphate groups, GAGs are 
classified in to four types [40].  
 
 
 
Fig. 10 Structure of the components of GAGs 
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They are, 
1. Heparan sulphate and  
2. Keratan sulphate 
3. Chondroitin sulphate  
4. Hyaluronic acid 
 
The proportion of GAGs in the connective tissues constitutes less than 10% of the 
weight of the fibrous proteins. It forms porous hydrated gel filling most of the extra-cellular 
space providing mechanical support to the tissue.  
 
2.4.3 Properties of GAGs 
The GAGs in the connective tissues are usually less than 10% of the weight of the 
fibrous proteins, but still they tend to adopt highly extended conformations and occupy a huge 
volume relative to their mass because they are highly hydrophilic and they form gels even at 
lower concentrations. As they have high density of negative charges that attracts a group of 
cations, most notable Na
+
, that are osmotically active, causing large amounts of water from 
the surrounding areas to be absorbed into the matrix [41]. This creates a swelling pressure that 
can withstand compressive forces. 
 
Table 3 Characteristics of GAGs [42]. 
GAGs Localization Comments 
Hyaluronic acid synovial fluid, vitreous humor, 
ECM of loose connective tissue 
large polymers, shock 
absorbing 
Chondroitin 
sulfate 
cartilage, bone, heart valves most abundant GAG 
Heparan sulfate basement membranes, components of cell surfaces contains higher acetylated  
glucosamine than heparin 
Heparin component of intracellular granules of mast cells 
lining the arteries of the lungs, liver and skin 
more sulfated than 
heparan sulfates 
Keratan sulfate cornea, bone, cartilage aggregated with 
chondroitin sulfates 
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2.4.4 Proteoglycans 
Proteoglycans are soluble polymers of the connective tissues that consist of a core 
polypeptide to which polysaccharide chains or glycans are attached [43]. The glycans are of 
three types, (1) heparan, (2) keratan and (3) chondroitin. They consist of repeating 
disaccharide units, one residue of which is always hexosamine, usually with sulphate ester 
groups attached at the 4 or 6 positions. 
 
 
Fig. 11 Schematic representation of Aggrecan, a type of proteoglycan. (Scheme taken from 
Ref: 38) 
 
(1) Heparans contain D-glucuronic and L-iduronic acid in varying proportions, and 
glucosamine, either as 2-deoxy-2-acetamido- or 2-deoxy-2-sulphamato-glucose. The 
glycosidic links are 1 4. The number of sulphate groups per disaccharide unit 
varies from < 0.5 in some heparan sulphates to > 2.5 in heparins. 
(2) Keratans contain N-acetylglucosamine and D-galactose, linked 1 3 and 1 4. The 
degree of sulphation is typically 0.8 – 1.5. 
(3) Chondroitin glycans contain N-acetyl-galactosamine, with D-glucuronic and /or L-
iduronic acid linked 1 4 and 1 3 respectively. Chondroitin by definition contains 
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no L-iduronic acid, when it contains L-iduronic acid then it is called Dermatan 
sulphate. 
A fourth glycan, hyaluronan, similar in structure to the chondroitins, is found in all 
connective tissues [74].  
 
Table 4 List of Proteoglycans (Summarised from Ref: 41, 43) 
Proteoglycan Approximate 
Molecular 
Weight Of Core 
Protein 
Type Of GAG Chains Number 
Of GAG 
Chains 
Location Functions 
Aggrecan 210,000 chondroitin sulfate + 
keratan sulfate 
~130 Cartilage mechanical support; 
forms large 
aggregates with 
hyaluronan 
Betaglycan 36,000 Chondroitin sulfate/ 
dermatan sulfate 
1 cell surface 
and matrix 
binds TGF-β 
Decorin 40,000 Chondroitin sulfate/ 
dermatan sulfate 
1 widespread in 
connective 
tissues 
binds to type I 
collagen fibrils and 
TGF-β 
Perlecan 600,000 Heparan sulfate 2–15 basal laminae structural and 
filtering function in 
basal lamina 
Syndecan-1 32,000 chondroitin sulfate + 
heparan sulfate 
1–3 epithelial cell 
surface 
cell adhesion; binds 
FGF and other 
growth factors 
Dally (in 
Drosophila) 
60,000 Heparan sulfate 1–3 cell surface co-receptor for 
Wingless and 
Decapentaplegic 
signaling proteins 
 
 
2.4.5 Hyaluronan 
It is the only glycan that is neither attached to peptide chains, nor contains sulphate 
groups and it consist of maximum of 25,000 regular repeating units of glucuronic acid and N-
acetylglucosamine [44]. It is found in variable amounts in all tissues and physiological fluids 
in adult animals, and is especially abundant in early embryos.  
 
Because of its simple structure without any peptide chains and its biological activities 
as it is present in large amounts in the adult animals, it was of fancy material for the 
researchers and many new biomedical materials have been synthesised based on it and many 
such new materials were successfully used as tissue engineering scaffolds, tissue space fillers 
and as cell and bioactive molecule delivery vehicles.  
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A detailed report on Hyaluronic acid covering its chemical and molecular structure, its 
physicochemical and biological properties, its functions, its flexibility to chemical 
modifications and finally its applications in tissue engineering scaffolds and drug delivery 
system is given below. 
 
Chemical and Molecular structure 
It was probably the French chemist Portes who first reported in 1880 that the mucin in 
the vitreous body, which he named hyalomucine, behaved differently from other mucoids in 
cornea and cartilage. Fifty-four years later, a German biochemist named Karl Meyer isolated a 
new polysaccharide from the vitreous, which he named hyaluronic acid [45]. Today its 
official name is hyaluronan (HA). It is a polymer of disaccharides themselves composed of D-
glucuronic acid and D-N-acetylglucosamine, linked together via alternating beta-1,4 and beta-
1,3 glycosidic bonds.  
 
 
 
Figure 12 Structure of Hyaluronic acid. 
 
Polymers of HA can range in size from 10
2
 to 10
4
 kDa in vivo. The contour length of a 
chain of molecular weight 4x10
6
 is 10µm. The average molecular weight in human synovial 
fluid is 3−4 million Da and hyaluronan purified from human umbilical cord is 3,140,000 Da 
[46].
 
In-vivo, it is synthesized by a class of integral membrane proteins called hyaluronan 
synthases (HAS), of which vertebrates have three types: HAS1, HAS2, and HAS3. These 
enzymes lengthen HA by repeatedly adding glucuronic acid and N-acetylglucosamine 
alternatively to the nascent polysaccharide as it is extruded through the cell membrane into 
the extracellular space. 
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Table 5: Localisation of HA 
 
Source pH Molecular weight (Dalton) Concentration 
Synovial fluid 
(normal human) 
7.768 ± 0.044 [Ref: 47]
 
1.6-10.9 x 10
6 
[Ref: 48]
 
1.45-3.12 g/l [Ref: 
48]
 
Synovial fluid 
(rheumatoid 
arthritis) 
7.549 ± 0.040 [Ref: 47]
 
1.2-4.5 x 10
6 
[Ref: 48]
 
1.09-1.20 g/l [Ref: 
48]
 
Vitreous humour 7.8 (normal human) 
[Ref: 49] 
2-3 x 10
6 
(rabbit) 
5-8 x 10
5
 (cattle) 
1.2 x 10
6
 (± 0.49 x 10
6
) 
(Bovine) [Ref: 46] 
0.14-0.338 g/l 
(normal human) 
[Ref: 49] 
Aqueous humour 7.38 (old people) 3 x 10
6 
(rabbit)
 
0.6 x 10
6
 (new born calf) 
[Ref: 46] 
 
 
 
Physicochemical properties 
HA is a highly hygroscopic molecule. Each glucuronic acid unit contains one carboxyl 
group, giving rise to HA’s polyanionic character at physiological pH. In the presence of 
water, HA molecules can expand in volume up to 1000 times and form loose hydrated 
matrices. This property is probably the key contributor to many of its biological functions, 
and can be further modified by its interaction with cells as well as other components of the 
ECM. For detailed physicochemical properties of HA, Refer [46]. 
 
HA as a component of eye (aqueous humor) and synovial fluid with its cushioning and 
lubricating effects is from the Viscoelastic properties of HA. This unique rheological property 
is exploited in the application of hyaluronan in ophthalmic surgery [51]. Because HA is a 
hygroscopic macromolecule, its solutions are highly osmotic, a property further increased in 
the presence of serum albumin as found in many tissue fluids [52]. This osmotic property is 
particularly necessary to function as an osmotic buffer in the kidney. In the skin, this property 
is likely to be important in controlling tissue hydration during embryonic development and 
during the inflammatory process. Elevated amount of HA is important for cell proliferation 
and migration during wound healing. In the hydrated state, much of the water around the HA 
is immobilized [53]. This results in restriction of movement of water and small molecules. 
Larger molecules, such as proteins, are excluded from the HA matrix by steric exclusion [54]. 
The highly viscous nature of HA also contributes to retardation of viral and bacterial passage 
through the HA-rich pericellular zone. HA is fully ionized in physiological conditions. As a 
pericellular matrix, it may have effects on ion flux which are important in cellular signalling 
through membrane ion channels. HA also serves as a scavenger of free radicals and as an 
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antioxidant [55]. These functions of HA may be particularly important in skin physiology, as 
a protectant against solar radiation.  
 
Biological Properties 
 Biological properties of HA is divided in to four parts describing its role in (1) ECM, 
(2) Cell migration, (3) Wound repair and angiogenesis and (4) pathological processes. 
 
Role of HA in ECM 
 It plays several important organisational roles in the ECM by binding with cells and 
other component through covalent and non-covalent interactions. It modulates the 
organisation of fibrin, fibronectin, and collagen networks [56] by specific interactions with 
proteoglycans like aggrecan, vesicant and etc. In addition to ECM structure homeostasis and 
hydration, it is also involved in other processes like cell migration, attachment and metastasis 
mediated by a group of proteins called hyaladherins and it is classified in to three categories. 
Those that are soluble, those that bind HA to other ECM molecules and the one that acts as 
cellular receptors for HA. CD44 and RHAMM (Receptor for HA-Mediated Mobility) are the 
two hyaladherins that have been extensively studied. CD44 has been considered as the major 
cell surface receptor for HA and it is expressed in variety of cell types like fibroblasts, 
keratinocytes, leukocytes and epithelial cells [57]. This receptor is involved with various 
cellular processes like adhesion, migration, proliferation, activation, HA degradation and 
uptake [44]. RHAMM has been assumed in regulating cellular responses to GF and plays a 
role in cellular migration, particularly for fibroblasts and smooth muscle cells. 
 
Role of HA in cell migration 
HA is considered to play a vital role in cellular behaviour not only through specific 
binding with cellular hyaladherins but also by indirect means by altering the physical 
properties of ECM [56]. As a response to tissue injury during inflammatory process, HA level 
is elevated and it is necessary to cell proliferation and migration when the HA synthesis 
contributes to local foci of tissue hydration. This results in weakening of cell anchorage from 
ECM, allowing for temporary detachment to facilitate cell migration and division [53]. 
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Role of HA in would repair and angiogenesis 
 Following injury, wound healing follows a series of regulated sequential events [58]. 
These are (i) Initiation phase, (ii) Inflammation phase, (iii) Proliferation phase and (iv) 
reepithelialization and remodelling. Chen and Abatangelo suggest that HA plays a 
multifaceted role in each wound healing stage. HA helps in setting off the early stages of 
inflammation and initiating the wound healing response. Granular tissue formation during the 
proliferation phase, forms a matrix that is rich in fibrin and high concentration of HA helps 
cell types like fibroblast and endothelial cells to migrate to the wounded area. 
 
Role of HA in Pathological processes 
Factors like HA concentration and molecular weights have much to do with the 
development of certain pathological conditions and can therefore be used as diagnostic 
markers for diseases. Vascular diseases like atherosclerosis and restenosis are the results of 
changes in the physical properties of HA [44]. Tumour or cancer is a result of uncontrolled 
cell division and the concentration of HA have a proportionate effect on the tumour growth 
and vascular diseases. Higher concentrations of HA increases the free volume and fluidity of 
ECM that enables more cell migration and proliferation causing the tumour growth. 
 
Basic Functions of Hyaluronic Acid  
As HA is present in most of the tissue of the body, its importance cannot be 
underestimated.  Retention of water is one of the most important biological functions of HA, 
[59] second only to providing nutrients and removing waste from cells that do not have a 
direct blood supply, such as cartilage cells.  With a lower than adequate amount of HA, 
nutrients cannot be moved into these cells and waste cannot be eliminated from cells. HA is 
found in the synovial joint fluid, the vitreous humor of the eye, the cartilage, blood vessels, 
extra-cellular matrix, skin and the umbilical cord. 
Synovial Joint Fluids 
Our joints (like the elbows and knees) are surrounded by a membrane called the 
synovial membrane, which forms a capsule around the ends of the bones.  This membrane 
secretes a liquid called the synovial fluid.  Basically, the synovial fluid is found in joint 
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cavities.  It has many functions, including serving as a lubricant, shock absorber and a nutrient 
carrier.  The fluid protects the joints and bones. 
Cartilage 
Cartilage is immersed in the synovial fluid and is a fibrous connective tissue.  
Cartilage is avascular, meaning it contains no blood vessels.  This is why the synovial fluid is 
so important.  Synovial fluid is the only way in which nutrients can be carried into the 
cartilage and waste can be removed. Hyaline cartilage is the most predominant form of 
cartilage in the body.  It lends strength and flexibility to the body.  A key component of 
cartilage is hyaluronic acid.   
Extra-cellular matrix 
 HA is found in the extracellular matrix (ECM).  The ECM is composed of material 
(fibrous elements, including glycosamino-glycans) produced by the cells and excreted to the 
extracellular space with the tissues. All nutrients and metabolic waste are transported through 
the ECM.  HA is a major constituent of the ECM and serves as an essential structural element 
of the ECM.  Hyaluronic acid maintains moisture in the ECM and it supports the structural 
integrity of the extracellular matrix [60]. 
 
 
Fig. 13 Confocal micrograph showing three 
different HA population in one cell [61]. 
  
 
 
Skin 
In the skin, the ECM is composed of HA and other sulfated GAGs, combined with 
collagen and elastin.  Large amounts of water are held in the ECM.  When elastin is not 
bathed in water, it becomes dry and brittle, and therefore skin looks dry when it contains less 
HA [59]. Half-life is defined as the time required for one half of the total amount of a 
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particular substance to be consumed, broken down, or depleted.  The half-life of HA in the 
cartilage is 2-3 weeks.  But the half-life of HA in the skin is less than 1 day. HA is present in 
both the dermis and the epidermis.  50% of the body’s naturally produced HA that is found in 
the epidermis is metabolized and excreted in less than 24 hours. As HA is produced in the 
body, it is taken as a nutritional supplement moisturizes from the dermis to the epidermis - 
from deeper layers of the skin to the outer layer. The ECM fills up the space between the skin 
cells.  This makes the skin soft, smooth and elastic.  But as we age, HA content in the skin 
changes due to two separate clinically proven factors [62].   
1. There is a decrease in synthesis of HA.  
2. Recompartmentalization – from the epidermis to the dermis.    
Both changes leave the epidermis depleted in HA resulting in thinning, aging, and decreased 
moisture in the skin.  
Medical Treatment with unmodified HA  
HA for use by humans has been derived from rooster combs.  Rooster combs provide 
the purest form of HA available.   
Osteoarthritis Treatment 
Injection of HA directly into the synovial fluid in the knee as a treatment for 
osteoarthritis of the knee has been followed for the past 20 years.  There are many peer-
reviewed articles written on the use of HA extracted from rooster combs for this purpose [63] 
but cost is a concern. The wholesale cost for the HA treatment series is about $620, plus the 
cost of the outpatient facility and the physician.   
From the Leaflet “Treating Knee Osteoarthritis with Injections” published by the American 
Academy of Family Physicians [64]:  
"Your doctor might inject an anaesthetic agent. This is a medicine that makes your 
knee numb. It can stop the pain for short time-maybe days or a few weeks. Another 
medicine, called a corticosteroid, can be injected along with the anaesthetic. These 
medicines together might make your pain stay away longer.  
"In the past few years, a medicine called HA has been used for knee injections. Some 
HA is already in the fluid in your joints. People with osteoarthritis, the HA gets 
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thinner. When this happens, there is not enough HA to protect the joint like it used to. 
Injections can put more HA into your knee joint to help protect it."  
Skin Treatment 
HA injection can be used to improve the skin's contour and reduce depressions in the 
skin due to acne, scars, injury or lines.  Immediately or within a few hours after injection the 
site may be red and swollen. This usually disappears within a week.  Another one or two 
treatments (at least a week apart) may be necessary to achieve the desired correction.  HA 
implantation is not permanent. Like natural HA, manufactured HA once injected into the skin 
will gradually break down and be absorbed by the body. In most cases, the HA augmentation 
usually lasts between 6-9 months. Compared to collagen implants HA appears to have a 
longer augmentation effect, possibly lasting 2 to 3 times longer than the average collagen 
implant. To maintain the initial results, repeat HA injections or top-up treatments will be 
necessary. Most people following this protocol have 2 to 3 treatments per year [62].  
Key Benefits of HA Supplementation  
 HA moisturizes skin from the inside out, smoothing out wrinkles in the process. HA 
acts as an internal cosmetic to hydrate the skin.   
 HA is for people who need to ease the flexing of their joints, especially their knees, by 
restoring cushioning to their joints.  
 HA is for men and women in their 30s and 40s who are beginning to see the first signs 
of aging.  
 HA is for seniors who have established joint conditions.   
 Studies show oral HA supplementation provides these benefits to most people after 
administration for only 2 to 4 months.  
Chemical modifications to HA to synthesise new biomaterials 
 HA is considered to be involved in many biological activities including embryonic 
development, wound healing, homeostasis of extra-cellular matrix and tissue regeneration 
[38]. It is clear that HA is somehow involved in all these activities, yet it is unclear of the 
exact mechanism. HA, having so much of biological importance, its half-life is so short in-
vivo because of its physicochemical properties. Treatment of HA deficient patients with HA 
supplementation seems to work some extent, however because of the HA’s short half-life, the 
frequency of HA supplementation increases the cost and that puts patients health at risk [63]. 
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As already mentioned, HA is a highly hydrophilic polymer and highly soluble in 
physiological solvents and in order to make any stable biomedical materials out of HA, there 
is a real need to modify its structure by blocking either one of its reactive groups like 
hydroxyl, carboxyl or acetamido as shown in figure 12. It offers a unique advantage as a 
building block for biomedical devices. It is a naturally derived polymer which is non-
immunogenic and enzymatically degradable [65]. It can withstand any harsh chemical 
modification procedures without losing its biological activities. In-order to prolong its in-vivo 
residence time, two main approaches are followed, namely (i) derivatization and (ii) cross-
linking methods. A detailed report on the two methods of chemical modifications is given by 
Prof. Glenn D Prestwich in glycoforum, 2001, Biomaterials from chemically-modified 
hyaluronan. A short summary of it is given here. 
 
HA derivatives: 
The three main types of derivatives that are widely studied are Ethyl ester derivative, 
carbodiimide-mediated derivative and sulphate derivative. These simple modifications are 
used to modify HA and the resulting modified HA can be used directly for applications or for 
further cross-linking procedures. 
 
 
 
Ester derivatives 
 Esterification of the available carboxylic groups forms a hydrophobic form of HA that 
are rigid and have resistance to enzymatic degradation [4]. This modification is done through 
an alkylation of HA with an alkyl halide yielding derivatives with 0-100% modification 
depending on the available number of carboxylic group of HA for the modification. Higher 
the modification, higher will be the rigidity of the modified HA and are highly hydrophobic 
that decreases the solubility in water and also gives much resistance to enzymatic degradation. 
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Carbodiimide derivatives 
 Reactions mediated by EDC or (1-ethyl-3-3’-dimethylaminopropyl) carbodiimide is a 
common means of covalently binding caryboxyl group of a bioactive molecule with an amine 
of another [66]. This reaction is highly pH dependent and often results in the formation of an 
unreactive intermediate, acylurea from carboxyl group.  
 
Sulphate derivatives 
 Reaction of sulphur trioxide pyridine with the hydroxyl group of HA, yields a range of 
sulphation from one to four sulphur groups coupled per disaccharide  repeating units of the 
HA [67]. This modified form of HA resembles more closely to heparin that is highly blood 
compatible molecule. 
 
Cross-linked HA 
 As mentioned before, HA having many important biological functions, that forms a 
base for the foundation of biomaterials. Cross-linking is another means of modifying HA to 
create new physicochemical properties. Depending on the cross-linking molecule and 
chemistry used, a wide variety of biomedical materials can be formed ranging from thin films 
of low water content to thick 3-D hydrogels with high water content. There are two general 
schemes followed in the cross-linking methods [68]. One is directly exposing the HA to the 
cross-linker which forms a single step procedure. The second scheme is, preparing a highly 
reactive HA derivatives in the first step and exposing it to the cross-linker in a subsequent 
reaction. 
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Diepoxy cross-linking 
 Using polyethylene glycol diglycidyl ether, Laurent and coworkers created diepoxy-
cross-linked HA [69]. Extension of this chemistry has been tried with ethylene glycol 
diglycidylether and polyglycerol polyglycidylether [70]. At low pH, diepoxy compounds form 
ester linkages with carboxyl groups and at high pH, it forms ether linkages with hydroxyl 
groups. 
 
Carbodiimide-mediated cross-linking 
 As already mentioned, carbodiimide mediated reactions are commonly between 
carboxylic acids and the amines. These reactions are highly sensitive to pH and often forms 
unreactive acylurea moiety with HA reactions. There are some special conditions under which 
this type of cross-linking works. To form cross-links, the carbodiimide-mediated reaction is 
performed on films of at least 70 weight-percent HA in acetone or ethanol-water solutions. 
 
Divinyl sulfone cross-linking 
 HA hydrogels which are highly insoluble in water can be prepared by cross-linking 
HA with divinyl sulfone [71]. At high pH, divinyl sulfone creates sulphonyl-bis-ethyl 
crosslinks with the hydroxyl groups of the HA. 
 
Photo cross-linking 
 This is a two step process. In the first step, HA is modified with photo cross-linkable 
groups like cinnamoyl, coumarin, thymine, methacrylic anhydride, glycidyl methacrylate and 
styrene. In the second step, exposing the modified HA to UV light of certain wavelength for a 
certain time, forms highly stable hydrogels [72]. 
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3. NCO-sP(EO-stat-PO) as cross-linker to HA 
 
3.1 Introduction 
Hydrogels are three dimensionally cross-linked polymer networks capable of taking up 
water many times their dry weight. They are thus predetermined for biomedical applications 
[1]  as they are excellent mimics of the in-vivo situation especially for soft tissues. For tissue 
engineering applications, many approaches have been made to prepare hydrogels from bio-
degradable materials like collagen, [2-4] fibrin, [5-7] gelatine, [8-11] alginate, [12-14] poly-
(α-hydroxyl esters) [15] and hyaluronic acid (HA) [16-21]. Out of all these materials, HA 
gains special importance as it is a component of the extra-cellular matrix (ECM) in soft 
tissues of mammals
 
[22]
 
where it mainly ensures water retention [23]. This enables transport 
of nutrients to and removing wastes from cells that do not have a direct blood supply such as 
cartilage cells. Moreover, HA is present in the synovial joint fluid, the vitreous humor of the 
eye, the cartilage, blood vessels and the umbilical cord. More detailed information about the 
biological functions and physicochemical properties of HA are described elsewhere
 
[24-26]. 
Besides its outstanding biological importance, poor biomechanical properties and 
rapid degradation in- vivo preclude many clinical applications of HA. Both properties 
originate from the chemical structure of HA which is a linear polysaccharide composed of 
unbranched repeating units of glucuronic acid and N-acetyl glucosamine. Thus, several 
strategies that all involve the alteration of either the carboxylic acid groups or the alcohol 
groups in the HA backbone have been developed to modify or cross-link HA to form more 
stable and robust gel-like systems. Direct modification of the HA acid includes ethyl-ester 
derivatives,
 
[27] carbodiimide-mediated hydrazide derivatives, [28-30] and sulphate 
derivatives [31]. Gelation of HA with cross-linkers includes using diepoxy compounds 
[32,33], aldehyde cross-linking [34], photo-cross-linking [35,36], divinyl-sulfone cross-
linking [37] and poly (ethylene oxide) (PEO) based polymers such as PEO propiondialdehyde 
[16] or PEO diglycidyl ether (PEODG) [17], and recently modified poly (vinyl alcohol) has 
successfully been used as cross-linker for aldehyde functional HA [38]. 
Recently we have shown that six arm star shaped poly (ethylene oxide-stat-propylene 
oxide) prepolymers (sP(EO-stat-PO)) with 80 % EO-content and reactive functional groups 
such as isocyanate (NCO) can be used to prepare three dimensional hydrogels [39]. Here we 
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present the use of this prepolymer as functional cross-linker system for HA. The simple 
mixing of aqueous solutions of HA and NCO-sP(EO-stat-PO) results in stable hydrogels with 
high water content. However, hydrolysis of NCO-groups and subsequent coupling of 
prepolymers via urea linkages occurs as side reaction. The synthesized hydrogels were 
characterized regarding sol-content, surface wettability, equilibrium water content (EWC) 
along with free water content determination by DSC. Chemical composition of the gels was 
followed by FTIR and RAMAN spectroscopy, the internal porous structure documented by 
cryo-FESEM, and time of gelation as well as shear modulus by rheological examination. 
Finally, the degradation behavior of the gels has been determined in-vitro by different 
concentrations of hyaluronidase. Both cross-linking mechanisms are compared and their 
effect on the resulting properties of the gels is presented and discussed on the basis of the 
results. 
3.2 Materials 
  Sodium Hyaluronic acid (Hyaluronic acid sodium salt, Sodium Hyaluronate, HA) of 
molecular weights (< 0.1x10
6) ≈ 53000 g/mol, (< 0.2x106) ≈ 150000 g/mol, (0.3-0.5x106) ≈ 
400000 g/mol, (0.5-0.9x10
6) ≈ 700000 g/mol and (1.5-2.0x106) ≈ 1750000 g/mol from 
streptococcus equi sp. was purchased from Dali HA Co., Ltd, (China). Star shaped poly-ethers 
with a backbone of statistically copolymerized 80% ethylene oxide and 20% propylene oxide, 
a molecular weight of 18000 g/mol (PD = 1.15) with isocyanate (NCO) groups at the distal 
endings of the arms (sP(EO-stat-PO)) were synthesized as described earlier [40].  
 
3.3 Hydrogel preparation 
Table 1 Molar ratios of sP(EO-stat-PO) to HA for the prepared hydrogels 
53000 g/mol 8% 
(w/v) 
X = 2% 
150000 g/mol 5% 
(w/v) 
X = 1.25% 
400000 g/mol 
5% (w/v) 
X =  1.25% 
700000 g/mol 
3% (w/v) 
X = 0.75% 
1750000 g/mol 
2% (w/v) 
X = 0.5% 
1: 0.030a
 
1: 0.011a 1: 0.004a
 
1: 0.002a
 
1: 0.001a 
1: 0.060b
 
1: 0.021b
 
1: 0.008b
 
1: 0.005b
 
1: 0.002b
 
1: 0.120c
 
1: 0.042c
 
1: 0.016c
 
1: 0.009c
 
1: 0.004c
 
1: 0.241d
 
1: 0.085d
 
1: 0.032d
 
1: 0.018
*
d 1: 0.008
*
d
 
1: 0.482
*
e
 
1: 0.17
*
e
 
1: 0.064
*
e
 
1: 0.036
*
e
 
1: 0.016
*
e
 
1: 0.964
*
f
 
1: 0.34
*
f
 
1: 0.128
*
f
 
1:0.072
*
f
 
1: 0.032
*
f
 
a, b, c, d, e and f corresponds to 8, 16, 32, 64, 128 and 256 HA monomer repeating units / sP(EO-stat-PO) 
prepolymers molecule respectively; [*] indicates no gelation. 
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  Aqueous HA of concentration x % (w/v) addition to the desired (end) concentration, 
(see Table 1), was prepared in deionised H2O. The NCO-sP(EO-stat-PO) was dissolved in 
certain amount of deionised H2O and added immediately to the aqueous HA in the molar 
ratios of NCO-sP(EO-stat-PO) to HA (see Table 1) and mixed vigorously, so that the final 
mixture turns to the desired concentration and the final mixture is dropped in to a Teflon mold 
of diameter 15 mm and depth 3 mm, covered airtight to allow the cross-linking reaction for 24 
hours. (Refer appendix A1) 
 
3.4 Contact angle measurements 
  For contact angle measurements, the homogenous aqueous gelation mixtures were 
dropped into a 1mm rakel (metal frame), wiped over a Teflon slab and covered airtight for 24 
hours to allow complete cross-linking. The hydrogel films in triplets were dried to zerogel 
condition by applying vacuum overnight. The zerogels were incubated in deionised H2O until 
equilibrium swelling conditions were reached. The swollen hydrogel films were fixed in a 
special sample holder of the captive bubble method arrangements. Measurements were made 
at least at eight different points on the hydrogel film surface using G-40 Goniometer, both on 
the left and right side of the bubble and average values were calculated with standard 
deviations. (Refer appendix A4) 
 
3.5 Equilibrium water content (EWC) measurements 
  The hydrogels as prepared were dried to zerogel condition in triplets by a vacuum 
chamber overnight and the dry weights were measured. The dried samples were placed in 
excess of deionised H2O at room temperature for studying its swelling kinetics. The weight of 
the swollen gels was measured at specific time intervals till it reaches its equilibrium state of 
swelling. The water content of the hydrogels was calculated according to equation 1: 
[(Ws – Wd) / Ws] • 100   equation 1 
Ws represent the weight of the swollen hydrogel and Wd is the weight of the dry hydrogel. 
(Refer appendix A2) 
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3.6 Differential Scanning Calorimetry (DSC) 
  The free water content (FWC) of the hydrogels were measured using Netzsch DSC 
204, at a heating and cooling rate of 10 degrees per minute using 4 to 6 mg of the weighed 
sample in an aluminium pan. Free water content is measured as a ratio of the heat of fusion of 
the sample measured to the heat of fusion of water (333.55 J/g). Bound water content (BWC) 
can be calculated by the difference between the total water content (EWC) determined by 
swelling experiments and the free water content. 
 
3.7 Fourier Transform Infra-Red Spectroscopy (FT-IR Spectroscopy) 
  FTIR spectra of unmodified HA, cross-linked hydrogels and NCO-sP(EO-stat-PO) 
were obtained using a Nexus 470 FTIR spectroscope with an attenuated total reflectance 
adapter installed (Thermo Nicolet, Madison, WI) by photo acoustic method. The Spectrum 
represents an average of 400 to 600 scans with CO2 peaks removed. 
 
3.8 Cryo- Field emission scanning electron microscopy (Cryo- FESEM) 
  The internal morphologies of hydrogels were visualized by cryo-FESEM. The 
hydrogels were frozen to -140 °C, placed inside the sample holder and the top section of the 
frozen gel was broken by a scraper and was imaged with Hitachi S-4800 at 1.5 kV. 
 
3.9 Rheological analysis 
  Time of gelation and shear modulus of the gels from NCO-sP(EO-stat-PO) / HA 
mixtures were determined by a dynamic time sweep test using Rheometrics-dynamic stress 
rheometer with a 25 mm flat plate geometer for a sample thickness of 1 mm at a frequency of 
6.283 (rad/s) at room temperature. 
 
 
 
3. NCO-sP(EO-stat-PO) as cross-linker to HA 
47 
 
3.10 In-vitro stability test in PBS 
  The stability of both types of sP(EO-stat-PO) / HA hydrogels were studied in-vitro in 
PBS (pH= 7.4, T= 37 °C). After completion of cross-linking, the gels were dried to zerogel 
condition and weighed. Swelling to EWC and drying to zerogel condition was repeated until 
the resulting weight did not change significantly. The experiments were done in triplets. 
  Separately, gels were placed in PBS (pH= 7.4, T= 37 °C) in the swollen state over 
several weeks, changing the medium every week and recording the hydrogel wet-weight until 
no further significant change could be detected or the gels were completely dissolved. 
 
3.11 Enzymatic degradation 
  In-vitro degradation of the NCO-sP(EO-stat-PO) / HA and ACR-sP(EO-stat-PO) / 
HS-HA hydrogels were measured as a function of time by incubating the gels in 
hyaluronidase solution and monitoring the mass of the hydrogel. First the gels were prepared 
approximately in pieces of 5x5 mm
2
 to 3 mm thickness, transferred to 24-well plates and 
soaked in PBS buffer (137 mM NaCl, 2.7 mM KCl and 10 mM phosphate buffered solution, 
pH 5.4) overnight to reach swelling equilibrium. After weighing, bovine testicular 
hyaluronidase of type IV-S from bovine testes (Sigma-Aldrich) in PBS buffer (1 mL of 5, 50, 
500 u/mL) was added to each gel and then incubated at 37 °C with mild shaking. Every hour, 
the gels were taken out of the solution, weighed, and incubated with fresh solution of 
hyaluronidase.  
 
3.12 Statistical analysis 
  Statistical analysis was performed using Student’s t-test with a minimum confidence 
level of 0.05 for statistical significance. All values are given as mean values and the standard 
deviation of the mean. 
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3.13 Results and Discussion 
  This study concerns the preparation of HA-based hydrogels with tailorable properties 
by the use of hydrophilic prepolymers with defined molecular structure as functional cross-
linkers. We used six armed star shaped PEO based molecule with isocyanate (NCO) 
functional groups at the distal endings of the arms NCO-sP(EO-stat-PO) with an EO content 
of 80% and a molecular weight of 3 kDa per arm. Due to the high EO content in the 
backbone, these molecules are water soluble.  
 
Fig. 1 Structure of NCO-sP(EO-stat-PO), HA and the two possible reaction ways for the 
NCO groups.  
  In this case, gelation occurs through reaction of the NCO group with alcohol-groups in 
the backbone of HA. This reaction results in urethane bridges between star molecules and HA 
chains and, due to the hexa-functionality of the star shaped molecules, to gel formation. Fig. 1 
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depicts the structure of both NCO-sP(EO-stat-PO) and HA. The molecular weights of HA 
used in this study range from 53000 to 1750000 g/Mol. An alternative possible reaction of the 
primary aliphatic NCO groups is hydrolysis. As the kinetics of this reaction is low [41], the 
NCO groups hydrolyse slowly upon dissolution in water, resulting in amino groups. Under 
physiological pH, these amino groups react quickly with NCO groups to result in urea-bridges 
between two prepolymers. We have reported before that this reaction may result in the 
formation of hydrogels [39]. In the presence of HA however, the high amount of OH-groups 
that is present in the HA backbone and the faster reaction kinetics between alcohol and 
isocyanate compared to hydrolysis result in preferential reaction of the NCOs with these 
alcohol groups. Depending on the concentration of both HA and NCO-sP(EO-stat-PO) as well 
as their molar ratio, this may lead to three dimensional cross-linking and hydrogel formation. 
When these factors are chosen unfavorably, it is possible that hydrolysis of the NCO groups 
becomes the dominant reaction, resulting either in NCO-sP(EO-stat-PO) gels with a minor 
content of HA or in no gel formation at all. A complete list of all prepared gels including the 
molar ratios and their concentration is given in Table 1. 
For all gels prepared from NCO-sP(EO-stat-PO) / HA, the cross-linking occurred 
within 5 to 15 minutes after mixing. After that time, the gels were stable enough to be taken 
out of the Teflon mold in which they were prepared. However, the gels were stored over night 
to allow for complete cross-linking in closed conditions. Consecutively, the gels were dried 
under vacuum until no further decrease in weight was observed. These zerogels were used for 
swelling in water until equilibrium water content (EWC) was reached. Since the drying step 
may induce entanglement and thus affect swelling of the gel to the real EWC, the gels were in 
an alternative method swollen to EWC after 24h cross-linking and subsequently dried. Both 
methods yielded almost identical values without significant differences in all cases. 
Surface wettability of the hydrogels has been determined by captive bubble contact 
angle measurements. With this technique, a needle is placed in the proximity of the swollen 
hydrogel in water from the bottom side and an air bubble is released. The contact angle can 
then be determined at the contact between the air bubble and the hydrogel sample. As 
expected, the contact angle decreases significantly (p < 0.05) with increasing HA content in 
the gels due to the pronounced hydrophilicity of HA [26]. 
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Table 2 Water-related properties of NCO-sP(EO-stat-PO) cross-linked HA with different 
molecular weights given in the table. All measurements were done in triplets. 
Molar ratio sP(EO-
stat-PO) to HA 
Contact 
angle (°) 
Swelling 
ratio 
EWC
a
 
(wt%) 
FWC
b
 
(wt%) 
BWC
c
 
(wt%) 
53000 g/Mol 
1: 0.030 
1: 0.060 
1: 0.120 
1: 0.241 
29.3 ± 1.0 
23.7 ± 1.2 
16.2 ± 0.4 
14.8 ± 0.5 
8.8 ± 0.2 
13.6 ± 0.1 
24.9 ± 1.5 
15.0 ± 0.1 
88.7 ± 0.3 
92.6 ± 0.4 
96.0 ± 0.2 
93.3 ± 0.3 
76.8 ± 1.2 
77.9 ± 1.8 
73.3 ± 0.9 
73.1 ± 1.6 
11.9 
14.7 
22.7 
20.2 
150000 g/Mol 
1: 0.011 
1: 0.021 
1: 0.042 
1: 0.085 
29.1 ± 1.2 
19.8 ± 1.0 
17.3 ± 0.5 
< 15 
11.1 ± 0.1 
17.3 ± 0.4 
36.8 ± 0.4 
89.9 ± 1.8 
91.0 ± 0.3 
94.3 ± 0.1 
97.3 ± 0.2 
98.9 ± 0.3 
77.6 ± 2.2 
76.2 ± 2.8 
71.6 ± 2.6 
60.1 ± 1.5 
13.4 
18.1 
25.7 
38.8 
400000 g/Mol 
1: 0.004 
1: 0.008 
1: 0.016 
1: 0.032 
29.5 ± 1.4 
21.3 ± 1.0 
17.3 ± 0.5 
< 10 
10.1 ± 0.2 
22.0 ± 0.9 
42.8 ± 1.8 
59.5 ± 5.7 
90.1 ± 0.2 
95.4 ± 0.3 
97.7 ± 0.1 
98.3 ± 0.2 
84.0 ± 1.9 
77.6 ± 1.6 
82.7 ± 1.6 
76.4 ± 2.3 
6.1 
17.8 
15.0 
21.9 
700000 g/Mol 
1: 0.002 
1: 0.005 
1: 0.009 
28.2 ± 1.0 
21.8 ± 0.8 
18.0 ± 0.8 
11.9 ± 0.1 
36.8 ± 2.8 
72.4 ± 1.1 
91.5 ± 0.3 
97.3 ± 0.2 
98.6 ± 0.3 
85.9 ± 1.7 
85.1 ± 1.3 
75.1 ± 0.9 
5.6 
12.2 
23.5 
1750000 g/Mol 
1: 0.001 
1: 0.002 
1: 0.004 
23.7 ± 1.0 
15.8 ± 1.0 
N/A 
19.2 ± 0.4 
55.4 ± 3.8 
193.8 ± 20 
94.8 ± 0.3 
98.2 ± 0.1 
99.5 ± 0.2 
88.0 ± 1.4 
86.6 ± 1.6 
78.4 ± 0.9 
6.8 
11.6 
21.1 
 
a
EWC = equilibrium water content;
 b
FWC = free water content; 
c
BWC = bound water content 
 
  Accordingly, the equilibrium water content (EWC) of the hydrogels increases with the 
molar ratio of HA in the gels with a statistical significance of p<0.05. With the exception of 
the hydrogel prepared from the lowest molecular weight HA with the lowest HA content 
(EWC = 88.7 wt %), all hydrogels show EWC values higher than 90%. The gel prepared from 
the highest molecular weight of HA with the highest amount of HA shows a EWC of 99.5 
wt%. Swelling-ratios for the gels are given in Table 2 and follow the trend according to the 
EWC values. The tremendous attraction of water by HA originates from the high density of 
negative charges that binds a cloud of cations, most notably Na
+
, which are osmotically active 
and cause further swelling of the gels. 
Water in hydrogels can be broadly classified into bound water and free water. When a 
zerogel is wetted, the first water molecules interact strongly with the polymer chains resulting 
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in so called bound water. Further swelling of the polymer network occurs as result of osmotic 
driving forces due to the hydration tendency of the hydrophilic network chains towards 
infinite dilution. This swelling is opposed by retractive forces of the three dimensionally 
cross-linked networks. When the two forces equalize each other, the swelling process stops 
and EWC is reached. DSC is a technique that allows the quantitative determination of free 
water in swollen hydrogels. This method is based on the assumption that only the free water 
in the swollen gels may be frozen, so that the endothermic peak measured at 0°C when 
warming the frozen gel represents the melting solely of the crystallized free water [42]. We 
have applied this method and calculated the amount of free water in EWC swollen gels using 
the bulk heat of fusion of water (333.55 J/g). The determined amount of free water (FWC) 
was then subtracted from the total water content as determined by the swelling experiments 
which resulted in estimation for the amount of bound water (BWC) in the gels. Table 2 
summarizes the obtained results and shows that the share of bound water in the gels increased 
significantly with increasing HA content due to the hydrophilicity and the strong interaction 
of the HA chains with water. 
5001000150020002500300035004000
Wave number (cm-1)
2869 1716
1120
3346
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Fig. 2 FT-IR spectra of unmodified HA (A), dry NCO-sP(EO-stat-PO) (B) and as 
representative examples cross-linked zerogels of molar ratio of 1: 0.001 (C1), 1: 0.0021 (C2) 
and 1: 0.0042 (C3) for a HA molecular weight of 1750000 g/Mol. 
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Fourier transform infrared spectroscopy (FTIR) of HA and dry NCO-sP(EO-stat-PO) 
before gel formation as well as the different hydrogels after drying and swelling was 
performed to confirm the chemical composition of the hydrogels. Fig. 2 presents 
representative spectra for gels obtained from HA with the molecular weight 1750000 g/Mol. 
Characteristic peaks for HA are the OH vibration at 3346 cm
-1
 and the broad carbonyl band of 
the acid and the N-acetylamide group at 1618 cm
-1
. In the spectrum of non-hydrolyzed NCO-
sP(EO-stat-PO), the NCO band at 2264 cm
-1
 as well as the C-H stretching vibration peak at 
2869 cm
-1
, the C-H bending vibration peak at 1450cm
-1
, and the C-O-C stretching and 
bending of ether at 1240 and 1120 cm
-1
 are characteristic. In addition, the NCO-sP(EO-stat-
PO) precursor spectrum contains a urethane group peak at 1716 cm
-1
 that originates from the 
reaction of IPDI with the OH terminated star precursor during the NCO-sP(EO-stat-PO) 
synthesis. 
Thus, although chemical cross-linking of the NCO-sP(EO-stat-PO)-HA occurs 
through urethane bond formation, the presence of this band in the spectra of the mixed 
hydrogels cannot be taken as proof for chemical cross-linking. However, the normalized 
spectra of the NCO-sP(EO-stat-PO) / HA gels show an increase in relative intensity of the 
characteristic sP(EO-stat-PO) bands according to the ratio that has been used for gel 
preparation. Since isocyanate yields extremely strong signals in IR spectroscopy and can be 
detected even in very low concentrations by this technique, absence of NCO group bands in 
the spectra demonstrates that the cross-linked hydrogels do not contain residual NCO groups. 
Finally, the spectra do not show a signal for possibly formed urea groups at 1705 cm
-1
. 
Despite the overlap of this band with the signal for the urethane bond, the lack of a shoulder 
shows that the amount of urea groups and thus inter-prepolymer cross-linking is small. 
  Sol-content of NCO-sP(EO-stat-PO) / HA hydrogels in PBS (pH: 7.4) at 37 °C has 
been determined by repeated swelling / drying cycles until the dry weight did not change 
significantly. The sol-content for gels prepared from high molecular weight HA (Fig. 3 A, B) 
generally accounts for 15 to 20 wt%. Gels prepared from lower molecular weight HA show a 
mass-loss that depends on the ratio between HA repeating units and prepolymer (Fig. 3 C-E), 
with mass-losses of about 15 wt% for higher cross-linker content and up to 40 wt% for lower 
cross-linking content. We explain this by the lack of entanglement for low molecular weight 
HA and a higher probability that at low cross-linker content a single chain is not covalently 
linked to the network. Furthermore, when these hydrogels are stored in PBS buffer with 
exchange of the buffer every week and the swollen weight of the hydrogel is measured, the 
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gels did not disintegrate with a mass loss that correlates to the values obtained by the method 
described above.  
 
Fig. 3 Swelling-drying cycles of hydrogel in PBS (pH: 7.4, 37 °C). (A) 1750000 g/Mol, (B) 
700000 g/Mol, (C) 400000 g/Mol, (D)150000 g/Mol and (E) 53000 g/Mol. The respective 
molar ratios between prepolymer and HA are listed in Table 1.  
 
  These gels were further investigated regarding the possibility to tailor porosity, 
mechanical stability and enzymatic degradation behavior by molar ratio between cross-linker 
and HA. Cryo-FESEM was employed as technique to visualize the internal morphology of the 
gels. 
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Fig. 4 Cryo-FESEM images of NCO-sP(EO-stat-PO)-HA hydrogels. Mw of HA and molar 
ratio prepolymer: HA is (A) 1750kDa (1: 0.004), (B) 700 kDa (1: 0.009), (C) 150 kDa (1: 
0.042) and (D) 53 kDa (1: 0.120). For all hydrogels the molar ratio of NCO-sP(EO-stat-PO) 
to repeat units of HA is 32. 
 
  In this method, fast freezing of small sample volumes minimizes structural changes 
and crystallization of water so that, upon sample fracturing in the measurement chamber of 
the SEM, the internal structure and porosity of the swollen hydrogels can be visualized. Fig. 6 
presents images of gels with a constant ratio of 32 repeating units of HA per NCO-sP(EO-
stat-PO) molecule in the cross-linking solution to enable a comparison of hydrogels obtained 
from different molecular weights of HA. Hydrogels prepared from HA with molecular weight 
between 53 and 400 kDa (SEM picture for 400 kDa is not shown) display very similar 
average porosity between 1 and 2 µm. A further increase in HA molecular weight results in 
significantly bigger pore sizes with an average value of 6 µm for 700 kDa and 12 µm for 1750 
kDa. While the molar ratio between cross-linker and repeating units of HA is constant for the 
gels compared in Fig. 4, the concentration (w/v) of HA in the gel-forming solution decreases 
and the molar ratio between cross-linker and HA chains increases with increasing HA 
molecular weight. Especially the lower concentration of high Mw HA which is necessary due 
to the increase in viscosity of the solutions leads to a situation where the NCO-functional 
prepolymer may attach to a HA chain but not be able to cross-link with another HA chain. 
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Overall, this leads to a reduced cross-linking density and thus an increase in porosity of the 
gels. 
  Gelation time of the HA-prepolymer mixtures and mechanical properties of the 
resulting gels have been analyzed by injecting the gelating mixture directly after mixing of the 
two solutions in between the two plates of a plate-plate rheometer. Rheological analysis 
allows documentation of loss and shear modulus over time, revealing the gel point as time 
point at which the shear modulus becomes bigger than the loss modulus and the final shear 
modulus of the hydrogel (Table 3).  
Table 3 Starting point of gelation (gel time) and shear modulus (shear mod.) for the different 
hydrogels measured by rheometry. 
Molar 
ratio r.u. 
HA / 
sP(EO-
stat-PO) 
HA molecular weight (g/mol) 
1750000 700000 400000 150000 53000 
gel 
time 
(sec) 
shear 
mod.(kPa) 
gel 
time 
(sec) 
shear 
mod. 
(kPa) 
gel 
time 
(sec) 
shear 
mod. 
(kPa) 
gel 
time 
(sec) 
shear 
mod. 
(kPa) 
gel 
time 
(sec) 
shear 
mod. 
(kPa) 
8 
692 
±35 
28.5±2.1 
671 
±11 
41.5 
±0.7 
570 
±33 
58.5 
±1.5 
644 
±16 
66.8 
±2.9 
663 
±11 
105    
±0.7 
16 
704 
±20 
8.6 ±0.5 
537 
±35 
18.2 
±3.6 
693  
±1 
31.2 
±1.2 
662 
±30 
31.8 
±4.5 
671 
±37 
51.7 
±1 
32 
707 
±20 
2.5 ±0.3 
628 
±6 
5.2 
±0.6 
785 
±11 
11.2 
±1.2 
738 
±15 
10.5 
±0.8 
727  
±5 
19.4 
±1.6 
64 N/A N/A N/A N/A 
913  
±7 
2.1   
±0.2 
962 
±18 
2.4   
±0.3 
921 
±10 
5      
±1 
 
  With NCO-sP(EO-stat-PO) / HA gels, the gelation time is similar for all gels with a 
significantly longer gelation time for the lowest cross-linker content. Rheology revealed that 
with NCO-sP(EO-stat-PO) cross-linking, high-Mw HA formed mechanically weaker gels 
than low molecular weight. For each molar ratios, there is a statistically significant (p < 0.05) 
decrease in the shear modulus with an increase in the molecular weight of the HA except 
between 400kDa and 150kDa. At the same time, for each molecular weight, there is a 
statistical significant (p < 0.05) decrease in shear modulus with an increase in HA content. 
(Fig. 5). 
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Fig. 5 Shear moduli of the hydrogels as determined by rheometer with plate-plate geometry. 
Panel (A) shows NCO-sP(EO-stat-PO) / HA gels. 
 
  These observations for stability of the gels in PBS buffer at 37 °C, their porosity and 
mechanical behaviour confirm the models for cross-linking indicated above. Isocyanate-
prepolymer cross-linking of HA results in mechanically stronger gels that possess increasing 
shear modulus, lower sol-content and lower average pore size with increasing prepolymer 
content. This can be assigned to the possibility of the NCO-functional prepolymer to cross-
link and form a hydrogel in water with only little or even without HA especially at increasing 
prepolymer concentration. The obtained decrease of mechanical strength for gels prepared 
with increasing molecular weight of HA can be assigned to the lower concentration of the 
high molecular weight HA during gel preparation.  
  In-vitro degradation of the hydrogels was determined by incubating hydrogels in three 
different concentrations of hyaluronidase solutions (5, 50, 500 u/mL in PBS buffer). Hydrogel 
mass was followed over time until no further mass-loss occurred or the gel was degraded 
completely.  
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Fig. 6 In-vitro degradation of NCO-sP(EO-stat-PO) / HA hydrogels with Mw of HA (A) 
1750000 g/Mol, (B) 700000 g/Mol, (C) 400000 g/Mol, (D) 150000 g/Mol and (E) 53000 
g/Mol in hyaluronidase solutions of three different concentrations at 37°C (n=3). As obtained 
from statistical analysis, p values < 0.05 were considered as statistically significant and were 
highlighted with one and high significance (p<0.01) with two stars. 
 
 
  Enzyme concentrations were chosen to approximate the endogenous level 
(hyaluronidase concentration in human serum is 2.6 u/mL [43]), as well as concentrations 10 
and 100 fold greater to ensure maximal hydrogel degradation before hyaluronidase 
inactivation (hyaluronidase remains active up to 5 h at 37°C [44]). The results are presented in 
3. NCO-sP(EO-stat-PO) as cross-linker to HA 
58 
 
Fig. 6. For NCO-sP(EO-stat-PO) / HA hydrogels, the concentration of hyaluronidase did not 
affect the degradation significantly with one exception for the gel prepared from highest 
molecular weight HA with the biggest amount of HA (Fig. 6). Hydrogels with higher HA 
content were degradable to a bigger extent with a maximum weight loss of about 50 wt%, but 
the hydrogels with lower HA content showed only very little weight loss of between 10 and 
20 wt%. The partial degradability of these hydrogels by hyaluronidase has two reasons. For 
gels with higher HA content, the amount of cross-linking due to reaction between 
prepolymers is as shown, above low. 
 
  However, the prepolymers do form the cross-links between HA chains with urethane-
bonds that the hyaluronidase cannot cleave. Furthermore, the mammalian-type hyaluronidases 
are endo-β-N-acetylhexosaminidases and produce tetrasaccharides and hexasaccharides as 
major end products [24]. Hence, more than 4 to 6 continuous monomer units of the HA chains 
have to be accessible for the enzyme to facilitate degradation by the hyaluronidase. Steric 
restrictions thus explain that the gels with lowest prepolymer content are only partially 
degradable. With increasing cross-linker content, cross-linking density and the amount of 
intermolecular reaction in between prepolymers increases, thus lowering the degradability of 
the resulting hydrogels. 
 
3.14 Conclusion 
  This study presents the use of reactive prepolymers with defined star-shaped 
molecular architecture as cross-linkers for the formation of hyaluronic acid (HA) based 
hydrogels. HA with a wide range of molecular weights was cross-linked with isocyanate 
functional NCO-sP(EO-stat-PO) prepolymers through reaction of the isocyanates with alcohol 
groups of the HA. As side reaction especially for gels with higher prepolymer content, 
hydrolysis of isocyanate groups and intermolecular bridging between prepolymers also 
contributed to the gelation process.  
 
  This systems result in hydrogels with high equilibrium water content and sol-phase 
contents of between 20 and 40 wt% depending on cross-linking density. With this system, 
porosity, mechanical strength and enzymatic degradability can be tailored by choosing the 
appropriate HA molecular weight, concentration and adjusting prepolymer content. This 
yielded hydrogels that are long-term stable in PBS buffer at 37°C with average porosities 
from 1 to 15 µm, shear moduli from 2 to 105 kPa and partial degradability by hyaluronidase 
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in endogenous concentration between 10 and 40 wt%. Since cross-linking in this system 
follows two mechanisms, mechanical strength of the resulting hydrogels increases with 
increasing cross-linker content, whereas average pore size, sol-content and degradability by 
hyaluronidase decrease.  
 
  The presented method for preparing HA based hydrogels is straightforward, fast and 
easy to perform in physiological conditions and allows the preparation of gels with a broad 
variety of properties. Ongoing studies concern biocompatibility of this system and the 
possibility to biofunctionalize the gels and use them for cell-encapsulation and drug-release. 
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4. Comparison of sP(EO-stat-PO) with Isocyanate and 
Acrylate end groups as respective cross-linker for 
unmodified and thiol modified Hyaluronic acid 
 
4.1 Introduction 
  Hydrogels made out of functionalised poly (ethylene glycol) (PEG) as cross-linker 
system to biopolymers find numerous applications in the field of biomedical engineering as 
PEG is known for its non-toxic, high water uptake, highly reactive towards natural and 
synthetic materials and lack of interaction with biological matter like the immune system, 
micro organisms and so on [1-5]. On the other hand, bio-polysaccharides mimic the natural 
environment for cells as seen in the extra cellular matrix [6]
 
(ECM) like the Hyaluronic acid 
(HA) [7-12], Chondroitin sulphate [13], Heparin [14], Keratan sulphate and heparan sulphate 
[15]. All these polysaccharides lack stability in water and in other physiological solvents. 
Several possibilities of using PEG based polymers as cross-linker system to these bio-
polysaccharides were studied and had a great success [16-21].  
 
  Of all the bio-polysaccharides, HA is the most widely studied polysaccharide because 
of its multiple biological functions in the mammals [22], like the water retention property that 
gives the anti-wrinkling effect to the skin, as lubricant, shock absorber and as nutrient carrier 
to the bone joints in the form of synovial fluid, again as nutrient carrier to the avascular 
cartilage, giving viscoelastic property to the vitreous humour of the eye and finally as an 
essential structural element of the ECM that helps in the flow of information or biological 
signals between the living cells. HA has reached the level of commercial products that are in 
use or are being researched as an aid in the prevention and treatment of symptoms related to 
fractures, hernias, glaucoma, keratoconus, detached retinas, osteoarthritis, temporomandibular 
joint disorder (TMJ), prevention of scarring, vocal chord repair insufficiency, wrinkled skin, 
cartilage damage, and wound and ligament healing, which are collectively called as 
connective tissue disorders [23]. Having that many biological importance and medical 
applications, it lacks in-vitro stability in water and in other physiological solvents as 
mentioned earlier. The research studies show that the molecular weight of the uncross-linked 
HA reduces upon degradation and the cross-linked HA has an infinite molecular weight with 
higher viscoelastic properties that makes its life longer [24]. 
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The studies on the different cross-linking methods of HA to increase its stability in 
water and other solvents were summarised in the previous chapter along with an introduction 
to six arm star shaped isocyanate (NCO) terminated PEG-stat-PPG prepolymers (NCO-s 
P(EO-stat-PO)) as a new cross-linker system to the HA. The simple mixing of aqueous 
solutions of HA and NCO-sP(EO-stat-PO) results in the linking of isocyanates with hydroxyl 
groups of HA forming stable hydrogels with high water content. However, hydrolysis of 
NCO-groups and subsequent coupling of prepolymers via urea linkages occurs as side 
reaction. Hence, thiol-functionalised HA was cross-linked with ACR-sP(EO-stat-PO) in order 
to have a system for comparison where cross-linking is exclusively occurring between 
prepolymer and HA. Therefore a comparison study in the physical properties of the cross-
linked hydrogel material made between 150 kDa of thiol modified HA and the same 
molecular weight of unmodified HA using Acrylate terminated PEG-stat-PPG prepolymers 
(ACR-sP(EO-stat-PO)) and (NCO-sP(EO-stat-PO)) as cross-linker respectively. The 
materials were characterized for its surface  wettability, its equilibrium water content, its 
morphology by cryo-FESEM, its chemical modifications by FTIR and RAMAN 
spectroscopy, its gelation time and mechanical strength by rheometer and finally its stability 
in PBS (T= 37°C, pH: 7.4) and enzymatic degradation behaviour in Hyaluronidase. 
 
4.2 Materials 
  Sodium Hyaluronic acid (Hyaluronic acid sodium salt, Sodium Hyaluronate, HA) of 
molecular weights (< 0.2x10
6) ≈ 150000 g/mol, from streptococcus equi sp. was purchased 
from Dali HA Co., Ltd, (China). Thiol modified HA of molecular weight 150000 g/mol with 
degree of thiolation: 50% was purchased from Glycosan biosystems (U.S.A). Star shaped 
poly-ethers with a backbone of statistically copolymerized 80% ethylene oxide and 20% 
propylene oxide, a molecular weight of 18000 g/mol (PD = 1.15) and isocyanate (NCO) 
groups and acrylate (ACR) at the distal endings of the arms (sP(EO-stat-PO)) were 
synthesized as described earlier [25, 26].  
 
4.3 Hydrogel preparation  
  Aqueous HA of concentration x % (w/v) addition to the desired (end) concentration, 
(see Table 1), was prepared in deionised H2O. The sP(EO-stat-PO) was dissolved in certain 
amount of deionised H2O and added immediately to the aqueous HA in the molar ratios of 
sP(EO-stat-PO) to HA (see Table 1) and mixed vigorously, so that the final mixture turns to 
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the desired concentration and the final mixture is dropped in to a Teflon mold of diameter 15 
mm and depth 3 mm, covered airtight to allow the cross-linking reaction for 24 hours. (Refer 
appendix A1) 
Table 1 Molar ratios of sP(EO-stat-PO) to HA 
150000 g/mol (unmodified HA)           
Conc. 5% (w/v) 
X = 1.25% 
150000 g/mol  (Thiol modified 
HA) Conc. 2% (w/v) 
X = 0.5 % 
1: 0.0106a 1: 0.0106a
 
1: 0.021b
 
1: 0.021b
 
1: 0.042c
 
1: 0.042c
 
1: 0.085d
 1: 0.085d
 
1: 0.17
*
e
 
1: 0.17e
 
1: 0.34
*
f
 
1: 0.34f
 
a, b, c, d, e and f corresponds to 8, 16, 32, 64, 128 and 256 HA monomer repeating units / sP(EO-stat-PO) 
prepolymers molecule respectively.  (* indicates no gelation.) 
 
4.4 Contact angle measurements 
  For contact angle measurements, the homogenous aqueous gelation mixtures were 
dropped into a 1mm rakel (metal frame), wiped over a Teflon slab and covered airtight for 24 
hours to allow complete cross-linking. The hydrogel films in triplets were dried to zerogel 
condition by applying vacuum overnight. The zerogels were incubated in deionised H2O until 
equilibrium swelling conditions were reached. The swollen hydrogel films were fixed in a 
special sample holder of the captive bubble method arrangements. Measurements were made 
at least at eight different points on the hydrogel film surface using G-40 Goniometer, both on 
the left and right side of the bubble and average values were calculated with standard 
deviations. (Refer appendix A4) 
 
4.5 Equilibrium water content (EWC) measurements 
  The hydrogels as prepared were dried to zerogel condition in triplets by a vacuum 
chamber overnight and the dry weights were measured. The dried samples were placed in 
excess of deionised H2O at room temperature for studying its swelling kinetics. The weight of 
the swollen gels was measured at specific time intervals till it reaches its equilibrium state of 
swelling. The water content of the hydrogels was calculated according to equation 1: 
[(Ws – Wd) / Ws] • 100   equation 1 
Ws represent the weight of the swollen hydrogel and Wd is the weight of the dry hydrogel. 
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4.6 Differential Scanning Calorimetry (DSC) 
  The free water content (FWC) of the hydrogels were measured using Netzsch DSC 
204, at a heating and cooling rate of 10 degrees per minute using 4 to 6 mg of the weighed 
sample in an aluminium pan. Free water content is measured as a ratio of the heat of fusion of 
the sample measured to the heat of fusion of water (333.55 J/g). Bound water content (BWC) 
can be calculated by the difference between the total water content (EWC) and the free water 
content (Appendix A5). 
 
4.7 Fourier Transform Infra-Red Spectroscopy (FT-IR Spectroscopy) 
  FTIR spectra of unmodified HA, cross-linked hydrogels and NCO-sP(EO-stat-PO) 
were obtained using a Nexus 470 FTIR spectroscope with an attenuated total reflectance 
adapter installed (Thermo Nicolet, Madison, WI) by photo acoustic method. The Spectrum 
represents an average of 400 to 600 scans with CO2 peaks removed. 
 
4.8  Fourier Transform-RAMAN spectroscopy 
  FT-RAMAN spectra of thiol modified HA, cross-linked hydrogels and ACR-sP(EO-
stat-PO) were obtained using a BRUKER RFS 100/S spectroscope with an Nd: YAG laser 
light of wavelength 1064 mm and 500 milli watts power. The spectrum represents an average 
of 800 to 1000 scans with spectral resolution of 4 cm
-1
. 
 
4.9 Cryo- Field emission scanning electron microscopy (Cryo- FESEM) 
  The internal morphologies of hydrogels were visualized by cryo-FESEM. The 
hydrogels were frozen to -140° C, placed inside the sample holder and the top section of the 
frozen gel was broken by a scraper and was imaged with Hitachi S-4800 at 1.5 kV. 
4.10 Rheological analysis 
  Time of gelation, shear modulus and viscous modulus of the gels from sP(EO-stat-
PO)-HA mixture was determined by a dynamic time sweep test using Rheometrics-dynamic 
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stress rheometer with a 25mm flat plate geometer for a sample thickness of 1mm at a 
frequency of 6.283 (rad/s) at room temperature (appendix A7). 
4.11 In-vitro stability test in PBS 
  The stability of both types of sP(EO-stat-PO) / HA hydrogels were studied in-vitro in 
PBS (pH= 7.4, T= 37 °C). After completion of cross-linking, the gels were dried to zerogel 
condition and weighed. Swelling to EWC and drying to zerogel condition was repeated until 
the resulting weight did not change significantly. The experiments were done in triplets. 
Separately, gels were placed in PBS (pH= 7.4, T= 37 °C) in the swollen state over several 
weeks, changing the medium every week and recording the hydrogel wet-weight until no 
further significant change could be detected or the gels were completely dissolved. (refer 
appendix A8) 
 
4.12 Enzymatic degradation 
  In-vitro degradation of the NCO-sP(EO-stat-PO) / HA and ACR-sP(EO-stat-PO) / 
HS- HA hydrogels was measured as a function of time by incubating the gels in hyaluronidase 
solution and monitoring the mass of the hydrogel (appendix A9). First the gels were prepared 
approximately in pieces of 5x5 mm
2
 to 3mm thickness, transferred to 24-well plates and 
soaked in PBS buffer (137 mM NaCl, 2.7 mM KCl and 10 mM phosphate buffered solution, 
pH 5.4) overnight to reach swelling equilibrium. After weighing, bovine testicular 
hyaluronidase of type IV-S from bovine testes (Sigma-Aldrich) in PBS buffer (1mL of 5, 50, 
500 U/mL) was added to each gel and then incubated at 37°C with mild shaking. The gels 
were weighed in certain interval of time and replenished with fresh solution of hyaluronidase.  
 
4.13 Statistical analysis 
 Statistical analysis was performed using Student’s t-test (to compare two individual 
groups) with a minimum confidence level of 0.05 for statistical significance. All values are 
given in this work as the mean and the standard deviation of the mean. 
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4.14 Results and Discussion 
  The aim of this work is to study the difference in the cross-linking mechanism 
between ACR-sP(EO-stat-PO) and NCO-sP(EO-stat-PO) to thiol modified and unmodified 
HA respectively (See Figure 1. for the structure of hydrogel components).  
 
 
 
Fig. 1 Structure of (A) NCO-sP(EO-stat-PO) and unmodified HA, (B) ACR-sP(EO-stat-PO) 
and thiol modified HA. 
  The cross-linking mechanism of the NCO-sP(EO-stat-PO) with the unmodified HA 
forming stable hydrogels is stated in our previous chapter. Briefly, the reaction of NCO group 
with alcohol-groups in the backbone of HA. This reaction results in urethane bridges between 
star molecules and HA chains to gel formation. As a possible side reaction, the NCO groups 
hydrolyse slowly upon dissolution in water, resulting in amino groups and under 
physiological pH, these amino groups react quickly with NCO groups to result in urea-bridges 
between two prepolymers. Although the amount of urea bond formation as a result of this side 
reaction is low, we wanted to examine a system where cross-linking is not susceptible to 
hydrolysis but exclusive for reaction between HA and cross-linker. Hence we make a 
A B 
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comparison study of ACR-sP(EO-stat-PO) and NCO-sP(EO-stat-PO) as respective cross-
linker to thiol modified and unmodified HA of both Mw: 150000 g/mol respectively.  
  Different molar ratios of sP(EO-stat-PO) to unmodified HA and the thiol modified HA 
as given in the Table 1 were tried to see the highest amount of HA, in terms of moles, that can 
be cross-linked by a mole of sP(EO-stat-PO). In this study we found that one mole of NCO-
sP(EO-stat-PO) could manage to cross-link a maximum of 0.085 mole of unmodified HA 
(Mw: 150000 g/mol), but the ACR-sP(EO-stat-PO) managed to cross-link a maximum of 0.34 
mole of the thiol modified HA (Mw: 150000 g/mol).  The reason for the ACR-sP(EO-stat-PO) 
to cross-link a higher amount of HA than the NCO-sP(EO-stat-PO) is as follows. The NCO-
sP(EO-stat-PO) has the ability to cross-link with itself (Intra cross-link) to form urea in 
addition to the urethane bond formation by cross-linking with OH groups of the HA. Here is 
the less probability for all the NCO groups of the sP(EO-stat-PO) available for the reaction 
with the OH groups of the HA. In the case of ACR-sP(EO-stat-PO), there is no intra cross-
linking occurs, instead all the acrylates are available for cross-linking with the thiol groups of 
the HA. The cross-linked hydrogels shows a tendency of increase in hydrophilicity, water 
content and the swelling ratio, when the amount of unmodified HA in the molar ratios of 
NCO-sP(EO-stat-PO) to unmodified HA is increased (statistical significance of p<0.05) 
(Table 2).  
Table 2 Water related properties. All measurements were done in triplets. 
  
  In the comparison study, a significant decrease in hydrophilicity of the cross-linked 
hydrogels was observed only from 1: 0.011 to 0.021 molar ratio of cross-linker to HS-HA and 
can be explained by the greater hydrophilicity of ACR-sP(EO-stat-PO) in comparison to the 
NCO functional prepolymers and a more pronounced hydrophobicity of the HS-HA when 
150000 g/mol (A- unmodified HA, B- thiol modified HA) 
Molar ratio of  sP(EO-
stat-PO) to HA 
Contact angle (°) EWC (%) Swelling ratio 
A B A B A B 
1: 0.011 
1: 0.021 
1: 0.042 
1: 0.084 
1: 0.168 
1: 0.336 
29.1 ±1.2 
19.8 ± 1.0 
17.3 ± 0.5 
< 15 
N/A 
N/A 
18.8 ± 1.8 
22.7 ± 0.9 
23.3 ± 0.5 
23.1 ± 0.6 
23.0 ± 0.4 
24.0 ± 1.1 
91.0 ± 0.3 
94.3 ± 0.1 
97.3 ± 0.2 
98.9 ± 0.3 
N/A 
N/A 
86.5 ± 0.6  
92.9 ± 0.3 
93.3 ± 0.7 
94.0 ± 0.6 
95.4 ± 0.2 
95.8 ± 0.2 
11.1 ± 0.1 
17.3 ± 0.4 
36.8 ± 0.4 
89.9 ± 1.8 
N/A 
N/A 
7.4 ± 0.0 
14.1 ± 0.6 
14.9 ± 0.5 
16.6 ± 1.6 
23.2 ± 0.3 
23.5 ± 0.4 
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compared to HA due to the thioethylene-side group that replaces every second carboxyl-
group.  
  A statistically significant (p>0.05) increase in water content and the swelling ratio 
with an increase in the amount of thiol modified HA in the mixture. In both types of 
hydrogels, water content of the cross-linked materials increases with an increase in the 
amount of the HA, for the reason that HA having a high density of negative charges that 
attracts a cloud of cations, most notably Na
+
, that are osmotically active, causing large 
amounts of water to be sucked into the matrix. In other words, HA is known for the water 
retention property. In this comparison study, for the same molar ratio, NCO-sP(EO-stat-PO) / 
HA mixture has got higher water content than the ACR-sP(EO-stat-PO) / HS-HA. We believe 
that the reason is, in the case of NCO-sP(EO-stat-PO) / HA mixture, in the unmodified HA all 
the carboxylic groups are available for the attraction of water, but in the case of ACR-sP(EO-
stat-PO) / HS-HA mixture, in thiol modified HA, 50% of its carboxylic groups are converted 
to thiols and that are not involved in the water attraction process. 
  Table 3 Free water content measurement by DSC 
Molar ratio of  sP(EO-stat-
PO) to HA 
FWC (%) BWC (%) EWC (%) 
(A- unmodified HA, B- 
thiol modified HA) 
A B A B A B 
1: 0.010 
1: 0.021 
1: 0.042 
1: 0.084 
1: 0.168 
1: 0.336 
79.2 
76.2 
73.4 
60.1 
--- 
--- 
85.4 
88.1 
87.6 
80.3 
72.0 
NA 
11.8 
18.1 
23.9 
38.8 
--- 
--- 
1.08 
4.79 
5.73 
13.7 
23.45 
NA 
91 ± 0.1 
94.3 ± 0.1 
97.3 ± 0.0 
98.9 ± 0.0 
--- 
--- 
86.5 ± 0  
92.9±0.28 
93.3 ± 0 
94 ± 0.6 
95.4 ± 0.06 
95.8 ± 0.08 
   
  Water content of any bio-polymeric hydrogels as such can be divided in to different 
classes, like the water that binds to the hydrophilic polymer forms the bound water content 
(BWC) that cannot be frozen and the water that enters the hydrogel system because of the 
osmotic pressure forms the free water content (FWC) that can be frozen. There is an 
intermediate class of water that lies between the bound and free water is called freezable 
bound water that is loosely bound to the hydrophilic polymer. DSC makes the possibility of 
finding the major two classes of water [27]
 
as mentioned in the materials and methods section 
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4.6. There is a general increase in the bound water content (Table 3) with an increase in the 
amount of HA in the molar ratios of sP(EO-stat-PO) to HA. 
Fourier transform infra-red (FT-IR) and Raman spectroscopy (FT-RAMAN) were 
performed to determine the chemical modifications happening to the unmodified and thiol 
modified HA respectively during the cross-linking reaction.  
 
Fig. 2A FT-IR spectra of the unmodified HA (A) uncross-linked NCO sP(EO-stat-PO) (B) 
and cross-linked materials of molar ratio of 1: 0.011 (C1), 1: 0.021 (C2), 1: 0.042 (C3) and 1: 
0.084 (C4).  
Fourier transform infrared spectroscopy (FTIR) of HA and dry NCO-sP(EO-stat-PO) 
before gel formation as well as the different hydrogels after drying and swelling was 
performed to confirm the chemical composition of the hydrogels (Fig.2A). Characteristic 
peaks for HA are the OH vibration at 3346 cm
-1
 and the broad carbonyl band of the acid and 
the N-acetylamide group at 1618 cm
-1
. In the spectrum of non-hydrolyzed NCO-sP(EO-stat-
PO), the NCO band at 2264 cm
-1
 as well as the C-H stretching vibration peak at 2869 cm
-1
, 
the C-H bending vibration peak at 1450cm
-1
, and the C-O-C stretching and bending of ether at 
1240 and 1120 cm
-1
 are characteristic. In addition, the NCO-sP(EO-stat-PO) precursor 
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spectrum contains a urethane group peak at 1716 cm
-1
 that originates from the reaction of 
IPDI with the OH terminated star precursor during the NCO-sP(EO-stat-PO) synthesis. Thus, 
although chemical cross-linking of the NCO-sP(EO-stat-PO) / HA occurs through urethane 
bond formation, the presence of this band in the spectra of the mixed hydrogels cannot be 
taken as proof for chemical cross-linking. However, the normalized spectra of the NCO-
sP(EO-stat-PO) / HA gels show an increase in relative intensity of the characteristic sP(EO-
stat-PO) bands according to the ratio that has been used for gel preparation. Since isocyanate 
yields extremely strong signals in IR spectroscopy and can be detected even in very low 
concentrations by this technique, absence of NCO group bands in the spectra demonstrates 
that the cross-linked hydrogels do not contain residual NCO groups. Finally, the spectra do 
not show a signal for possibly formed urea groups at 1705 cm
-1
. Despite the overlap of this 
band with the signal for the urethane bond, the lack of a shoulder shows that the amount of 
urea groups and thus inter-prepolymer cross-linking is small. 
 
Fig. 2B Raman spectra of the uncross-linked thiol modified HA (A), ACR-sP(EO-stat-PO) 
(B) and cross-linked material (C) of molar ratio 1: 0.010 (C1), 1: 0.021 (C2), 1: 0.042 (C3), 1: 
0.084 (C4), 1: 0.168 (C5) and 1: 0.336 (C6). 
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  Due to the different cross-linking mechanism and the reactive groups involved, 
RAMAN spectroscopy was chosen instead of FTIR for characterization of the ACR-sP(EO-
stat-PO) / HS-HA hydrogels. Fig. 2B presents RAMAN spectra of HS-HA (A), ACR-sP(EO-
stat-PO) (B) and the cross-linked zerogels (C1-C6, in increasing amount of HS-HA). Thiols of 
the uncross-linked HA can be identified by the signal at 2563 cm
-1
. The band at a wave 
number of 1636 cm
-1 
indicates the presence of acrylic C=C groups. This band indirectly 
proves the formation of Michael-type addition reaction since it decreases with increasing 
amount of HS-HA. Signals at the wave number 2930 cm
-1 
correspond to the CH2 of ACR-
sP(EO-stat-PO) and their intensity increases with increasing ACR-sP(EO-stat-PO) ratio in the 
gels. Accordingly, the band at 1665 cm
-1 
which corresponds to the acetamide groups of the 
HS-HA decreases in intensity with decreasing HS-HA content in the hydrogel. Interestingly, 
also the formation of disulfide bridges is observed with signals at a wave number of 502 to 
508 cm
-1
. The intensity of this peak increases with increasing amount of HS-HA in the gels. 
  Cryo-FESEM pictures show the differences in the porous structures of the different 
compositions of the hydrogel systems. With the NCO-sP(EO-stat-PO)-unmodified HA 
mixture hydrogels (Fig. 3 A, B, C &D), there is an increase in the pore size with a decrease in 
the amount of NCO-sP(EO-stat-PO) in the mixture for the already mentioned reason that 
NCO-sP(EO-stat-PO) has got the ability to react with itself and also with the HA that forms 
the cross-linking point. Therefore, higher the amount of NCO-sP(EO-stat-PO), higher will be 
the amount of cross-linking points, hence, smaller will be the pore size.  
  With the ACR-sP(EO-stat-PO) / HS-HA mixture hydrogels (Fig. 3 E, F, G &H), the 
pore size depends not only on the amount of ACR-sP(EO-stat-PO) but also on the amount of 
the disulphide bond formation, that occurs between the thiol groups. With this system, ACR-
sP(EO-stat-PO) being not able to cross-link with itself, it searches thiol groups for the cross-
linking. When there is more ACR-sP(EO-stat-PO) available than the required amount, the 
unreacted ACR-sP(EO-stat-PO) remains in between the cross-linking points as free molecules 
that lead to the bigger sized pores. On the other hand, when there is more thiol groups 
available than the ACR-sP(EO-stat-PO), the unreacted thiol groups that does not find its 
ACR-sP(EO-stat-PO) partner will react to its neighboring thiols forming disulphide bonds (a 
relatively slow reaction) which is also a kind of cross-linking points leading to the smaller 
sized pores. 
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Fig. 3 Internal morphology of NCO-sP(EO-stat-PO) / HA mixture with the molar ratio of 
NCO-sP(EO-stat-PO) to HA of (A) 1: 0.011 (B) 1: 0.021 (C) 1: 0.042 and (D) 1: 0.085 and 
ACR-sP(EO-stat-PO) / HS-HA mixture with the molar ratio of ACR-sP(EO-stat-PO) to HS-
HA of (E) 1: 0.011 (F) 1: 0.021 (G)1: 0.042 and (H) 1: 0.34.  
   
  The formation of hydrogels from NCO-sP(EO-stat-PO) / HA and ACR-sP(EO-stat-
PO) / HS-HA mixture were analyzed by a rheometer from the starting point till to the end of 
cross-linking reaction. Rheological analysis gives the starting point of gelation, the time for 
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complete cross-linking reaction and its shear modulus at any point of time within the 
complete cross-linking time (Fig. 4). 
 
 
Fig. 4 Rheological analysis showing shear modulus and the starting point of gelation of 
hydrogels based on NCO-sP(EO-stat-PO) / HA (Panel A) and ACR-sP(EO-stat-PO) / HS-HA 
(Panel B). 
  In the case of NCO-sP(EO-stat-PO) / HA mixture, where the cross-linking happens 
both between the NCO-sP(EO-stat-PO) and between the NCO-sP(EO-stat-PO) and the 
unmodified HA, the cross-linking points are more denser (higher mechanical strength) than 
the ACR-sP(EO-stat-PO) / HS-HA mixture where the cross-linking happens only between the 
ACR-sP(EO-stat-PO) and the thiol groups of the HA. In this comparison study, where the 
Acrylates specifically reacts with the thiols shows that, when there is an excess or deficit of 
acrylates than the thiols, there is a decrease in the elastic modulus of the gels in comparison to 
gel composition that contains same number of acrylates as that of thiols. It can be concluded 
that it is the cross-linking density that determines the modulus of our Hydrogels. 
   
  Sol-content of both types of sP(EO-stat-PO) / HA hydrogels in PBS (pH: 7.4) at 37 °C 
has been determined by repeated swelling / drying cycles until the dry weight did not change 
significantly. For NCO-sP(EO-stat-PO) / HA hydrogels, the sol-content for gels prepared 
from high molecular weight HA (Fig. 5 A) generally accounts for 15 to 40 wt%. We explain 
this by the lack of entanglement of polymeric chain and a higher probability that at low cross-
linker content a single chain is not covalently linked to the network. 
 
 
4. Comparison of sP(EO-stat-PO) with Isocyanate and Acrylate end groups as respective   
     cross-linkler for unmodified and thiol modified Hyaluronic acid 
75 
 
 
Fig. 5 Swelling-drying cycles of hydrogel in PBS (pH: 7.4, 37°C). (A) 150000 g/Mol, (B) 
150000 g/Mol (thiol modified) and (C) represents incubation of HS-HA (150000 g/Mol) 
based hydrogels in PBS at 37°C for several weeks. 
 
  In the case of ACR-sP(EO-stat-PO) / HS-HA hydrogels, the weight loss also depends 
on cross-linker content, but the lowest mass-loss of about 20 wt% is obtained for hydrogels 
with medium cross-linker content (Fig. 5B), while high and low cross-linker content leads to 
mass-losses of 50 and 35 wt%, respectively. Furthermore, when the hydrogels are stored in 
PBS buffer with exchange of the buffer every week and the swollen weight of the hydrogel is 
measured, the gels gained additional weight over several weeks before they disintegrated 
completely (Fig. 5C). When the same experiments are performed with the NCO-sP(EO-stat-
PO) cross-linked gels, no additional swelling was observed and the gels did not disintegrate 
with a mass loss that correlates to the values obtained by the method described above. We 
explain this by hydrolysis of the ester groups within the ACR-sP(EO-stat-PO) prepolymers 
that link the acrylate endgroups to the polymer backbone. This decreases the cross-linking 
density of the hydrogels, thus reducing the network forces that counter-balance the swelling-
pressure of the hydrophilic polymers which results in a higher EWC and thus swelling of the 
gel. Ongoing ester-hydrolysis finally leads to complete degradation of the hydrogels. 
Furthermore, sol content, degree of swelling during long-term incubation and the time point 
of disintegration are related to the ratio between cross-linker and HS-HA. For low and high 
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prepolymer content, the gels disintegrate faster and the swelling is moderate. At a ratio of 64 
monomer units HA per prepolymer, an optimum in cross-linking of the network results in 
most pronounced swelling of the gel up to 800 wt% and disintegration of the network only 
after more than 11 weeks.  
 
 
 
Fig. 6 In-vitro degradation of (A) NCO-sP(EO-stat-PO) / HA hydrogels  and (B) ACR-
sP(EO-stat-PO) / HS-HA hydrogels  in hyaluronidase solution at 37°C (n=3). As obtained 
from statistical analysis, p values < 0.05 were considered as statistically significant and were 
highlighted with one and high significance (p<0.01) with two stars. 
 
  In-vitro degradation of the NCO-sP(EO-stat-PO) / HA and ACR-sP(EO-stat-PO) / HS-
HA hydrogels were determined by incubating hydrogels in three different concentrations of 
hyaluronidase solutions (5, 50, 500 U/mL in PBS buffer). Hydrogel mass was followed over 
time until no further mass-loss occurred or the gel was degraded completely. Enzyme 
concentrations were chosen to approximate the endogenous level (hyaluronidase 
concentration in human serum is 2.6 U/mL [28]), as well as concentrations 10 and 100 fold 
greater to ensure maximal hydrogel degradation before hyaluronidase inactivation 
(hyaluronidase remains active up to 5 h at 37°C [29]). The result presented in Fig. 6 A, for 
NCO-sP(EO-stat-PO) / HA hydrogels, the concentration of hyaluronidase did not affect the 
degradation significantly with one exception for the molar ratio of 1: 0.085. For gels with 
higher HA content, the amount of cross-linking due to reaction between prepolymers is, as 
shown above, low. However, the prepolymers do form the cross-links between HA chains 
with urethane-bonds that the hyaluronidase cannot cleave. Furthermore, the mammalian-type 
hyaluronidases are endo-β-N-acetylhexosaminidases and produce tetrasaccharides and 
hexasaccharides as major end products.
24
 Hence, more than 4 to 6 continuous monomer units 
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of the HA chains have to be accessible for the enzyme to facilitate degradation by the 
hyaluronidase. Steric restrictions thus explain that the gels with lowest prepolymer content are 
only partially degradable. With increasing cross-linker content, cross-linking density and the 
amount of intermolecular reaction in between prepolymers increases, thus lowering the 
degradability of the resulting hydrogels. In the case of ACR-sP(EO-stat-PO) / HS-HA, 
complete degradation of the gels of all molar ratios were seen in hyaluronidase concentration 
of 500 U/mL. At a concentration of 50 U/mL, the weaker gels were completely degrading, 
while the stronger gels were only partially degradable. At the endogenous level of 
hyaluronidase concentration (5 U/mL), almost all the gel compositions were stable. 
Interestingly, the strongest gels are, at endogeneous level, within the time frame of the 
experiments even degraded to a lower extent than the stronger isocyanate cross-linked gels, 
indicating a high cross-linking density.  
 
4.15 Conclusion 
 
  In this chapter, a comparison study was made on the difference in the cross-linking 
mechanism of NCO-sP(EO-stat-PO) and ACR-sP(EO-stat-PO) with the unmodified and thiol 
modified HA respectively. With the NCO-sP(EO-stat-PO) / HA mixture, it is the cross-
linking density (proportional to the amount of NCO-sP(EO-stat-PO)) that determines the 
properties of the cross-linked material. It is shown in this study that, when the cross-linking 
density is increased, the modulus of the materials increases but the water absorbing capacity 
along with its swelling ratio decreases and also the mesh size decreases. With the ACR-
sP(EO-stat-PO) / HS-HA mixture, again it is the cross-linking density (proportional to the 
amount of acrylates that are available for the reaction with the thiols) that determines the 
properties of the cross-linked material in a same way as that of the NCO-sP(EO-stat-PO) / HA 
mixture. 
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5. Hydrophilic prepolymer as universal cross-linker to 
GAGs 
 
5.1 Introduction 
Tissues are not made up solely of cells but a substantial part of their volume is extra-
cellular space, which is largely filled by a complex network of macromolecules constituting 
the extra-cellular matrix (ECM) [1]. It is the extra-cellular part of the tissue that normally 
provides structural support and anchorage to the cells in addition to segregating tissues from 
one another, and regulating intercellular communication. In addition to these functions, it acts 
as a local depot to a wide range of cellular growth factors [2]. The natural ECM is a complex 
collection of covalent and non-covalent molecular interactions primarily between proteins and 
GAGs like Hyaluronic acid, Chondroitin sulphate and Heparin, in which proteins, help cells 
to adhere to it along with structural support to the matrix, while GAGs maintain the moisture 
content of the matrix along with a function of storing wide range of cellular growth factors 
[3]. There have been many ideas proposed for the formulation of an artificial ECM and each 
method describes different compositions along with different cross-linking chemistries which 
involves an initial modification of the GAGs followed by a reaction with a cross-inker [4-8] 
which results in the formation of hydrogels in most cases. The advantageous part of selecting 
hydrogels as materials for the tissue engineering is that its higher water content, increased 
permeability, improved biocompatibility and tailorable enzymatic biodegradation [9]. 
 
Our approach is basically a simple and straight forward method, where we use a six 
arm star shaped poly (ethylene oxide-stat-propylene oxide) prepolymers (sP(EO-stat-PO)) 
with 80% EO content and reactive functional group such as isocyanate (NCO) as single 
synthetic cross-linker (NCO-sP(EO-stat-PO)) which has the ability to bind to the hydroxyl 
groups of GAGs forming a hydrogel matrix without any initial modifications to the 
polysaccharides. Also the possibility of biofunctionalisation [10] just by the addition of 
peptide sequence to the cross-linker makes our approach, too straight forward. We report 
here, the formation of hydrogels from GAGs like Hyaluronic Acid (HA) [11], Chondroitin 
Sulphate (CS) and Heparin (He) and Non-GAGs like Alginate (Alg) and Chitosan (Chi) by a 
single cross-linker NCO-sP(EO-stat-PO). Also a study on the hydrogel preparation from 
mixture of HA, CS and He (an approach towards artificial ECM) using the mentioned cross-
linker is presented in this work. The hydrogels prepared were characterized regarding 
chemical composition by FTIR, sol-content, surface wettability, equilibrium water content 
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(EWC), internal porous structure by cryo-FESEM, the time of gelation and shear modulus by 
rheological examination. 
 
5.2 Materials  
  Sodium Hyaluronic acid (Hyaluronic acid sodium salt, Sodium Hyaluronate,) of 
molecular weight 150000 g/mol from streptococcus equi sp, was purchased from Dali HA 
Co., Ltd, (China). Sodium Chondroitin sulphate-A from bovine trachea of molecular weight 
17000 g/mol was purchased from Sigma-Aldrich, Germany. Sodium Heparin from bovine 
intestinal mucosa of molecular weight 18000 g/mol, Sodium Alginate (Alginic acid Sodium 
salt) of molecular weight 150000 g/mol from brown algae and Chitosan from crab shells of 
molecular weight 70000 g/mol were purchased from Fluka Biochemika, Germany. Star 
shaped poly-ethers with a backbone of statistically copolymerized 80% ethylene oxide and 
20% propylene oxide, of molecular weight 18000 g/mol (PD = 1.15) and isocyanate (NCO) 
groups at the distal endings of the arms (sP(EO-stat-PO)) were synthesized as described 
earlier [12]  and transferred into a glove-box with nitrogen atmosphere. 
 
5.3 Hydrogel preparation 
  Solutions of all the biopolymers mentioned in this work except chitosan were prepared 
in deionised H2O and solution of chitosan was prepared in 0.4 M acetic acid. The respective 
amount of NCO-sP(EO-stat-PO) was dissolved in deionised H2O and added immediately to 
the aqueous biopolymers and mixed vigorously. Volumes of the solutions were chosen so that 
the resulting mixture was obtained in the desired concentration. The homogenized mixture 
was dropped in to a Teflon mold of diameter 15 mm and depth 3 mm and covered airtight to 
allow the cross-linking reaction for 24 hours. A complete list of all gel preparation molar 
ratios is given in Table 1. 
Table 1 Molar ratios of sP(EO-stat-PO) to HA for the prepared hydrogels 
Hyaluronic Acid 
150000 g/Mol 
5% (w/v) 
Chondroitin Sulphate 
17000 g/Mol 
20% (w/v) 
Heparin 18000 
g/Mol 20% 
(w/v) 
Alginate 
150000 g/Mol 
5% (w/v) 
Chitosan 
70000 g/Mol 
4% (w/v) 
1: 0.04 1: 1 1: 0.5 1: 0.03 1: 0.18 
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5.4 Contact angle measurements 
  For contact angle measurements, the homogenous aqueous gelation mixtures were 
dropped into a 1mm rakel (metal frame), wiped over a Teflon slab and covered airtight for 24 
hours to allow complete cross-linking. The hydrogel films in triplets were dried to zerogel 
condition by applying vacuum overnight. The zerogels were incubated in deionised H2O until 
equilibrium swelling conditions were reached. The swollen hydrogel films were fixed in a 
special sample holder of the captive bubble method arrangements. Measurements were made 
at least at eight different points on the hydrogel film surface using G-40 Goniometer, both on 
the left and right side of the bubble and average values were calculated with standard 
deviations. 
 
5.5 Equilibrium water content (EWC) measurements 
  The hydrogels as prepared were dried to zerogel condition in triplets by a vacuum 
chamber overnight and the dry weights were measured. The dried samples were placed in 
excess of deionised H2O at room temperature for studying its swelling kinetics. The weight of 
the swollen gels was measured at specific time intervals till it reaches its equilibrium state of 
swelling. The water content of the hydrogels was calculated according to equation 1: 
[(Ws – Wd) / Ws] • 100   equation 1 
Ws represent the weight of the swollen hydrogel and Wd is the weight of the dry hydrogel. 
 
5.6 Fourier Transform Infra-Red Spectroscopy (FT-IR Spectroscopy) 
  FTIR spectra of unmodified biopolymers, cross-linked hydrogels and NCO-sP(EO-
stat-PO) were obtained using a Nexus 470 FTIR spectroscope with an attenuated total 
reflectance adapter installed (Thermo Nicolet, Madison, WI) by photo acoustic method. The 
Spectrum represents an average of 400 to 600 scans with CO2 peaks removed. 
 
5.7 Cryo- Field emission scanning electron microscopy (Cryo- FESEM) 
  The internal morphologies of hydrogels were visualized by cryo-FESEM. The water 
saturated hydrogels were frozen to -140° C, placed inside the sample holder and the top 
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section of the frozen gel was broken by a scraper and was imaged with Hitachi S-4800 at 1.5 
kV. 
 
5.8 Rheological analysis 
  Time of gelation and shear modulus of the gels from all the combinations of NCO-
sP(EO-stat-PO)-Biopolymer mixture were determined by a dynamic time sweep test using 
Rheometrics-dynamic stress rheometer with a 25mm flat plate geometer for a sample 
thickness of 1mm at a frequency of 6.283 (rad/s) at room temperature. 
 
5.9 In-vitro stability test in PBS 
  The stability of all NCO-sP(EO-stat-PO) / biopolymer hydrogels were studied in-vitro 
in PBS (pH: 7.4, T= 37°C). After completion of cross-linking, the gels were dried to zerogel 
condition and weighed. Swelling to EWC and drying to zerogel condition was repeated until 
the resulting weight did not change significantly. The experiments were done in triplets. 
  Separately, gels were placed in PBS (pH: 7.4, T= 37°C) in the swollen state over 
several weeks, changing the medium every week and recording the hydrogel wet-weight until 
no further significant change could be detected or the gels were completely dissolved. 
 
5.10 Results and Discussions 
  The aim of this work is to prepare stable hydrogels based on water soluble GAG’s 
with engineered properties by the use of hydrophilic prepolymers with defined molecular 
structure as functional cross-linkers. Our cross-linker is a water soluble six arm star shaped 
PEO based molecule with isocyanate (NCO) functional groups at the distal end of the arms 
with an EO content of 80% and a molecular weight of 3 kDa per arm.  
  Gelation happens through the reaction of NCO-groups of the cross-linker with 
alcohol-groups of the bio-polysaccharides backbone forming biocompatible urethane bridges. 
Fig.1 shows the structure of both NCO-sP(EO-stat-PO) and bio-polysaccharides along with 
its molecular weight and the working concentrations. As a possible side reaction of the 
primary aliphatic NCO groups is hydrolysis. The NCO groups hydrolyze slowly upon 
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dissolution in water, resulting in amino groups, but the kinetics of the reaction is low [10]. 
These amino groups react quickly with NCO groups resulting in urea-bridges forming a 
hydrogel network under physiological pH [13]. 
  With the high amount of hydroxyl groups in the backbone of bio-polysaccharides and 
faster reaction kinetics between alcohol and isocyanate compared to hydrolysis of NCO result 
in preferential reaction of the NCOs with these alcohol groups. Different molar ratios of 
NCO-sP(EO-stat-PO) to polysaccharides were tried and the one that formed stable hydrogels 
with the highest amount of polysaccharides in-terms of moles that can be made stable by a 
mole of NCO-sP(EO-stat-PO) is given in the Table 1. 
 
Fig. 1 Structure of Bio-polysaccharides and the universal cross-linker. 
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 The amount of cross-linker in the molar ratio of NCO-sP(EO-stat-PO) / polysaccharide, 
anything above or below as mentioned in Table 1 will form highly synthetic or weak gel 
respectively.  
Table 2 Water related properties of NCO-sP(EO-stat-PO) cross-linked polysaccharides. All 
measurements were done in triplets. 
List of Polysaccharides 
under study 
Molar ratios of 
NCO-sP(EO-stat-PO) to 
polysaccharides 
Contact 
angle (°) 
Swelling 
ratio 
EWC 
(wt%) 
Hyaluronic acid 
Chondroitin sulphate 
Heparin 
Alginate 
Chitosan 
HA + CS+ He 
1: 0.04 
1: 1 
1: 0.5 
1: 0.03 
1: 0.18 
a+b+c 
17.3 ± 0.5 
40.3 ± 1.3 
38.3 ± 1.3 
36.0 ± 1.2 
33.5 ± 1.3 
37.8 ± 1.2 
36.8 ± 0.4 
9.44 ± 1.7 
7.57 ± 0.2 
25.2 ± 3.0 
42.1 ± 1.2 
9.91 ± 0.3   
97.3 ± 0.5 
89.2 ± 1.9 
86.8 ± 0.4 
96.0 ± 0.5 
97.6 ± 0.1 
89.9 ± 0.4 
   
The so formed stable hydrogels are highly hydrophilic as the air contact angle falls below 45° 
and have good water content above 85% (Refer Table 2). 
FTIR was performed to confirm the chemical reaction between the isocyanates of 
NCO-sP(EO-stat-PO) and primary hydroxyl groups of the polysaccharides. The FTIR spectra 
of all the unmodified polysaccharides (Figure2 A-E) show the presence of OH groups of the 
polysaccharides at a wave number of 3340 (cm
-1
) and highly reactive isocyanates and CH2 
groups of the dry NCO-sP(EO-stat-PO) (Fig. 2F) is seen at 2264 and 2865 cm
-1
 respectively. 
Urethane bond formation as a result of the reaction between isocyanates of NCO-sP(EO-stat-
PO) and hydroxyl groups of polysaccharides is seen at 1714 cm
-1
 although urethane is already 
seen in the NCO-sP(EO-stat-PO) precursor at the same wave-number that originates from the 
reaction of IPDI with the OH terminated star precursor during NCO-sP(EO-stat-PO) 
synthesis. After cross-linking (Fig. 2G-K), there were no free isocyanates seen at 2264 cm
-1 
also the absence of urea groups at around 1705 cm
1
 confirms the reaction between isocyanates 
and the hydroxyl groups of polysaccharides as a major one and the inter-prepolymer cross-
linking is small. Spectral peaks (Fig. 2G-K) are a combination of both the polysaccharides 
and the cross-linker. 
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Fig. 2 FT-IR spectrum of the Hydrogel components. (A)- unmodified HA, (B)- unmodified 
Chondroitin sulphate, (C)- unmodified Heparin, (D)- unmodified Alginate, (E)- unmodified 
Chitosan, (F)- dry NCO-sP(EO-stat-PO), (G)- cross-linked HA, (H)- cross-linked Chondroitin 
sulphate, (I)-cross-linked Heparin, (J)- cross-linked Alginate and (K)- cross-linked Chitosan. 
(G+H+I) is a combination of HA, CS and He cross-linked with NCO-sP(EO-stat-PO). 
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The internal micro-structures of the cross-linked hydrogels were visualised by cryo-
FESEM and the pictures show that the cross-linked hydrogels are highly porous (Fig. 3), 
however the inter-connectivity of these pores were not confirmed by this characterization 
method. The pore size and shape varies according to the structure and the molecular weight of 
the polysaccharides along with the amount of the cross-linker. 
 
 
Fig. 3 Cryo-FESEM of the cross-linked hydrogels made of (A) Hyaluronic acid (B) 
Chondroitin sulphate (C) Heparin (D) Alginate (E) Chitosan and (F) mixture of A, B and C. 
 
The hydrogels from NCO-sP(EO-stat-PO) / polysaccharides mixture were prepared 
between the two flat plates of the rheometer, by which shear modulus from the starting point 
till to the end of cross-linking reaction was recorded. This type of rheological analysis gives 
the starting point of gelation, the time for complete cross-linking reaction and its shear 
modulus at any point of time within the complete cross-linking time. Fig. 4 shows the starting 
point of gelation and the shear modulus at the end of the gelation. Here the pore sizes can be 
related to the shear modulus. Pore size is inversely proportional to the shear modulus and the 
cross-linking density and directly proportional to starting point of gelation. 
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Fig. 4 Rheological analysis of the NCO-sP(EO-stat-PO)-Polysaccharides hydrogels. 
 
Upon incubation of NCO-sP(EO-stat-PO) cross-linked Polysaccharide hydrogels in 
PBS (37°C, pH: 7.4), showed a mass loss over several days as a result of the hydrolysis of 
some of the polysaccharide chains that were not strongly bound to the network are being  
released out of the matrix and the gels reaches an equilibrium state where the gels did not 
show any further mass loss. 
 
 
Fig. 5 Stability of NCO-sP(EO-stat-PO) / Polysaccharides hydrogels in PBS (pH: 7.4, T= 
37°C) 
 
This shows that, all the isocyanate groups of NCO-sP(EO-stat-PO) are not available 
for the complete reaction with OH groups of the polysaccharides, instead some of the 
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isocyanates reacts with itself forming urea which also contributes to the cross-linking density. 
Nevertheless, the gels were not completely degradable as the urethane bond formed as a result 
of the reaction between isocyanate groups of the cross-linker and the hydroxyl groups of the 
polysaccharides are highly stable. 
 
5.11 Conclusion 
In this study, we showed the ability of NCO-sP(EO-stat-PO) as an universal cross-
linker to different polysaccharides considered for this study in the formation of hydrogels 
which is a suitable material type for biomedical applications. Conversion of isocyanates in to 
urethane bonds as a result of reaction with the hydroxyl groups of the polysaccharides 
removes the toxic behaviour of our cross-linker. By chance, if any isocyanates are blocked 
from reacting with the OH groups of the polysaccharides, it hydrolyse to form primary amines 
which further reacts with other free NCO to form urea. The cross-linking chemistry was 
followed up by FTIR and the resulting hydrogels did not show any free isocyanates and were 
highly hydrophilic and has high water content. The mechanical properties of hydrogels 
depend on the pore sizes which is an indirect measure of the cross-linking density and the 
nature of the polysaccharides. The hydrogels formed were semi-stable in the sense that the 
loosely bound polysaccharide chains were washed out of the hydrogel network when 
incubating in PBS at physiological condition. 
The presented method for preparing GAGs based hydrogels using our special cross-
linker is straightforward, fast and easy to perform in physiological conditions. Ongoing 
studies concern biocompatibility of this system and the possibility to biofuntionalise the gels 
and use them as cell-encapsulation and drug-release system. 
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6. PEG based hydrogels in Drug delivery system 
 
6.1 Introduction 
The efficacy of the drug released from a system depends on the method by which it is 
coupled and delivered from the system [1]. Any drug will have an optimum concentration 
range within which its benefits can be derived and anything above or below the optimum 
concentration range will be toxic or will have no effect respectively [2]. In-order to keep the 
efficacy of drug from degradation, to prevent from harmful side-effects, to increase its 
bioavailability, to deposit the right amount at the right spot, it needs a carrier system, that 
carries the drug and delivers it to the required spot at the right time with the right amount 
without affecting its efficacy. PEG based hydrogels have been under consideration as a carrier 
system for drug delivery because of the following advantages. Poly (ethylene glycol) PEG is 
known for its non-toxicity, highly hydrophilic, as a result highly soluble in water and is highly 
resistant to immune system [3-5]. However, cross-linked PEG based hydrogels are insoluble 
in water, imbibes large amount of water in to the matrix as they are highly hydrophilic in 
nature.  
 
The physico-chemical properties of the hydrogels and the drug loading methods 
determine the mechanism by which the drug will be delivered from the hydrogel system [1]. 
There are three primary mechanisms by which the drug finds its way to come out of the 
carrier system. They are swelling controlled, diffusion controlled and chemically controlled 
[2]. Swelling controlled mechanism works on the carrier system that changes its volume in the 
biological environment in response to a change in the environmental condition, for instance, 
pH, temperature, ion concentration. In such carrier system, the drug is loaded during the 
hydrogel synthesis, i.e the drug is mixed together with the hydrogel precursor and the cross-
linking is allowed to happen. In such system, the drug diffuses out of the hydrogel during the 
hydrogel swelling followed by an increase in the pore size. Diffusion controlled mechanism 
works on the carrier system that stays fundamentally stable in the biological environment. 
Therefore, loading of drugs in to the carrier system is done after the hydrogel synthesis by 
placing the hydrogel in the high concentrated drug solution, where drug enters the hydrogel 
matrix by means of diffusion. Chemically controlled mechanism works on the carrier system 
that changes its chemical structure in the biological environment by which it releases the 
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encapsulated drugs. Here the carrier system undergoes degradation either bulk or surface 
depending on the polymer type used in the preparation of the carrier system. 
In this chapter, we use three different hydrogel system as drug carrying and delivering 
system. The first one is synthetic hydrogel made of NCO-sP(EO-stat-PO). The second one is 
based on unmodified Hyaluronic acid of different molecular weights cross-linked with NCO-
sP(EO-stat-PO) and the third one is based on thiol-modified hyaluronic acid cross-linked with 
ACR-sP(EO-stat-PO). From these three different hydrogel systems, drug release study has 
been done both on its free form (Hydrogels swells in all direction in the presence of water and 
releases the encapsulated drug) and also in a constricted environment (Hydrogels filled in a 
silicon tube in which water can reach the hydrogel in one direction alone causing a very slow 
swelling followed by a delayed or slow release of drug). The model drugs used in this study 
are Dexamethasone 21 phosphate disodium salts, Ampicillin sodium salt and Ciprofloxacin.  
 
6.2 Materials 
  Sodium Hyaluronic acid (Hyaluronic acid sodium salt, Sodium Hyaluronate, HA) of 
molecular weights (< 0.1x10
6) ≈ 53000 g/mol, (< 0.2x106) ≈ 150000 g/mol, (0.3-0.5x106) ≈ 
400000 g/mol, (0.5-0-9x10
6) ≈ 700000 g/mol and (1.5-2.0x106) ≈ 1750000 g/mol from 
streptococcus equi sp. was purchased from Dali HA Co., Ltd, (China). Thiol modified HA of 
molecular weight 150000 g/mol with degree of thiolation: 50% was purchased from Glycosan 
biosystems (U.S.A). Star shaped poly-ethers with a backbone of statistically copolymerized 
80% ethylene oxide and 20% propylene oxide,  molecular weight of 18000 g/mol (PD = 1.15) 
with isocyanate (NCO) groups and acrylate (ACR) at the distal endings of the arms (sP(EO-
stat-PO)) were synthesized as described earlier [25, 26]. Dexamethasone 21 phosphate 
disodium salt of molecular weight 516.4 g/mol and Ampicillin sodium salt of molecular 
weight 371.39 g/mol were purchased from sigma-aldrich Germany. Ciprofloxacin HCl of 
molecular weight 331.34 g/mol was purchased from Bayer Germany. Silicon tubes of internal 
diameter 0.31mm and length 60mm were a gift from MED-EL Austria. 
 
6.3 Hydrogel preparation together with drug encapsulation 
(Drug release by Swelling controlled mechanism)  
 Free form hydrogels: (appendix A1) 
 Hydrogel system 1: NCO-sP(EO-stat-PO) based hydrogel: 
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NCO-sP(EO-stat-PO) was dissolved in deionised H2O to make a concentration 
of 10% and 20% (w/v) together with a desired amount of dexamethasone 21 phosphate 
disodium salt and mixed vigorously to make a homogenous solution and dropped in a 
Teflon mold of diameter 15 mm and depth 3 mm, covered airtight to allow the cross-
linking reaction for 24 hours. 
Hydrogel system 2: unmodified HA cross-linked with NCO-sP(EO-stat-PO): 
Hydrogel system 3: Thiol-modified HA cross-linked with ACR-sP(EO-stat-PO): 
 Aqueous HA of concentration x % (w/v) addition to the desired (end) 
concentration, (see Table I), was prepared in deionised H2O. The sP(EO-stat-PO) was 
dissolved in certain amount of deionised H2O and added immediately to the aqueous 
HA in the molar ratios of sP(EO-stat-PO) to HA (see Table I,) and mixed vigorously, 
so that the final mixture turns to the desired concentration. To the final homogenous 
mixture, add the desired amount of dexamethasone 21 phosphate disodium salt, 
followed by homogenous mixing and were dropped in to a Teflon mold of diameter 15 
mm and depth 3 mm, covered airtight to allow the cross-linking reaction for 24 hours. 
Hydrogels in constricted environment: 
 The hydrogel precursor mixtures before cross-linking (Hydrogel system 3) 
together with a certain amount of dexamethasone 21 phosphate disodium salt were 
sucked in to silicon tubes of diameter 0.31 mm and length 6 cm without any air 
bubbles, protected from atmospheric air for 24 hours for the complete gelation 
(appendix A1a). 
Table 1 Molar ratios of sP(EO-stat-PO) to HA 
Hydrogel System-1 Hydrogel System-2 Hydrogel System-3 
Concentration of 
NCO-sP(EO-stat-PO) 
(%) w/v 
Molecular weight of HA (g/Mol) 150000 g/mol     
(Thiol modified HA) 
2% (w/v) 
X = 0.5% 
53000  
8% (w/v) 
X = 2% 
150000  
5% (w/v) 
X = 1.25% 
700000  
3% (w/v) 
X = 0.75% 
1750000  
2% (w/v) 
X = 0.5% 
10 
 
20 
 
1: 0.06a  
 
1: 0.021a  
 
1: 0.0045a 
 
1: 0.002a 
1: 0.042b 
1: 0.085c  
1: 0.170d  
a, b, c and d corresponds to 16, 32, 64 and 128 HA monomer repeating units / sP(EO-stat-PO) prepolymers 
molecule respectively.   
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6.4 Drug release by Diffusion controlled mechanism 
  Hydrogel system-1 is prepared as mentioned in section 6.3 without drugs. The gels are 
made to dry to its zerogel condition by a vacuum chamber. These dry gels are made to swell 
in two different solutions, one containing Ampicillin sodium salt of concentration 20 mg/ml 
and the other containing Ciprofloxacin HCl of concentration 20 mg/ml. After the gel reaches 
its swelling equilibrium state in these drug solutions, the fully swollen gels are placed 
seperately in fresh water for the release of the encapsulated drug. 
 
6.5 Equilibrium water content measurement of hydrogels without the 
model drug 
  The hydrogels as prepared were dried to zerogel condition in triplets by a vacuum 
chamber overnight and the dry weights were measured. The dried samples were placed in 
excess of deionised H2O at room temperature for studying its swelling kinetics. The weight of 
the swollen gels was measured at specific time intervals till it reaches its equilibrium state of 
swelling. The water content of the hydrogels was calculated according to equation 1: 
[(Ws – Wd) / Ws] • 100   equation 1 
Ws represent the weight of the swollen hydrogel and Wd is the weight of the dry hydrogel. 
(Refer appendix A2) 
 
6.6     In-vitro drug release study 
  The freshly prepared free form hydrogels and the hydrogels in the silicon tubes 
containing the model drug after complete cross-linking was placed in a defined volume of 
deionised H2O and the drug concentration released in to the deioned H2O was detected by 
CARY 100 Bio UV-visible spectrophotometer in a certain interval of time till to the lowest 
measuring limits of the instrument. The wavelength used to detect dexamethasone, 
ampicilling and ciprofloxacin are 238-242 nm, 225 and 275 respectively (appendix A10). 
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6.7    Results and Discussions 
 Isocyanates of NCO-sP(EO-stat-PO) hydrolyse slowly upon dissolution in water, 
resulting in amino groups. Under physiological pH, these amino groups react quickly with 
neighboring NCO groups to result in urea-bridges resulting in the formation of hydrogels and 
this forms our hydrogel system 1. In the presence of aqueous Hyaluronic acid, NCO groups of 
the NCO-sP(EO-stat-PO) tends to react with the hydroxyl groups of HA forming urethane 
bonds that leads to the formation of hydrogels and this forms our hydrogel system 2. Thiol-
modified HA cross-linked with ACR-sP(EO-stat-PO) forms the hydrogel system 3 in this 
study. The detailed reaction mechanisms and the selection of molar ratios of sP(EO-stat-PO) 
to HA to form stable hydrogels are given in the previous chapters.  
 
Fig. 1 Swelling ratios of the three types of free hydrogel system. 
 
 
 
6. PEG based hydrogels in drug delivery system 
97 
 
Table 2 Equlibrium water content of three types of free hydrogel system 
Hydrogel System-1 Hydrogel System-2 Hydrogel System-3 
Concentration of 
NCO-sP(EO-stat-PO) 
(%) w/v 
Molecular weight of HA (g/Mol) 150000 g/mol     
(Thiol modified HA) 
 
53000  
 
150000  
 
700000  
 
1750000  
 
10 (95.41%) 
 
20 (92.69%) 
1: 0.06a 
(92.6%) 
1: 0.021a 
(94.3%) 
1: 0.0045a 
(97.3%) 
1: 0.002a 
(98.2) 
1: 0.042b (93.3%) 
1: 0.085c  (94.0%) 
1: 0.170d (95.4%) 
a, b, c and d corresponds to 16, 32, 64 and 128 HA monomer repeating units / sP(EO-stat-PO) prepolymers 
molecule respectively.   
  
 Water absorption capacity is one of the most important properties of hydrogels; also 
the swelling ratio or the rate of swelling is important in the context of drug delivery, when the 
drug carrying system undergoes swelling followed by diffusion mechanism for the release of 
encapsulated drug. The swelling kinetics determines how fast the encapsulated drug will be 
released from the carrying system as during swelling the pore size increases and that lets the 
drug molecules to come out of the gels. For all the three types of hydrogels discussed in this 
chapter, the maximum amount of swelling reaches in less than 500 minutes (8.3 hours). This 
shows the highly hydrophilic properties of the polymer chains involved in the hydrogel 
network. A gel that swells rapidly in the presence of water will undergo swelling controlled 
drug release mechanism. Once the gel swells to its maximum before all the drugs are being 
released then the remaining drugs follows a diffusion controlled release mechanism. 
 
Drug release by swelling controlled mechanism 
 
 
 
Fig. 2 Schematic description of the swelling controlled drug release mechanism 
 
From the drug release profile of the three types of hydrogel system (Fig. 4), it is clear 
that the major portion of the encapsulated drug comes out of the carrier system in 
approximately 8 hours and this is the time period which the hydrogels take to swell to its 
equilibrium state (fig 1). Therefore it can be said that the maximum release of the drug 
undergoes swelling controlled release of the drugs out of the carrier system followed by the 
diffusion controlled release of the remaining of the drugs.  
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Fig. 3 Release of drugs by swelling controlled mechanism. 
 
Within the gel, the solute molecule (drug) needs sufficient free volume within the 
liquid inside the gel along with pore openings large enough for the solute (drug) to allow its 
passage. 
 
 
 
Fig. 4 Drug (Dexamethasone 21 phosphate disodium salt) release profile of the three types of 
free hydrogel system by swelling controlled mechanism. 
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Drug release by diffusion controlled mechanism 
 
 
 
Fig. 5 Schematic description of the diffusion controlled drug release mechanism. 
 
In the diffusion controlled drug release mechanism, where the gels were loaded during 
the hydrogel swelling in a solution containing a high concentration of drug and during the 
release in a fresh medium, the volume of the hydrogel remains the same and the drug comes 
out of the hydrogel by purely diffusion controlled mechanism. 
 
 
Fig. 6 Ampicillin and Ciprofloxacin release profile from Hydrogel system-1 by Diffusion 
controlled mechanism. 
 
Even with this type of release mechanism, what we observe from the release profile as given 
in Fig. 6 is a kind of burst release where the major portion of the encapsulated drug is 
released. 
 
The diffusivity of a solute (drug) in the gel (Dg) is given by the product of the 
probabilities of finding a proper free volume and a large pore size within the polymer chains 
in the hydrogel matrix.  
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Fig. 7 Drug release profile from the encapsulated hydrogel in the silicon tubes. 
Refer fig. 7 for the dimensions of the silicon tube and also for the design of the release 
experiment. 
 
D0 is the diffusion coefficient of the solute in the liquid at infinite dilution, P0 is the 
probability of finding an opening between the polymer chains (open pores), a
*
 is the effective 
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cross-sectional area of the solute molecule, B is an undefined constant of proportionality, φ 
represents the volume fraction of the polymer in the gel and Vf,w represents free volumes per 
molecule of the water within the gel. In our case, irrespective of the hydrogel types, both the 
release mechanisms have the similar release kinetics. This shows that the solute (drug) size is 
not comparable with the pore sizes of the hydrogels. 
 
Since the drug carrier system-free form hydrogel swells and releases the drugs in the 
range of 8 hours, which is considered as a burst release or fast release and in order to delay 
the release kinetics, the hydrogels together with drugs were loaded in to a silicon tube with 
one end open to the entry of water and the release of drug. 
 
 The complete release of drugs from the hydrogels which is inside the silicon tubes 
takes almost 800 hours. In the first 50 hours, there were negligible release of drugs and this is 
the time required for the water to enter the small capillary tube to make the hydrogels swell a 
bit and starts the release of the drug. Since the release kinetics is not as fast as that of free 
form hydrogels, the release kinetics does not follow swelling controlled release mechanism, 
instead it follows diffusion controlled mechanism. As the silicon tube completely covers the 
hydrogel, the hydrogel does not have enough void space to swell and the release of drugs 
happens by diffusion through the small opening in the silicon tube. 
 
6.8    Conclusion 
 In this chapter, hydrogels in their free form and constricted form (hydrogels inside a 
silicon tube with one end open) as carrier system for drug delivery has been studied. In the 
case of free hydrogel system, in the swelling controlled release mechanism, the time for 
hydrogels to reach their swelling equilibrium is same as that of the time for the maximum 
amount of drugs to come out of the hydrogels. For the diffusion controlled release 
mechanism, where the gels were loaded with drugs during the swelling process and during the 
release, the hydrogel did not change its volume and this shows that the release is purely by 
diffusion controlled mechanism. The release of the drugs from all the three types of free form 
hydrogel systems by both types of release mechanism shows a kind of burst release or fast 
release kinetics. In order to delay the release kinetics, the hydrogels precursors before cross-
linking were mixed with drug molecules and were encapsulated in a silicon tube with one end 
kept open for the entry of water and the diffusion of the drug, showed that the release kinetics 
can be delayed almost 100 times as that of the free form hydrogel systems. 
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7. Poly-saccharide based covalently linked multi-
membrane hydrogels 
 
 
7.1  Introduction: 
Hydrogels based on synthetic and biopolymers finds numerous applications in 
biomedical devices and tissue engineering due to their high water content and tissue like 
physical, bio-chemical and mechanical properties [1, 2]. The advantages of hydrogels based 
on synthetic polymers rely on the ability to determine their properties through tailored 
polymer synthesis and choice of cross-linking mechanism. This allows control over the degree 
of swelling, stability and biodegradability, mechanical strength and allows the generation of 
responsiveness to external stimuli. Biopolymers on the other hand offer the advantage of 
inherent functionalities for example for the reversible binding of growth factors, the creation 
of a microenvironment close to the natural situation and the degradation through specific 
enzymatic processes.  
 
Usually, hydrogels are used to as injectable or preformed single-phase materials for 
drug delivery or as matrix for the encapsulation of bacteria or cells. However, release of 
different drugs in a certain sequential order or the formation of hierarchically ordered cell 
layers to mimic the structure of tissue is hard to achieve by a single layered hydrogel system. 
This may be achieved with multi-layered systems that are comprised of discrete hydrogel 
membranes with different biochemical and physical properties which allows loading of each 
layer with different drugs or cells.  
 
Ladet et al. [3] recently presented multi-membrane onion like hydrogels based on 
polysaccharides with micro-meter scaled inter membrane spacing. However, their preparation 
method restricts the ability to embed cells or drugs during the hydrogel formation and is 
biochemically restricted to the use of one single type of hydrogel system. S. Kizilel et al. [4] 
proposed the idea of forming multi-layered hydrogels without inter spacing using photo cross-
linking. However, their method implies the use of solid supports such as silicon wafers or 
glass substrates. Amy C. Richards Grayson et al. [5] showed the possibility of controlled drug 
delivery using a special micro chip with degradable polymers as membranes. Johnson et al. 
very recently presented the possibility of making 3D hydrogel multilayers by enzyme-
mediated redox chain initiation involving glucose oxidase, where they made multilayers of 
thickness ranging from 150 to 650 µm [6]. 
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For many applications and in view of practicability and possible translation, 
procedures to generate multi-layered hydrogels should be easy to apply and allow the 
possibility to change the chemistry from layer to layer. It has been previously described the 
formation of hydrolytically stable and mechanically strong hydrogels from isocyanate 
functional hydrophilic prepolymers in aqueous solutions through hydrolysis of the isocyanate 
groups to amines and subsequent cross-linking with remaining isocyanates to urea-cross 
linked networks [7]. In chapter 3 & 4, We have also described the use of isocyanate or 
acrylate functional hydrophilic prepolymers as cross-linkers for native and thiofunctional 
hyaluronic acid, respectively, by mixing of the aqueous precursor solutions and subsequent 
cross-linking through urethane formation and Michael-type addition, respectively [8]. Here 
we present the application of this approach to produce multi-layered hydrogels with the 
possibility of varying the biochemical composition of the layers and embedding different 
drugs in distinct layers. Our approach has the ability to form constructs with good mechanical 
strength, which can be used as sequential drug releasing device and as scaffolds with 
hierarchical degradation kinetics.  
 
7.2. Materials 
 
Hyaluronic acid sodium salt (sodium hyaluronate, HA) of molecular weight 150000 
g/mol from streptococcus equi sp. was purchased from Dali HA Co., Ltd (China). Thiol 
modified HA of molecular weight 150 000 g/mol with a degree of thiolation of 50% (HA-SH) 
was purchased from Glycosan biosystems (U.S.A). Star shaped poly-ethers with a backbone 
of statistically copolymerized 80% ethylene oxide and 20% propylene oxide, a molecular 
weight of 18 000 g mol/l (PD = 1.15) and either acrylate (ACR) or isocyanate (NCO) groups 
at the distal ends of the arms (sP(EO-stat-PO)) were synthesized as described earlier [9, 10]. 
THF was dried over LiAlH4, distilled under argon, and transferred into a glove-box. 
Dexamethasone 21- phosphate disodium salt and Ampicillin sodium salt were purchased from 
Sigma Aldrich. Alexafluor 
® 
488 cadaverine sodium salt and Alexafluor 
® 
568 cadaverine 
diammonium salt were purchased from Invitrogen life technologies, Germany. 
7.3 Single layered bulk hydrogel preparation 
Pure NCO-sP(EO-stat-PO) hydrogels were prepared as reported before [7] by 
dissolution of NCO-sP(EO-stat-PO) prepolymers in deionised H2O in a concentration of 20% 
(w/v) (= 12.5mM). After thorough stirring for 60 sec to ensure complete dissolution of the 
polymer and homogeneity of the solution, the mixture was dropped into a Teflon mold of 
7. Multi-membrane hydrogels 
105 
 
diameter 15 mm and depth 3 mm and covered airtight to allow the cross-linking reaction and 
prevent vaporization of water. 
Also HA / NCO-sP(EO-stat-PO) and HA-SH / ACR-sP(EO-stat-PO) hydrogels were 
prepared according to a procedure published earlier [8]. Briefly, aqueous solutions of HA or 
HA-SH and NCO-sP(EO-stat-PO) or ACR-sP(EO-stat-PO), respectively, were mixed 
vigorously to yield a mixture with a final molar ratio of sP(EO-stat-PO) to HA equaling 
1:0.085 and a final concentration of 2.0 w/v % in the case of HA-SH / ACR-sP(EO-stat-PO) 
hydrogels and 5.0 w/v % in the case of HA / NCO-sP(EO-stat-PO) hydrogels, respectively. 
The final homogenous mixture was dropped into a Teflon mold of diameter 15 mm and depth 
3 mm and covered airtight to allow the cross-linking reaction and prevent vaporization of 
water. 
7.4 Preparation of multi-membrane hydrogels 
For preparation of multi-membrane systems, a core hydrogel is first prepared as 
described in 2.2 in a syringe where the piston is pulled backward and the front part where the 
needle is attached was removed by a razor blade. After 20 minutes, the mechanically stable 
but not yet fully cross-linked gel is removed from the mold by pushing the sliding piston up. 
The gel is immobilized on the tip of a needle and placed in the middle of a freshly prepared 
mixture of precursors for the following hydrogel layer in a bigger syringe. This procedure 
may be repeated several times with any of the three hydrogel systems until the desired number 
of membranes is achieved. After the last membrane is added, the multi-membrane gels are 
immersed in deionised water. 
7.5 Drug loading procedure 
Stock solutions of Dexamethasone 21-phosphate disodium salt and Ampicillin sodium 
salt were prepared in deionised water in concentrations of 10 mg/mL and used for the 
preparation of the hydrogels as described in section 2.2.  
Multi-membrane hydrogels prepared as described in section 2.3 where loaded with 
different drugs in separate layers. In a three layered hydrogel, the inner core layer was 
prepared with pure NCO-sP(EO-stat-PO) using 0.5 mL of a 0.4 mg/mL Dexamethasone 21-
phosphate disodium salt solution. The outer layer was prepared with the HA-SH / ACR-
sP(EO-stat-PO) system using 2.5 mL of a 1 mg/mL Ampicillin sodium salt solution.  
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7.6 Rheological analysis of the hydrogels 
Gelation point and storage modulus of the gels was determined by a dynamic time 
sweep test using Rheometrics-dynamic stress rheometer with a 25mm flat plate geometer for a 
sample thickness of 1mm at a frequency of 6.3 (rad/s) at room temperature. Storage modulus 
(G’) and loss modulus (G”) were monitored over time and the gelation point was determined 
to be the point where G’=G”. Increase of G’ was followed until a plateau was reached at 
completed cross-linking of the gel. This value was taken as storage modulus of the respective 
hydrogel. 
7.7 Drug release study 
The freshly prepared gels after complete cross-linking were incubated in deionised 
water. After certain interval of time the incubated medium was removed and analysed in UV-
spectrophotometer for the presence of drug. The gels were replenished again with fresh 
deionised water and analyzed till to the lower detectable limit of the UV spectrophotometer. 
 
7.8 Results and Discussions 
Four arm star shaped poly ethylene glycol (PEG) molecules have been introduced in 
the literature as versatile building blocks for the preparation of hydrogels by Hubbell et al. 
and since then been used by many groups with a variety of functional endgroups such as 
thiols, vinyl sulfones, carboxylates and amines to form hydrogels. It has been already 
described the use of isocyanate terminated six armed star shaped polyethylene glycol based 
prepolymers (NCO-sP(EO-stat-PO)) as functional alternative for the preparation of hydrogels. 
Water solubility of the molecules as well as reactivity towards water by hydrolysis of 
isocyanates to amines and subsequent reaction of those amines with isocyanates to urethanes 
enables hydrogel formation by dissolution in water without an additional component to 
mechanically stable, macroporous hydrogels [7]. We have also shown the use of NCO-sP(EO-
stat-PO) and the corresponding molecules with acrylate groups at the distal ends of the arms 
(ACR-sP(EO-stat-PO)) as functional cross-linkers to unmodified (HA) and thiol modified 
hyaluronic acid (HA-SH), respectively, and showed characterization of the resulting 
hydrogels regarding stability, swelling behaviour, hydrolytic and enzymatic degradation and 
mechanical strength in chapter 3 & 4 [8]. Briefly, isocyanates react with the hydroxyl groups 
of HA forming hydrogels covalently cross-linked by hydrolytically stable urethane bonds. As 
described above, cross-linking between the PEG-based prepolymers also occurs as kinetically 
7. Multi-membrane hydrogels 
107 
 
and stoichiometrically unfavoured side reaction. Hence, the resulting gels are stable against 
hydrolysis and only partially degradable by hyaluronidase. Acrylate functional star polymers 
in contrast cannot react with each other directly, so that hydrogel formation exclusively takes 
place through Michael-type addition between the thiol groups of HA-SH and the acrylate 
groups in ACR-sP(EO-stat-PO). As the acrylate groups are linked to the polymer via ester 
bonds, these hydrogels are hydrolytically labile and degrade by time in PBS buffer (pH = 7.4) 
with a kinetics that is correlated with the crosslinking density [8].  
Here we combine these different hydrogels to a robust platform for the preparation of 
chemically diverse, covalently linked multi-layered hydrogels using a layer-by-layer 
approach. For that, hydrogel compositions (molar ratios between the components and 
concentration in water) were chosen for each of the systems so that the equilibrium water 
content of the hydrogels is comparable, while the storage modulus of the gels covers a range 
from 6 to 24 kPa (Table 1). This allows certain flexibility in adjusting the mechanical strength 
of the hydrogel, while the overall water content and thus the speed of diffusion processes 
remains constant. As the isocyanate groups of NCO-sP(EO-stat-PO) are reactive towards 
alcohols and thiols, covalent cross-linking between the separate layers can be achieved.  
 
Table 1: Equilibrium water content (EWC), gel time and storage modulus of the single layer 
hydrogels NCO-sP(EO-stat-PO) (20 w/v %), ACR-sP(EO-stat-PO) / HA-SH (molar ratio 1: 
0.085; Mw of HA-SH = 150000 g/Mol) and NCO-sP(EO-stat-PO) / HA (molar ratio 1: 0.085; 
Mw of HA = 150000 g/Mol). All measurements were done in triplets.  
 EWC  
(wt%) 
Gelation point 
(sec) 
Storage modulus  
(G’, kPa) 
ACR-sP(EO-stat-PO) / HA-SH 
NCO-sP(EO-stat-PO) 
NCO-sP(EO-stat-PO) / HA 
94.0 ± 0.6 
94.4 ± 0.2 
97.3 ± 0.2 
320 ± 5 
410 ± 10 
740 ±15 
6.3 ± 0.2 
23.7 ± 0.7 
10.5 ± 0.8 
 
Therefore, the hydrogel layers have to be prepared onto each other after the gelation 
point, meaning the point at which the gel-forming solution solidifies, but before the cross-
linking is complete and the reactive isocyanate groups are hydrolysed. Gelation points of the 
three systems are given in Table 1 and vary between 5 and 13 minutes. Pure NCO-sP(EO-stat-
PO) based hydrogels exhibit the fastest cross-linking and reach a plateau in G’ after 50 
minutes. Accordingly, a general gel preparation routine can be derived in which at first, the 
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central hydrogel is prepared in a mold. After 20 minutes this gel will be solidified but not yet 
completely cross-linked, so that it can be immersed into a mixed precursor solution for the 
subsequent layer. Practically this can be done in a simple manner as schematically shown in 
Scheme 1 by pinning the gel onto a needle to place it inside the gel-forming solution for the 
next layer. This process can now be repeated every 20 minutes to build up a multi-layer 
hydrogel system. Importantly, any variation of the hydrogel chemistry between the three 
systems described above is possible with covalent attachment between the layers. 
 
Scheme 1: Preparation of multi-membrane hydrogels by sequential gel formation around the 
pre-formed inner-part. Each gel-layer is allowed to solidify for 20 minutes, is subsequently 
pinned on a needle and transferred into a bigger mold to which the mixed precursor solution 
for the following layer is added.  
 
This general preparation method can be used to generate multi-membrane hydrogels. 
Figure 1 presents some examples for three layered hydrogels that have been prepared 
accordingly. In all cases, gel preparation was finished within 60 minutes up to a point where 
the gels are stable and can for example be transferred to other solutions or media. As the 
modulus of the different gels is significantly different, it is possible to selectively remove a 
part of the outer membrane for better visualization of the onion-like structure (Figure 1a). 
Importantly, the covalent attachment between the layers and the similar equilibrium water 
content ensures that the multi-layer systems can swell to equilibrium without breaking as 
demonstrated in Figure 1b. For better visualisation and in order to check whether covalently 
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linked molecules remain in the distinct hydrogel layers or at least partially diffuse out of the 
gels, a three layered gel was prepared in which the core membrane and the middle layer were 
covalently labelled with amino functional Alexa Fluor 568 and 488, respectively, while the 
outer membrane was not labelled. For labelling ACR-sP(EO-stat-PO), the dye was added to 
the aqueous prepolymer solution 2 hours before HA-SH. Reaction of the dye with NCO-
sP(EO-stat-PO) is ensured due to the much higher reactivity of amines towards isocyanates 
that water. Figure 1d shows the three steps in gel preparation. The core membrane and the two 
layer system are shown after 20 minutes of preparation after being taken out of the mold in 
which they were prepared to demonstrate the mechanical stability of the gels 20 minutes after 
mixing of the precursor solutions. The final three layer system was stored in water for 7 days 
without leakage of flurescent dye. The light greenish color of the outer membrane in Figure 
1d originates from scattered light of the second membrane. However, after incubation over 
longer time periods and especially when the gel is stored in the slightly basic PBS buffer (pH 
= 7.4), the ester groups of ACR-sP(EO-stat-PO) are degrading over time with full degradation 
in PBS after 11 weeks [8]. This demonstrates the advantage of a possible chemically 
heterogeneous multi-membrane hydrogel. Non degradable, partially degradable and fully 
degradable hydrogels can be added onto each other in an application-driven manner. 
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Figure 1: Multi-membrane hydrogels. a) Three layer system with NCO-sP(EO-stat-PO) / HA 
core, ACR-sP(EO-stat-PO) / HA-SH as middle layer and NCO-sP(EO-stat-PO) as outer layer. 
The outer layer is partially removed for better visualization. A comparison of the system 
before (b) and after (c) swelling demonstrates that the multi-layer gels remain intact after 
swelling to EWC (the black scale bar is valid for (b) and (c)). Panel (d) shows subsequent 
steps of a three layer gel preparation using fluorescent dyes for visualization with Alexafluor 
® 
568 cadaverine diammonium salt-labelled ACR-sP(EO-stat-PO) / HA-SH as core, 
Alexafluor 
® 
488 cadaverine sodium salt-labelled NCO-sP(EO-stat-PO) / HA as middle layer 
and NCO-sP(EO-stat-PO) as outer membrane. No dye leakage was observed during 
incubation of the gels in water for 1 week. The red scale bar is valid for (d) only. 
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One possible application is the preparation of systems that release multiple drugs in a 
consecutive way based on simple diffusion-mediated release without the need for chemical 
modification of the drugs. In order to evaluate whether gel preparation in the presence of 
drugs is possible and to which extent the embedded drugs are release, single-layer hydrogels 
of ACR-sP(EO-stat-PO) and NCO-sP(EO-stat-PO) were prepared with Ampicillin and 
Dexamethasone supplemented in the gelating solution, respectively. Ampicillin, a broadly 
applicable antibiotic, and Dexamethasone, a widely used anti-inflammatory drug, are only 
model drugs to demonstrate the possibility to achieve consecutive drug release from multi-
layer hydrogels. Drug release from the single layer hydrogels was studied using UV/Vis 
spectroscopy through medium exchange after the timepoints shown in Figure 2 (a, b). The 
curves show typical diffusion controlled release with a total cumulative drug release of more 
than 95% in both cases. This demonstrates that covalent binding of Dexamethasone, which 
bears a primary and a secondary alcohol group, to the isocyanate groups of NCO-sP(EO-stat-
PO), and Ampicillin, which bears an amino group, to the acrylate groups of ACR-sP(EO-stat-
PO), only occurs to a minor extent and can be negelcted. In both cases, the molar shortcut of 
the drug towards the competing reactive groups (water in the case of Dexamethasone and 
thiols from HA-SH in the case of Ampicillin) is an important factor, especially for 
Dexamethasone. In case of the Ampicillin, the reaction conditions at neutral pH strongly favor 
Michael addition between the thiols and acrylates due to protonation of the amine groups. 
Ampicillin is release about twice as fast from ACR-sP(EO-stat-PO) as Dexamethasone from 
NCO-sP(EO-stat-PO). We hypothesize that the NCO-sP(EO-stat-PO) hydrogels can retain 
Dexamethasone longer due to hydrogen-bridge formation between the urea- and amino groups 
of the hydrogel and the drug. However, almost compete drug release is accomplished in both 
cases. 
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Figure 2: Release of Ampicillin from the ACR-sP(EO-stat-PO) / HA-SH hydrogel (a) and 
release of Dexamethasone from the NCO-sP(EO-stat-PO) hydrogel follow simple second 
order release kinetics as expected for diffusion controlled release. When a three-layered 
hydrogel is prepared with a Dexamethasone loaded NCO-sP(EO-stat-PO) hydrogel as core, a 
non-loaded NCO-sP(EO-stat-PO) membrane in the middle and an Ampicillin-loaded ACR-
sP(EO-stat-PO) / HA-SH layer as outer membrane, the kinetics can be tuned for successive 
release of the two drugs (c). Release is plotted cumulative in per-cent against hours. 
 
Based on these experiments, a three layered system was prepared with a 
Dexamethasone loaded NCO-sP(EO-stat-PO) hydrogel as core, a non-loaded NCO-sP(EO-
stat-PO) hydrogel membrane as diffusion barrier in the middle and an Ampicillin-loaded 
ACR-sP(EO-stat-PO) / HA-SH hydrogel layer as outer membrane. Depending on the 
thickness of the non-loaded middle membrane and the drug concentrations, the release 
kinetics can be tuned for successive release of the two drugs. As depicted in Figure 2c, 
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Ampicillin is completely released (Phase I) before onset of Dexamethasone release (Phase II). 
Due to the significantly larger Volume of the outer membrane in comparison to the core 
membrane, more drug can be loaded in the outer membrane, so that the amount fo drug 
release first is higher. Moreover, in order to achieve such a sharp and complete separation 
between the release phases of the two drugs as depicted in Figure 2c, the amount of drug in 
the core gel has to be significantly smaller than the amount of drug in the outer membrane. 
Here, 2.5 mg of Ampicillin sodium salt were loeaded in the outer membrane, while 0.2 mg 
Dexamethasone 21-phosphate disodium salt were embedded in the core membrane.  
 
7.9 Conclusion and Outlook 
In this chapter we have shown the possibility to construct covalently linked multi-
layer hydrogels based on artificial functional prepolymers and hyaluronic acid through a 
sequential encapsulation technique. This system does not require external stimuli for cross-
linking with a preparation time of 20 minutes per hydrogel layer. Hydrogel preparation is easy 
and robust, without the need for complex methodology or instrumentation. We have shown 
that covalent immobilization of molecules is possible in the gels, and that embedding and 
release of drugs can be facilitated from distinct layers. This can be tuned to successive release 
of multiple drugs based on simple diffusion without the need for chemical modification of the 
drugs which is a clear advantage for application.  
Based on these proof-of-principle experiments, the system may be used with 
automatized printing systems for the generation of smaller sized multi-layered systems with 
custom made geometry. Also, encapsulation of cells in ACR-sP(EO-stat-PO) / HA-SH core 
gels and subsequent addition of a non degradable NCO-sP(EO-stat-PO) layer will be of high 
interest in biomedical applications, for example for the protected embedding of islet cells to 
treat diabetes or adult stem cells to suppress immune reaction after transplantations. 
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8. Encapsulation of cells in Hydrogels – Cell Scaffold 
 
8.1    Introduction:  
Cells in-vitro needs a substrate to have a grip to proliferate and to stay alive. Standard 
tissue-culture poly-styrene (TCPS) plates are used to multiply cells in a 2-D manner. With 
TCPS, after few days of culture, cells reach a level of confluence beyond which they cannot 
proliferate anymore. In-order to have cells in a 3-D manner, we need a 3-D material that 
serves as a natural environment for cells to adhere and proliferate [1], with its inter-connected 
porous structures facilitate the supply of nutrients and the removal of metabolic products from 
the cells and the scientific term for this 3-D material with porous structure is called scaffold. 
They are the base for tissue engineering which aims to fabricate a living replacement parts for 
the body [2]. 
 
The scaffold materials and its physical properties are selected based on the tissue of 
interest following its application. PLA and PGA are approved by FDA as scaffold materials 
that are mechanically strong and non-toxic [3]. Since they are hydrophobic in nature along 
with the severe conditions that involves like heating it to over 150°C or using toxic solvents 
like chloroform, di-chloromethane, during the fabrication of scaffold it is hard to entrap cells 
during the scaffold preparation. In order to mimic a natural ECM, we need a scaffold with its 
physical and bio-chemical properties that are more close to that of the natural ECM. Natural 
ECM has a lot of water content that keeps the cells from drying out and has several cell 
adhesion sites that attract cells to migrate and make them involve in biological processes.  
 
Hydrogels, a class of biomedical materials maintains a high water content that 
resembles the natural extra-cellular matrix. It is composed of hydrophilic polymer chains that 
are connected either by chemical or physical means that determines the stability of the 
scaffolds in the physiological environment. Hydrogels used in these applications are 
processed under relatively mild conditions, its mechanical and structural properties resembles 
that of the natural ECM and can be delivered in a minimally invasive manner [4]. 
 
A group of hydrophilic synthetic and natural polymers are being employed for the 
preparation of hydrogels. Synthetic materials include poly (ethylene oxide) (PEO) [5], poly 
(vinyl alcohol) (PVA) [6], poly (acrylic acid) (PAA) [7] and poly-peptides [8]. Synthetic 
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hydrogels are prominent for tissue engineering because their properties and chemistries are 
controllable and reproducible as synthetic polymers can be produced with required molecular 
weight, block structures, degradable linkages and the cross-linking modes [9]. These 
properties in-turn dictates the properties of the formed hydrogel in terms of its gel forming 
dynamics, cross-linking density, its degradation kinetics, its mechanical strength and its 
ability to bind other bio-active molecules. Natural polymers are more frequently used in the 
formation of tissue engineering scaffolds at they forms a part of the natural ECM or have 
macromolecular properties similar to natural ECM. Some of the natural polymers employed 
as the tissue engineering scaffold materials include agarose [10], alginate [11], chitosan [12], 
collagen [13], fibrin [14], gelatine [15], and hyaluronic acid (HA) [16]. 
 
Chapter 3, 4 and 5 shows the possibility of using NCO-sP(EO-stat-PO) and ACR-
sP(EO-stat-PO) as stabilizer for polysaccharides with hydroxyl and thiol groups on its back 
bone respectively that resulted in the formation of bulk hydrogels. In this chapter, we see the 
potential application of these hydrogels as scaffolds for two different types of cell lines 
namely, mouse connective tissue fibroblast cell line NIH L929 and human dermal fibroblasts 
P3-P6. After some days of culture, cells were tested for its viability using Live/Dead staining, 
immunological staining of the cytoskeleton followed by the DNA staining. Finally the cell 
morphology and growth were monitored by light microscopy. 
 
8.2  Materials  
  Sodium Hyaluronic acid (Hyaluronic acid sodium salt, Sodium Hyaluronate, HA) of 
molecular weights (< 0.2x10
6) ≈ 150000 g/mol, from streptococcus equi sp. was purchased 
from Dali HA Co., Ltd, (China). Thiol modified HA of molecular weight 150000 g/mol with 
degree of thiolation: 50% was purchased from Glycosan biosystems (U.S.A). Star shaped 
poly-ethers with a backbone of statistically copolymerized 80% ethylene oxide and 20% 
propylene oxide, a molecular weight of 18000 g/mol (PD = 1.15) and isocyanate (NCO) 
groups and acrylate (ACR) at the distal endings of the arms (sP(EO-stat-PO)) were 
synthesized as described earlier [17, 18].  
  Mouse connective tissue fibroblast cell line NIH L929 (DMSZ, Braunschweig, 
Germany) and human dermal Fibroblasts (hdF) (P3-P6) were applied for the cell experiments. 
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8.3  Cell culture 
Mouse connective tissue fibroblast cell line NIH L929 (DMSZ, Braunschweig, 
Germany) and human dermal Fibroblasts (hdF) (P3-P6) were applied for the cell experiments. 
Cells were cultured at 37 °C in a 5 % CO2 supplied incubator. RPMI-1460 (L929) or DMEM 
(hdF) medium supplemented with 10 % fetal bovine serum and 1 % penicillin/streptomycin 
was used. The culture medium was exchanged every two days. Cells were harvested with 
0.25 % trypsin/EDTA (all reagents purchased from PAA, Cölbe, Germany). 
 
8.4 Hydrogel preparation-Cell encapsulation 
 Solutions of HA were prepared in PBS (pH: 7.4). The respective sP(EO-stat-PO) was 
dissolved in PBS and added immediately to the aqueous HA and mixed vigorously. Before 
the hydrogel precursors gelate cells from L929 or hdF that were resuspended in PBS at a 
concentration of app. 5 mio or 2 mio cells/mL, respectively without further dilutions, 50 or 
100 µL of the cell suspension were added and stirred gently with a spatula. Volumes of the 
solutions were chosen so that the resulting mixture was obtained in the desired concentration. 
The still visuous mixture was transferred (100µL per well) into a 48-well suspension culture 
plate. After 30 min incubation at 37 °C, 750 µl of the appropriate cell culture medium were 
added to the gels. Samples were kept at 37 °C in a 5 % CO2 supplied incubator throughout the 
experiment. The medium was exchanged every two days. 
 
8.5 Cell culture on PEG electrospun fibres – encapsulated in hydrogel 
Prior to the cell culture experiments the glass substrates with the attached fibers were 
transferred into a 24-well suspension culture plate (Greiner Bio-One, Frickenhausen, 
Germany) and rinsed three times with sterile water and subsequently three times with PBS. 
For the cultivation experiments with L929, 1.5 mL of a 50,000 cells/mL suspension in RPMI 
medium were used; for the cultivation experiments with hdFs 1.5 ml of a 25,000 cells /ml 
suspension in DMEM medium were used. Samples were kept at 37 °C in a 5 % CO2 supplied 
incubator for 24 h. 
After 24 h cultivation time the medium was removed and the samples were rinsed 
once with PBS. 100 µL of the gel mixture were added immediately without letting the 
samples fall dry. After 30 min incubation at 37 °C, 750 µL of cell culture medium were added 
to the gels. Samples were kept at 37 °C in a 5 % CO2 supplied incubator throughout the 
experiment. The medium was exchanged every two days. 
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8.6 Viability Staining 
Viability staining of the cells was carried out according to protocol with the Live/Dead 
Staining kit (Invitrogen, Oregon, USA). Briefly, after removing the culture medium from the 
samples and two rinsing steps with buffer, the samples were covered with the staining 
solution. Images were taken after 30 min incubation at 37 °C in the dark. 
 
8.7 Immunological staining 
For immunological staining of the cytoskeleton, cells were fixed in 4.0 % 
formaldehyde, pH 7 (Carl Roth, Karlsruhe, Germany), permeabilized with 0.1 % Triton X-
100 (Sigma-Aldrich Chemie, Munich, Germany) and blocked in 1 % BSA (Servia 
Electrophoresis, Heidelberg, Germany) in PBS. Samples were incubated with 
tetramethylrhodamine isothiocyanate (TRICT)-conjugated phalloidin (1:500) for 30-45 min,  
followed by DNA staining with 4’6-diamidino-2-phenylindole (DAPI) (1:1000) for 5 min 
(Chemicon, Schwalbach, Germany). 
 
8.8 Optical and Fluorescence Microscopy 
Cell morphology and growth were monitored by light microscopy using an inverted 
Axiovert 100A Imaging microscope (Carl Zeiss, Goettingen, Germany), equipped with 
fluorescent filter sets 43HE, 10 and 49. Pictures were taken using an AxioCam MRm digital 
camera and analyzed using the AxioVisionV4.7/V4.8 software package. 
 
8.9  Results and Discussions 
  Hydrogels as tissue engineering scaffold is not a new story to tell but there are new 
methods that are being invented to prepare an easy method of doing it with several advantages 
over the other methods. We present in this work, the possibility of biofunctionalisation and 
cell encapsulation, both during the hydrogel preparation which is a highly advantageous 
method over other methods. The type of hydrogels used in this study is a combination of 
NCO-sP(EO-stat-PO) / HA and ACR-sP(EO-stat-PO) / HS-HA. The cross-linking chemistries 
of these two different hydrogels are already discussed in chapter 4 and 5. 
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Fig. 1 L/D staining pictures of mouse connective tissue fibroblast cell line NIH L929 
encapsulated inside NCO-sP(EO-stat-PO) / HA hydrogels without peptide sequence. 
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Fig. 2 L/D staining pictures of mouse connective tissue fibroblast cell line NIH L929 
encapsulated inside ACR-sP(EO-stat-PO) / HS-HA hydrogels with and without peptide 
sequence. 
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Fig. 3 L/D staining pictures of human dermal Fibroblasts (hdF) (P3-P6) encapsulated inside 
ACR-sP(EO-stat-PO) / HS-HA hydrogels at the end of day 10 (A) with RGDC peptide 
sequence and (B) without peptide sequence. (C & D) hdF adhered to PLGA-NCOsPEG-fibres 
containing GRGD covered by ACR-sP(EO-stat-PO) / HS-HA hydrogels at the end of day 7. 
 
8.10  Conclusions 
  
The results shows that the hydrogel made of NCO-sP(EO-stat-PO) / HA is not the best 
environment for the cells to live. The Isocyanate stuff in this hydrogel combination proves to 
be toxic to cells, as the cells were added during the hydrogel synthesis and this combination 
of hydrogel precursor needs atleast 10 minutes to cross-link to form solid hydrogel. On the 
otherhand ACR-sP(EO-stat-PO) / HS-HA combination of hydrogel precursor seems to work 
well as an artificial environment to the cells. Even after 4 days of culture, this hydrogel 
combination with and without peptide sequence houses the cells as that of its natural 
environment. As an alternative to hydrogel alone as scaffolds to cells, we tried 
A 
A 
B 
c D 
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electrospunning PLGA-NCO-sPEG fibres with GRGD peptide sequence, after complete 
cross-linking, we covered the electro-spun fibres with ACR-SP(EO-stat-PO) / HS-HA 
hydrogels with cells encapsulated. Even after  7 days of culture, cells were attaching to the 
peptide sequence sites and looks healthy. This shows that ACR-SP(EO-stat-PO) / HS-HA 
hydrogels alone or with the combination of PLGA-NCO-sPEG with peptide sequence seems 
to accomodate cells and provide a shelter to it as that of its natural environment. 
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A1:  Preparation of hydrogels (free form hydrogels) 
 Procedure for the preparation of three types of hydrogel systems studied in this thesis is presented here. 
 
Hydrogel system-1:  
 
Materials  
NCO-sP(EO-stat-PO) (Mw: 18000 g/mol) 
Glass vials (5ml)  
Spatula 
Deionised water 
Teflon mold 
  
Procedure 
Dissolve NCO-sP(EO-stat-PO) in seral water of concentrations 5%, 7.5%, 10% and 20% (w/v) and drop 
in to the Teflon of diameter 15mm and depth 3mm covered air tight to allow the cross-linking reaction 
for 24 hours. 
 
Hydrogel system-2:  
 
 Materials 
Unmodified Hyaluronic acid (HA) of different molecular weights (53kDa, 150kDa, 400kDa, 700kDa, 
1750kDa) 
 NCO-sP(O-stat-PO) (Mw: 18000 g/mol) 
 Glass vials (5ml) 
 Spatula 
 Deionised water 
 Teflon mold 
 
 Procedure 
Aqueous HA of concentration x % (w/v) higher than the desired (end) concentration, (see Table I), was 
prepared in deionised H2O. The NCO-sP(EO-stat-PO) was dissolved in certain amount of deionised 
H2O and added immediately to the aqueous HA in the molar ratios of NCO-sP(EO-stat-PO) to HA (see 
Table I) and mixed vigorously, so that the end mixture turns to the desired concentration. The final 
homogenous mixture was dropped in to a Teflon mold of diameter 15 mm and depth 3 mm, covered 
airtight to allow the cross-linking reaction for 24 hours. 
  Table I: Molar ratios of NCO-sP(EO-stat-PO) to HA 
53000 g/mol 
Conc. 8% (w/v) 
X=2% 
150000 g/mol 
Conc. 5% (w/v) 
X=1.25% 
400000 g/mol 
Conc. 5% (w/v) 
X= 1.25% 
700000 g/mol 
Conc. 3% (w/v) 
X= 0.75% 
1750000 g/mol 
Conc. 2% (w/v) 
X=0.5% 
1: 0.03a
 
1: 0.0106a 1: 0.004a
 
1: 0.0023a
 
1: 0.0009a 
1: 0.06b
 
1: 0.021b
 
1: 0.008b
 
1: 0.0045b
 
1: 0.00179b
 
1: 0.120c
 
1: 0.042c
 
1: 0.016c
 
1: 0.009c
 
1: 0.00359c
 
1: 0.241
d 
1: 0.085d
 
1: 0.032d
 
1: 0.018
*
d 1: 0.00719
*
d
 
1: 0.482
*
e
 
1: 0.17
*
e
 
1: 0.064
*
e
 
1: 0.036
*
e
 
1: 0.01438
*
e
 
a, b, c, d and e corresponds to 8, 16, 32, 64 and 128 HA monomer repeating units / sP(EO-stat-PO) 
prepolymers molecule respectively or in simple workds a, b, c, d and e corresponds to 100%, 50%, 
25%, 12.5% and 6.25% of cross-linking (* indicates no gelation.) 
 
Hydrogel system-3:  
 
 Materials 
 Thiol modified Hyaluronic acid of different molecular weights (150kDa) 
 Acr-sP(O-stat-PO) (Mw: 18000 g/mol) 
Glass vials (5ml) 
 Spatula 
 Deionised water 
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 Teflon mold 
 Procedure 
Aqueous HA of concentration x % (w/v) higher than the desired (end) concentration, (see Table I), was 
prepared in deionised H2O. The sP(EO-stat-PO) was dissolved in certain amount of deionised H2O and 
added immediately to the aqueous HA in the molar ratios of sP(EO-stat-PO) to HA (see Table II) and 
mixed vigorously, so that the end mixture turns to the desired concentration. The final homogenous 
mixture was dropped in to a Teflon mold of diameter 15 mm and depth 3 mm, covered airtight to allow 
the cross-linking reaction for 24 hours. 
 
  Table II: Molar ratios of sP(EO-stat-PO) to HA 
150000 g/mol (unmodified HA)           
Conc. 5% (w/v) X=1.25% 
1: 0.0106a 
1: 0.021b
 
1: 0.042c
 
1: 0.085d
 
1: 0.17
*
e
 
1: 0.34
*
f
 
a, b, c, d, e and f corresponds to 8, 16, 32, 64, 128 and 256 HA monomer repeating units / sP(EO-stat-
PO) prepolymers molecule respectively.  (* indicates no gelation.) 
 
A1a: Hydrogels in constricted environment 
o This type of preparation protects hydrogels from free swelling 
o Here we use a silicon tube with one end opened and the other closed for the restricted contact 
of water with the hydrogels. 
 
Materials 
Hydrogel precursors 
Glass vials 
Silicon tube 
Insulin syringe 
 
 
 
Procedure 
Mix the hydrogel precursors in the compostion as given in appendix A1 as required and take it in a 
insulin syringe. Hit the silicon stocking as shown above correctly to and release the hydrogel mixtures 
(prior to gelation) in to the silicon tubes. 
 
A2:  Swelling experiments of hydrogels 
o Swelling experiments gives the swelling kinetics (swelling ratios) and the water content of the 
hydrogels at any time till it reaches its equilibrium state. Swelling ratios are measured by the 
swollen weight (Ws) divided by the dry weight (Wd) 
o The swelling ratios are measured by weighing balance 
o The calculated swelling ratios will allow us to compare the different gels prepared by varying 
the molar ratios of cross-linker:HA and by varying the molecular weight of HA 
 
Materials 
Hydrogel samples 
Weighing balance 
Weights boats 
 
Procedure 
After complete cross-linking, the hydrogel samples were completely dried by a vacuum chamber till no 
further change in the mass of the dry gel. Measure its dry weight by the weighing balance. Place the dry 
gel in abundant of deionised water and try measuring its swelling weight at certain interval of time till 
no further change in the mass of the swollen gel. Calculate the swelling ratios by dividing the swollen 
weight by its dry weight. 
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A3:  Sample preparation for FTIR and RAMAN spectroscopy 
Dry the hydrogel samples completely without any fraction of water to avoid disturbances in the 
sepectroscopy peaks. 
 
A4:  Contact angle measurement by goniometer 
o Contact angle measurement gives the surface wettability of the samples being tested 
o For materials like hydrogels, captive bubble method of measuring the contact angle is more 
suitable, as with this method, the samples being tested is in water that avoids the sample being 
dried out. 
o By measuring the contact angle, it allows us to compare the materials formed by different 
cross-linking ratios, in terms of how hydrophilic the surface is. 
 
Materials 
Hydrogel samples 
Goniomter 
Sample holder for hydrogels 
Deionised water 
 
 
Procedure 
After complete cross-linking, the hydrogel samples were completely dried by a vacuum chamber and 
allowed to swell to its equilibrium state. The fully swollen samples were placed in the sample holder as 
shown here and fixed upside down so that the hydrogel sample hangs without falling down. An air 
bubble is made by a needle in such a way that the air bubble as shown above hanging from the hydrogel 
sample surface. Now measure the angle by which the air bubble makes contact with the hydrogel 
surface. 
 
A5:  Differential scanning calorimetry (DSC) 
o DSC is performed to study the classification of water that is present in the hydrogels.   
o There are two broad classes of water, free water and bound water.  
o DSC makes the possibility to measure the free water by which the bound water can be 
calculated by subtracting the free water from the total water content that is measured from 
swelling experiments. 
 
Materials 
Fully swollen hydrogel samples 
Aluminium pans  
Netzsch DSC 204 (Instrument) 
Liquid nitrogen to run the experiment 
 
Procedure 
Take a small swollen hydrogel sample of mass 4 to 6 mg and put it in an aluminium pan closed air tight. 
Place the close aluminium pan with the swollen sample in to the instrument together with an empty 
aluminium pan as reference. Cool down the sample to -40 degrees to freeze the water inside the 
hydrogel, with the cooling rate of 10° per minute using the liquid nitrogen. Stay at -40° for a minute and 
start heating the sample to +40° at a heating rate of 10°. When the temperature reaches 0° the water 
inside the hydrogel (assuming this is the free water inside the hydrogel) starts to melt and we a get a 
peak. The peak is the result of the energy dissipated during the melting of the water (melting enthalpy) 
(Ref: Figure I). Try measuring the area under the peak using the software provided with the instrument. 
It is known from literature that the melting enthalpy of ice is 333.5 J/g. By dividing the enthalpy 
measured for the sample by the enthalpy of ice, gives the free water content of the sample. Bound water 
content can be measured by subtracting the free water from the total water content measured by the 
swelling experiment.   
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Figure I: Area under the peak gives the enthalpy measured from the melting of the free water content. 
 
 
 
 
A6: Cryo-FESEM 
o Cryo-FESEM shows the internal micro porous structure of the hydrogels. 
o From the pore size measured, it is possible to compare the hydrogels prepared from different 
composition. Because pores are the spaces that are between cross-linking points. Therefore 
pore size decreases with increase in the cross-linking density and vice-versa. 
 
Materials 
Swollen hydrogel samples 
Cryo-FESEM sample holder 
Hitachi S-4800 (Instrument) 
Liquid nitrogen 
  
 
Procedure 
A small piece of the swollen sample is fixed in to the sample holder. Shock-freeze the sample using 
liquid nitrogen to -140°C cut a small portion of the gel by a scalper and placed it inside the instrument 
under vacuum. The sample is imaged at 1.5kV. 
 
A7: Rheological analysis 
o Rheology is performed to study the starting point of gelation and its shear modulus at any 
point till the sample is completely cross-linked. 
o With this data, it is possible to compare hydrogels prepared with different cross-linking 
densities. 
o Cross-linking densities determines how fast the material gelates and its mechanical strength. 
 
Materials 
Hydrogel precursors ready before 
mixing. 
Rheometer 
Moving parts of the rheometer of 
diameter 25 mm. 
 
 
Procedure 
Mix the hydrogel precursors and mix vigorously and place it between the two moving plates kept at a 
distance of 1mm (gap) of the rheometer. Measure the time required from the point of mixing to the 
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point when it is kept between the moving parts of the rheometer and the measurement is started (Dead 
time).  
The parameters given to the rheometer are as follows: 
Frequency of rotation of the moving part: 6.2832 (rad/s) 
Stress applied: 0.3197 Pascal (auto stress adjustment mode) 
Temperature: 23°C (Room temperature) 
Time per measurement: 10seconds 
Once the measurement is started, and before the cross-linking starts, the viscous modulus is higher than 
the shear modulus and when the shear modulus equals the viscous modulus, it indicates the starting 
point of gelation. Add this time to the dead time and that gives the time required for the starting of the 
gelation. The end of gelation is confirmed when the shear modulus reaches a plateau as shown above. 
 
A8: Stability test in PBS (pH: 7.4, at 37°C) 
o This test is done to see how stable the gel is in physiological condition over time. 
o A decrease in the gel mass indicates that the fraction of the gel that is weakly bounded with the 
gel comes out of the gel slowly. 
 
Materials 
Hydrogel samples 
Weighing balance 
PBS (pH: 7.4) 
Incubator to maintain the temperature 
Small glass vials with cover 
Shaker 
 
Procedure 
Place the dry gels in PBS till the samples reach the equilibrium swelling condition. Measure its swollen 
weight (Wi). Now place the swollen samples in fresh PBS in a closed glass vial in the incubator. Try 
measuring the weight of the sample at certain interval of time (Wf). The percentage of degradation is 
measured by [(Wi - Wf) / Wi] x 100 
 
A9:  Enzymatic degradation study 
o This test is done to see how fast the gel degrades in the presence of hyaluronic acid specific 
enzyme- Hyaluronidase 
o This test was done in three different concentration of the hyaluronidase 
Materials 
Swollen hydrogel samples 
Hyaluronidase enzyme 
PBS (pH: 5.4) 
Shaker 
Incubator to maintain the temperature 
Weighing balance 
 
Procedure 
Swollen hydrogel samples were cut in to small sizes of dimensions (5x5x3mm) placed in PBS buffer 
(137 mM NacL, 2.7 mM KCl and 10 mM phosphate buffered saline) in a 24 well plates. Measure its 
swollen weight. Now prepare the hyaluronidase solution in PBS in different concentrations of 5, 50 and 
500 U/ml. Add 1ml of the freshly prepared hyaluronidase solution of different concentrations separately 
to the swollen hydrogel samples in 24 well plates and incubated at 37°C with mild shaking. The gels 
were weighed at certain interval of time and replenished with fresh solution of hyaluronidase till there is 
no further decrease in the gel mass is observed.  
 
A10: Quantification of drug delivered by UV-Spectrophotometer 
o This is done to measure the amount or the concentration of drug delivered from the hydrogels 
at certain interval of time 
o To do this, first a calibration curve is made with known concentrations of the model drug 
(Dexamethasone 21 phosphate disodium salt) in deionised water. 
 
Materials 
Hydrogel precursors 
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Dexamethasone 21 phosphate disodium salt 
Plastic cuvettes of volume 1ml 
UV-visible spectrophotometer 
 
Calibration curve for Dexamthasone 21 phosphate disodium salt 
 
 
 
 
 
 
 
X corresponds to the concentration (mg/ml) 
 
Y corresponds to the intensity 
Procedure 
Prepare the hydrogels as per the procedure given in appendix A1 together with certain 
amount of dexamethasone 21 phosphate disodium salt. After complete cross-linking, 
place the gel in 6 well plates and add 5ml of deionised water to swell the gels. Remove 
the water completely at a regular interval of time and adjust the volume to 5ml by 
adding the required amount of deionised water (as gels take some amount of water 
during swelling) and measure the amount of drug inside the water by the UV-visible 
spectrophotometer using the 1ml plastic cuvettes. The spectrophotometer gives the 
intensity, and use the calibration curve equation to find the concentration of the 
corresponding intensity. 
 
A11: Flory-Rehner Calculation 
 
Mw of Hyaluronic Acid: 1650000 g/mol. 
Number of repeating units n = 4115 
Concentration:  2% (w/v) 
 
 
The things that can be calculated from Flory-Rehner equations are 
1) Molecular weight between cross-links (Mc) 
2) Effective crosslink density (υe) 
3) Swollen hydrogel mesh size (ξ) 
 
Qv 
5/3
 = (υMc / V1) x (0.5 – χ) 
 
Qv       Volumetric swelling ratio 
υ specific volume of the dry polymer (0.512 cm3 g-1)     [1] 
Mc average molecular weight between cross links (g/mol) 
V1 molar volume of the solvent (18 mol/cm
3
 for water)     [2] 
χ Flory polymer interaction parameter (0.473)     [2] 
 
Qv = 1 +  ρp/ ρs x (QM -1) 
ρp  density of the dry polymer (1.229 g/cm
3
)      [2] 
ρs density of the solvent (1 g/cm
3
)       [2] 
QM hydrogel swelling ratio based on mass (determined experimentally) 
υe = ρp / Mc 
ξ = Qv
1/3
 (ro
2
) 
½ 
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(ro
2
/ 2n) 
½
  = 2.4 nm 
n number of disaccharide repeat units for HA 
  in our case it is 4115 
therefore (ro
2
) 
½ 
 = 217.42 nm 
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100 % cross-linking (Molar ratio of StarPEG to HA of 1: 0.001) Method 2 of mixing 
 
Qv  = 1 + (1.229/1) x (18.301 – 1) 
Qv = 22.26 (no units) 
 
Qv 
5/3
 =  υMc / V1 x (0.5 – χ) 
(22.26)
5/3
 = (0.512 Mc /18) x (0.5- 0.473) 
180 = 0.028 Mc x 0.027 
Mc = 2.34 x 10
5 
g/mol 
 
υe =  ρp / Mc 
    = 1.229 / 2.34 x 10
5 
υe = 5.24 x 10
-6
 mol/cm
3
 
 
ξ = Qv
1/3
 (ro
2
) 
½ 
   = (22.26)
1/3
 217.72 
ξ = 611.82 nm 
 
50 % cross-linking (Molar ratio of StarPEG to HA of 1: 0.002) Method 2 of mixing 
 
Qv  = 1 + (1.229/1) x (38.301 – 1) 
Qv = 46.84 (no units) 
 
Qv 
5/3
 =  υMc / V1 x (0.5 – χ) 
(46.84)
5/3
 = (0.512 Mc /18) x (0.5- 0.473) 
614.49 = 0.028 Mc x 0.027 
Mc = 8 x 10
5 
g/mol 
 
υe =  ρp / Mc 
    = 1.229 / 8 x 10
5 
υe = 1.53 x 10
-6
 mol/cm
3
 
 
ξ = Qv
1/3
 (ro
2
) 
½ 
   = (46.84)
1/3
 217.72 
ξ = 783.81 nm 
  
25 % cross-linking (Molar ratio of StarPEG to HA of 1: 0.004) Method 2 of mixing 
 
Qv  = 1 + (1.229/1) x (67.33 – 1) 
Qv = 82.51 (no units) 
 
Qv 
5/3
 =  υMc / V1 x (0.5 – χ) 
(82.51)
5/3
 = (0.512 Mc /18) x (0.5- 0.473) 
1586.96   = 0.028 Mc x 0.027 
Mc = 20.66 x 10
5 
g/mol 
 
υe =  ρp / Mc 
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    = 1.229 / 20.66 x 10
5 
υe = 0.594 x 10
-6
 mol/cm
3
 
ξ = Qv
1/3
 (ro
2
) 
½ 
   = (82.51)
1/3
 217.72 
ξ = 946.44 nm 
 
 
Summary: 
 
(method 2 of mixing) 
% of crosslinking/ molar ratio 
of StarPEG to HA 
Qm Qv Mc 
(g/mol) 
υe (mol/cm
3
) ξ 
(nm) 
25 / 1: 0.004 67.33 ± 6.85 82.51 20.66 x 10
5
 0.594 x 10
-6 
946.44 
50 / 1: 0.002 38.30 ± 9.15 46.84 8 x 10
5
 1.53 x 10
-6 
783.81 
100 / 1: 0.001 18.30 ± 0.0 22.26 2.34 x 10
5
 5.24 x 10
-6 
611.82 
 
A12: Diffusion Coefficient of Dexamethasone 21 phosphate disodium salt from Acr-
sP(EO-stat-PO)-HA(SH) hydrogels. 
 
Shape of the hydrogel used for drug release: 
          
                             
 
Volume of the cylinder (V)  = 1.134 x 10
-6
 m
3
 
Surface area of the cylinder (A) = 8.058 x 10
-4
 m
2 
Molecular weight of Dexamethasone-21 phosphate disodium salt = 516.40 g/mol. 
 
Mathematical equation used to calculate diffusion co-efficient of Dexamethasone 21 phosphate disodium salt 
is 
 
                     Mt / A = (2DCs Co t) 
1/2 
     for Co >> Cs ……………1 
 
Where Mt = Amount of drug released during time t 
            A  = Surface area of the drug carrier, in our case it is hydrogel sample 
            Cs  = Solubility of drug in polymer (amount of drug per unit volume of         
                        gel in mol/m
3 )  ……………………………………………. 2 
            Co  = Initial drug concentration in the gel (mol /m
3
) 
   D  = Diffusion coefficient. (A factor of proportionality representing the amount of substance 
diffusing across a unit area through a unit concentration gradient in unit time) 
 
Initial drug concentration in gel, Co = 100 mg/mL = 190 mol / m
3
  
               (1 mL = 1 cm
3
, which is equal to 1 x 10
-6 
m
3
)                                                       
0.004 m 
0.019 m 
0.0095 m 
r 
h= 
Volume of hydrogel sample = ∏ r  h 2 
Surface area of cylinder  = 2 ∏ r  h + 2 ∏ r  h 2 
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Solubility of drug in polymer, Cs = 50mg / 1.134 x 10
-6
 m
3
 = 85.36 mol / m
3
 
(Only 0.5 mL of polymer solution was used to make gel, therefore it contains only 50 mg of drug. 
In our case, Co >> Cs 
 
Number of hours (time 
is also cumulative)  
Cumulative amount of 
drug released (mg) 
1  28.67 
2  37.112 
3  40.808 
5.5  43.388 
8  45.74 
24  46.48 
30  47.154 
88.5  47.824 
145.5  48.688 
233.5  48.709 
 
The above table is the release profile of the drug from the gel, at the given time. 
 
Model calculations: 
 
1) For the first 1 hour (3600 seconds). 
The amount of drug released from the gel is 28.67 mg = 5.55 x 10
-5
mol (Mt). 
 
Diffusion coefficient calculation using equation 1 
5.55 x 10
-5 
mol / 8.058 x 10
-4
 m
2 
= (2 x D x 85.36 mol/m
3
 x 190 mol/m
3
 x 3600 sec ) 
1/2 
0.0689 = 10806.13 (D
1/2
) 
D = 0.4x10
-10 
m
2
/s 
 
2) For the second 1 hour (3600 seconds). 
The amount of drug released from the gel is 8.442 mg = 1.63 x 10
-5
mol (Mt). 
 
Diffusion coefficient calculation using equation 1 
1.63 x 10
-5 
mol / 8.058 x 10
-4
 m
2 
= (2 x D x 85.36 mol/m
3
 x 190 mol/m
3
 x 3600 sec ) 
1/2 
0.02022 = 10806.13 (D
1/2
) 
D = 0.035x10
-10 
m
2
/s. 
 
Summary 
S.No Time in 
hours 
Diffusion co-efficient 
(m
2
/s) 
1 1 0.4x10
-10 
2 1 0.035x10
-10
 
3 1 0.006x10
-10
 
4 1.5 0.002x10
-10
 
5 2.5 0.001x10
-10
 
6 16 0.001x10
-12
 
7 6 0.003x10
-12
 
8 58.5 0.0003x10
-12
 
9 57 0.00064x10
-12
 
10 88 0.00024x10
-12
 
 
  
Diffusion co-efficient is a measure of the velocity of the 
solute that travels from the region of higher 
concentration to a region of lower concentration. 
 
Here, we see that the diffusion coefficient decreases, as 
the solute concentration between the gel inside and 
outside decreases over time. 
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